Вы находитесь на странице: 1из 414

STATE REPORT

01.10.2021
ALABAMA Issue 30
SUMMARY
• Alabama is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 26th highest rate in the country.
Alabama is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 10th highest rate in the country.
• Alabama has seen a decrease in new cases but an increase in test positivity and rising hospitalizations, suggesting under-testing could be
artificially lowering case counts and hiding the ongoing significant community spread.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Jefferson County, 2. Madison County, and 3.
Mobile County. These counties represent 30.7% of new cases in Alabama.
• 99% of all counties in Alabama have moderate or high levels of community transmission (yellow, orange, or red zones), with 97% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 43% of nursing homes had at least one new resident COVID-19 case, 70% had at least one new staff
COVID-19 case, and 20% had at least one new resident COVID-19 death.
• Alabama had 475 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 42 to support operations activities from
FEMA; 1 to support operations activities from USCG; and 20 to support medical activities from VA.
• The federal government has supported surge testing in Birmingham, AL.
• Between Jan 2 - Jan 8, on average, 411 patients with confirmed COVID-19 and 148 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in Alabama. This is an increase of 9% in total new COVID-19 hospital admissions.
• As of Jan 8, 283,200 vaccine doses have been distributed to Alabama. 57,105 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-
Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating
of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• The decreasing cases are most likely related to decreased testing. Rising test positivity, number of LTCF with positive staff members, and
hospitalizations suggest significant, ongoing community spread.
• Significantly increase public mitigation and increase communication around the importance of personal mitigation with masking,
physical distancing, and avoiding family gatherings.
• Ensure aggressive, proactive testing as many more individuals may be asymptomatic and actively spreading virus in the community.
• All K-12 teachers and older students, community colleges, and universities should require weekly testing, as it dramatically decreases
COVID-19 viral spread by identifying and isolating the asymptomatic individuals, as well as symptomatic individuals, and allows for
contact tracing.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

ALABAMA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 23,298 401,743 1,744,828


-16%
(RATE PER 100,000) (475) (600) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
20.1% +1.8%* 16.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 85,895** 1,521,048** 9,104,878**


-8%**
(TESTS PER 100,000) (1,752**) (2,273**) (2,774**)

COVID-19 DEATHS 319 3,680 21,090


+65%
(RATE PER 100,000) (6.5) (5.5) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
43% N/A*† 35% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
70% N/A*† 59% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
20% N/A*† 16% 16%

TOTAL NEW COVID-19 HOSPITAL 3,915 +9% 38,210 165,234


ADMISSIONS (RATE PER 100 BEDS) (27) (+8%) (25) (23)

NUMBER OF HOSPITALS WITH 26 -3% 160 1,086


SUPPLY SHORTAGES (PERCENT) (27%) (-10%*) (17%) (21%)

NUMBER OF HOSPITALS WITH 38 -1% 201 1,177


STAFF SHORTAGES (PERCENT) (39%) (-3%*) (22%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
283,200 5,775 57,105 1.5%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 92% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

ALABAMA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

ALABAMA
STATE REPORT | 01.10.2021

98 hospitals are expected to report in Alabama


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

ALABAMA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Birmingham-Hoover Jefferson
Huntsville Madison
Montgomery Mobile
LOCALITIES
27 65
Mobile Shelby
Tuscaloosa Baldwin
IN RED Daphne-Fairhope-Foley Montgomery
ZONE Decatur
Florence-Muscle Shoals
Tuscaloosa
Morgan
▲ (+1) Dothan ▲ (+4) Lee
Auburn-Opelika Etowah
Gadsden Calhoun
Anniston-Oxford Elmore

LOCALITIES
IN ORANGE
ZONE
0 N/A 1 Macon

■ (+0) ■ (+0)

LOCALITIES
IN YELLOW
ZONE
0 N/A 0 N/A

▼ (-1) ▼ (-4)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Birmingham-Hoover, Huntsville, Montgomery, Mobile, Tuscaloosa, Daphne-Fairhope-Foley, Decatur, Florence-Muscle Shoals, Dothan,
Auburn-Opelika, Gadsden, Anniston-Oxford, Albertville, Cullman, Talladega-Sylacauga, Fort Payne, Enterprise, Scottsboro, Jasper, Ozark, Atmore,
LaGrange, Troy, Columbus, Alexander City, Eufaula, Selma
All Red Counties: Jefferson, Madison, Mobile, Shelby, Baldwin, Montgomery, Tuscaloosa, Morgan, Lee, Etowah, Calhoun, Elmore, Houston, Lauderdale,
Limestone, Marshall, Cullman, St. Clair, Autauga, Talladega, DeKalb, Colbert, Coffee, Jackson, Walker, Blount, Dale, Chilton, Escambia, Chambers,
Franklin, Lawrence, Pike, Russell, Marion, Bibb, Clarke, Covington, Geneva, Winston, Tallapoosa, Hale, Monroe, Henry, Marengo, Barbour, Pickens,
Crenshaw, Dallas, Cherokee, Butler, Fayette, Washington, Bullock, Randolph, Lamar, Clay, Wilcox, Cleburne, Lowndes, Perry, Greene, Sumter, Coosa,
Conecuh

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

ALABAMA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

ALABAMA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
ALASKA Issue 30
SUMMARY
• Alaska is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 39th highest rate in the country.
Alaska is in the green zone for test positivity, indicating a rate at or below 4.9%, with the 48th highest rate in the country.
• Alaska has seen an increase in new cases and stability in test positivity.
• The following three boroughs had the highest number of new cases over the last 3 weeks: 1. Anchorage Municipality, 2. Matanuska-
Susitna Borough, and 3. Bethel Census Area. These boroughs represent 67.7% of new cases in Alaska.
• 31% of all boroughs in Alaska have moderate or high levels of community transmission (yellow, orange, or red zones), with 3% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 11% of nursing homes had at least one new resident COVID-19 case, 22% had at least one new staff
COVID-19 case, and 6% had at least one new resident COVID-19 death.
• Alaska had 361 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 15 to support operations activities from
FEMA and 24 to support operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 11 patients with confirmed COVID-19 and 2 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Alaska. This is an increase of 13% in total new COVID-19 hospital admissions.
• As of Jan 8, 93,175 vaccine doses have been distributed to Alaska. 24,562 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast,
Mid-Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular
updating of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best
practice. Given persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community
influencers are needed.
• Increasing hospitalizations of both confirmed and suspected COVID cases are the best indication that consequential transmission is
increasing, indicating an urgent need to expand testing and increase compelling local messages.
• Incorporate new concerns about virus variants in public health messaging that emphasizes the critical importance of mask wearing and
social distancing; work with local leaders to enforce community mitigation ordinances.
• Continue efforts to improve turnaround time of test results (within 48 hours of specimen taken) and maintain contact tracing of all
diagnosed cases, using previous recommendations to reduce workload and expand capacity as needed.
• Given possibility of increased transmission and transmissibility, ensure all schools that are planning to reopen are prepared for active
testing of students and teachers. Ensure requirements for mask wearing and appropriate distancing, as well as protocols to enforce.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

ALASKA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 2,642 39,189 1,744,828


+41%
(RATE PER 100,000) (361) (273) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
4.9% -0.2%* 10.0% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 44,026** 288,163** 9,104,878**


+2%**
(TESTS PER 100,000) (6,018**) (2,008**) (2,774**)

COVID-19 DEATHS 17 431 21,090


+112%
(RATE PER 100,000) (2.3) (3.0) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
11% N/A*† 18% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
22% N/A*† 33% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
6% N/A*† 10% 16%

TOTAL NEW COVID-19 HOSPITAL 97 +13% 3,059 165,234


ADMISSIONS (RATE PER 100 BEDS) (7) (+12%) (13) (23)

NUMBER OF HOSPITALS WITH 4 -3% 39 1,086


SUPPLY SHORTAGES (PERCENT) (17%) (-43%*) (18%) (21%)

NUMBER OF HOSPITALS WITH 1 +0% 18 1,177


STAFF SHORTAGES (PERCENT) (4%) (+0%*) (8%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
93,175 12,736 24,562 4.5%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 90% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating borough-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

ALASKA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP BOROUGHS

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating borough-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

ALASKA
STATE REPORT | 01.10.2021

24 hospitals are expected to report in Alaska


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

ALASKA
STATE REPORT | 01.10.2021
COVID-19 BOROUGH AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) BOROUGHS

LOCALITIES
IN RED
ZONE
0 N/A 1 Matanuska-Susitna

■ (+0) ■ (+0)

LOCALITIES
IN ORANGE
ZONE
1 Fairbanks 4 Bethel Census Area
Fairbanks North Star
North Slope
Northwest Arctic
▲ (+1) ▲ (+3)

LOCALITIES
IN YELLOW
ZONE
1 Anchorage 4 Kusilvak Census Area
Valdez-Cordova Census Area
Aleutians West Census Area
Dillingham Census Area
▼ (-1) ■ (+0)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating borough-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 boroughs based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating borough-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

ALASKA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating borough-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

ALASKA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating borough-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
ARIZONA Issue 30
SUMMARY
• Arizona is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 2nd highest rate in the country.
Arizona is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 5th highest rate in the country.
• Arizona has seen increases in new cases, test positivity, new hospital admissions, numbers of LTCF staff positive, and fatalities.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Maricopa County, 2. Pima County, and 3. Pinal
County. These counties represent 81.3% of new cases in Arizona.
• 100% of all counties in Arizona have moderate or high levels of community transmission (yellow, orange, or red zones), with 100% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 33% of nursing homes had at least one new resident COVID-19 case, 68% had at least one new staff
COVID-19 case, and 21% had at least one new resident COVID-19 death.
• Arizona had 907 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 40 to support medical activities from DoD; 9
to support operations activities from FEMA; 8 to support medical activities from ASPR; 2 to support epidemiology activities from ASPR; and
5 to support operations activities from ASPR.
• Between Jan 2 - Jan 8, on average, 582 patients with confirmed COVID-19 and 292 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Arizona. This is an increase of 9% in total new COVID-19 hospital admissions.
• As of Jan 8, 453,875 vaccine doses have been distributed to Arizona. 106,288 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000
total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic,
and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of
monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible,
we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and
on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital
should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of
the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Arizona is in full COVID-19 resurgence despite ongoing summer-level mitigation and must aggressively address community spread as there
is no evidence of improvement.
• Significantly increase public mitigation and increase communication around the importance of personal mitigation with masking, physical
distancing, and avoiding family gatherings.
• Along with the excellent increase in testing, ensure aggressive, proactive testing as many more individuals may be asymptomatic and
actively spreading virus in the community.
• All K-12 teachers and older students, community colleges, and universities should require weekly testing, as it dramatically decreases
COVID-19 viral spread by identifying and isolating the asymptomatic individuals, as well as symptomatic individuals, and allows for contact
tracing.
• Ensure access to testing, monoclonal antibody infusions, and vaccination for all Tribal Nations.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

ARIZONA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 65,984 369,307 1,744,828


+52%
(RATE PER 100,000) (907) (720) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
22.2% +0.7%* 18.7% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 258,397** 1,533,674** 9,104,878**


+28%**
(TESTS PER 100,000) (3,550**) (2,990**) (2,774**)

COVID-19 DEATHS 923 4,076 21,090


+53%
(RATE PER 100,000) (12.7) (7.9) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
33% N/A*† 20% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
68% N/A*† 32% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
21% N/A*† 10% 16%

TOTAL NEW COVID-19 HOSPITAL 6,120 +9% 28,479 165,234


ADMISSIONS (RATE PER 100 BEDS) (42) (+7%) (31) (23)

NUMBER OF HOSPITALS WITH 14 +1% 105 1,086


SUPPLY SHORTAGES (PERCENT) (16%) (+8%*) (20%) (21%)

NUMBER OF HOSPITALS WITH 31 -5% 235 1,177


STAFF SHORTAGES (PERCENT) (34%) (-14%*) (44%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
453,875 6,235 106,288 1.9%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 86% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

ARIZONA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

ARIZONA
STATE REPORT | 01.10.2021

90 hospitals are expected to report in Arizona


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

ARIZONA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Maricopa
Phoenix-Mesa-Chandler
Pima
Tucson
Pinal
Yuma
LOCALITIES
11 15
Yuma
Lake Havasu City-Kingman
Mohave
IN RED Prescott Valley-Prescott
Sierra Vista-Douglas
Yavapai
ZONE Flagstaff
Cochise
Coconino
■ (+0) Show Low
Nogales
■ (+0) Navajo
Apache
Safford
Santa Cruz
Payson
Graham

LOCALITIES
IN ORANGE
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)

LOCALITIES
IN YELLOW
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red Counties: Maricopa, Pima, Pinal, Yuma, Mohave, Yavapai, Cochise, Coconino, Navajo, Apache, Santa
Cruz, Graham, Gila, La Paz, Greenlee

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

ARIZONA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

ARIZONA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
ARKANSAS Issue 30
SUMMARY
• Arkansas is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 9th highest rate in the country.
Arkansas is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 22nd highest rate in the country.
• Arkansas has seen an increase in new cases and stability in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Pulaski County, 2. Benton County, and 3.
Washington County. These counties represent 31.1% of new cases in Arkansas.
• 96% of all counties in Arkansas have moderate or high levels of community transmission (yellow, orange, or red zones), with 75% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 27% of nursing homes had at least one new resident COVID-19 case, 50% had at least one new staff
COVID-19 case, and 13% had at least one new resident COVID-19 death.
• Arkansas had 643 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 8 to support operations activities from
FEMA.
• Between Jan 2 - Jan 8, on average, 170 patients with confirmed COVID-19 and 270 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in Arkansas. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 225,100 vaccine doses have been distributed to Arkansas. 40,899 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast,
Mid-Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular
updating of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best
practice. Given persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community
influencers are needed.
• COVID-related new admissions, total hospitalizations, and deaths in Arkansas continue to be at very serious levels. Arkansas's COVID-
related mortality rate is one of the highest in the country. More aggressive mitigation and treatment is needed to reverse this.
• Early and limited data from returning university students and staff indicate COVID presence at universities; mandatory, weekly testing
will identify asymptomatic cases and can prevent transmission into the community.
• In K-12 schools, establish public health protocols to conduct active testing for teachers and students in districts with high positivity and
cases. In accordance with CDC guidelines, masks should be worn by students and teachers.
• With the high percentage of LTCF sites having COVID-positive staff, continue weekly testing of all staff until residents and staff are fully
vaccinated.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

ARKANSAS
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 19,418 243,956 1,744,828


+20%
(RATE PER 100,000) (643) (571) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
14.4% +0.5%* 18.4% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 65,113** 853,979** 9,104,878**


+13%**
(TESTS PER 100,000) (2,158**) (1,999**) (2,774**)

COVID-19 DEATHS 255 2,639 21,090


-7%
(RATE PER 100,000) (8.4) (6.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
27% N/A*† 31% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
50% N/A*† 52% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
13% N/A*† 15% 16%

TOTAL NEW COVID-19 HOSPITAL 3,082 +0% 25,494 165,234


ADMISSIONS (RATE PER 100 BEDS) (40) (-2%) (27) (23)

NUMBER OF HOSPITALS WITH 19 +1% 211 1,086


SUPPLY SHORTAGES (PERCENT) (22%) (+6%*) (24%) (21%)

NUMBER OF HOSPITALS WITH 18 -3% 283 1,177


STAFF SHORTAGES (PERCENT) (20%) (-14%*) (32%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
225,100 7,459 40,899 1.8%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 88% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

ARKANSAS
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

ARKANSAS
STATE REPORT | 01.10.2021

88 hospitals are expected to report in Arkansas


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

ARKANSAS
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Little Rock-North Little Rock-Conway Pulaski
Fayetteville-Springdale-Rogers Benton
Fort Smith Washington
LOCALITIES
19 56
Jonesboro Faulkner
Russellville Sebastian
IN RED Hot Springs Saline
ZONE Searcy
Paragould
Craighead
Garland
▲ (+1) El Dorado ■ (+0) White
Memphis Pope
Blytheville Lonoke
Texarkana Crawford

Jackson
Sharp
LOCALITIES
2 9
Columbia
IN ORANGE Hope
Madison
Franklin
ZONE Magnolia
Van Buren
▼ (-1) ■ (+0) Pike
Cleveland
Searcy

Jefferson
LOCALITIES
2 7
Independence
IN YELLOW Pine Bluff
Randolph
Clay
ZONE Batesville
Howard
■ (+0) ▼ (-1) Stone
Chicot

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Little Rock-North Little Rock-Conway, Fayetteville-Springdale-Rogers, Fort Smith, Jonesboro, Russellville, Hot Springs,
Searcy, Paragould, El Dorado, Memphis, Blytheville, Texarkana, Malvern, Harrison, Mountain Home, Camden, Forrest City, Arkadelphia,
Helena-West Helena
All Red Counties: Pulaski, Benton, Washington, Faulkner, Sebastian, Saline, Craighead, Garland, White, Pope, Lonoke, Crawford, Greene,
Union, Crittenden, Mississippi, Hot Spring, Yell, Conway, Baxter, Johnson, Miller, Poinsett, Boone, Cleburne, St. Francis, Cross, Ouachita,
Logan, Carroll, Grant, Drew, Clark, Lawrence, Polk, Izard, Bradley, Arkansas, Hempstead, Ashley, Phillips, Fulton, Desha, Scott, Lincoln,
Perry, Marion, Prairie, Lee, Woodruff, Monroe, Montgomery, Dallas, Newton, Calhoun, Lafayette

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

ARKANSAS
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

ARKANSAS
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
CALIFORNIA Issue 30
SUMMARY
• California’s viral surge continues to worsen with extremely high levels of cases, hospitalizations, and deaths. California is in the red zone for cases, indicating
101 or more new cases per 100,000 population, with the 6th highest rate in the country. California is in the red zone for test positivity, indicating a rate at or
above 10.1%, with the 14th highest rate in the country.
• California has seen stability in new cases (+3%) and an increase in test positivity, indicating that the epidemic worsening is likely to continue over at least the
short term. New hospitalizations edged upward from an extremely high rate; current hospitalizations set new records last week, exceeding 22,000. Deaths
increased sharply, averaging ~410 per day with 695 reported on Dec 9.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Los Angeles County, 2. San Bernardino County, and 3. Riverside
County. These counties represent 52.3% of new cases in California.
• 74% of all counties in California have moderate or high levels of community transmission (yellow, orange, or red zones), with 57% having high levels of
community transmission (red zone).
• Surveillance: More than 30 cases of the B.1.1.7 variant have been detected in San Diego County following initial detection from a sample Dec 29; additional
cases have been detected in San Bernardino County.
• During the week of Dec 28 - Jan 3, 18% of nursing homes had at least one new resident COVID-19 case, 28% had at least one new staff COVID-19 case, and 9%
had at least one new resident COVID-19 death.
• California had 723 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 118 to support medical activities from DoD; 125 to support
operations activities from FEMA; 55 to support medical activities from ASPR; 22 to support operations activities from ASPR; and 296 to support operations
activities from USCG.
• Between Jan 2 - Jan 8, on average, 2,373 patients with confirmed COVID-19 and 610 patients with suspected COVID-19 were reported as newly admitted each
day to hospitals in California. This is an increase of 5% in total new COVID-19 hospital admissions.
• As of Jan 8, 2,315,325 vaccine doses have been distributed to California. 584,366 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased cases,
increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains slope in the fall
and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread, increasing
hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large metros.
Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-19
inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests increasing
and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data suggest
the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the presence of the UK
variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as more
transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible viruses
emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to action
for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient infusion sites
immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate isolation
and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with use of
EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms now; active and
aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public confidence and
maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of individuals vaccinated to
date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy, continued active encouragement by
the Governor, health officials, and community influencers are needed.
• We share the extreme ongoing concern of California’s leaders over the extreme burden on the health care system due to the ongoing surge and likelihood of
further worsening as indicated by the trends in test positivity and the recent detection of the B.1.1.7 variant extensively in San Diego County. In the near term,
preventing overwhelm of the health care system will be dependent on the effort of Californians to follow social distancing measures until immunization levels
can be increased. This message must be delivered frequently and by all effective modalities.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that could
limit morbidity and hospitalizations. The recent report confirming the benefit of convalescent plasma when administered early strengthens the case for
expanded utilization of plasma and monoclonal antibodies. The effort of US Renal Care to establish infusion capacity for monoclonal antibodies through their
existing network of dialysis sites is commended.
• Mitigation measures in public spaces remain critical and need careful balancing of risk and economic/social benefit. Effective implementation requires a
balance of education and enforcement. Proactive testing must be part of mitigation efforts inclusive of universal masking, physical distancing, hand hygiene,
and the active promotion of activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in LTCFs as
vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Ensure all K-12 schools are following CDC guidelines, including wearing masks and routinely utilizing the BinaxNOW tests. Ensure all universities returning
after winter break implement mandatory weekly testing of all on and off campus students.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

CALIFORNIA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 285,550 369,307 1,744,828


+3%
(RATE PER 100,000) (723) (720) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
18.1% +1.4%* 18.7% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 1,160,429** 1,533,674** 9,104,878**


-35%**
(TESTS PER 100,000) (2,937**) (2,990**) (2,774**)

COVID-19 DEATHS 2,888 4,076 21,090


+21%
(RATE PER 100,000) (7.3) (7.9) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
18% N/A*† 20% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
28% N/A*† 32% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
9% N/A*† 10% 16%

TOTAL NEW COVID-19 HOSPITAL 20,884 +5% 28,479 165,234


ADMISSIONS (RATE PER 100 BEDS) (32) (+4%) (31) (23)

NUMBER OF HOSPITALS WITH 77 +0% 105 1,086


SUPPLY SHORTAGES (PERCENT) (21%) (+0%*) (20%) (21%)

NUMBER OF HOSPITALS WITH 188 +5% 235 1,177


STAFF SHORTAGES (PERCENT) (52%) (+3%*) (44%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
2,315,325 5,859 584,366 1.9%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 98% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

CALIFORNIA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

CALIFORNIA
STATE REPORT | 01.10.2021

364 hospitals are expected to report in California


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

CALIFORNIA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Los Angeles-Long Beach-Anaheim Los Angeles
Riverside-San Bernardino-Ontario San Bernardino
San Diego-Chula Vista-Carlsbad Riverside
LOCALITIES
26 33
Sacramento-Roseville-Folsom San Diego
Fresno Orange
IN RED Bakersfield Fresno
ZONE Oxnard-Thousand Oaks-Ventura
Stockton
Kern
Ventura
▲ (+5) Salinas ▲ (+4) Sacramento
Modesto San Joaquin
Visalia Contra Costa
Vallejo Monterey

LOCALITIES
4 5
Santa Clara
San Francisco-Oakland-Berkeley
IN ORANGE San Jose-Sunnyvale-Santa Clara
Alameda
San Mateo
ZONE Santa Rosa-Petaluma
Ukiah
Sonoma
▼ (-3) ▼ (-3) Mendocino

LOCALITIES
2 5
San Francisco
IN YELLOW Sonora
Yolo
Marin
ZONE Eureka-Arcata
Tuolumne
▼ (-2) ▲ (+1) Humboldt

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Los Angeles-Long Beach-Anaheim, Riverside-San Bernardino-Ontario, San Diego-Chula Vista-Carlsbad, Sacramento-
Roseville-Folsom, Fresno, Bakersfield, Oxnard-Thousand Oaks-Ventura, Stockton, Salinas, Modesto, Visalia, Vallejo, Santa Maria-Santa
Barbara, Merced, San Luis Obispo-Paso Robles, Santa Cruz-Watsonville, El Centro, Madera, Hanford-Corcoran, Yuba City, Chico, Napa,
Redding, Red Bluff, Clearlake, Truckee-Grass Valley
All Red Counties: Los Angeles, San Bernardino, Riverside, San Diego, Orange, Fresno, Kern, Ventura, Sacramento, San Joaquin, Contra
Costa, Monterey, Stanislaus, Tulare, Solano, Santa Barbara, Merced, Placer, San Luis Obispo, Santa Cruz, Imperial, Madera, Kings, Butte,
El Dorado, Napa, Shasta, Sutter, San Benito, Yuba, Tehama, Lake, Nevada

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

CALIFORNIA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

CALIFORNIA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
COLORADO Issue 30
SUMMARY
• Colorado continues to improve since the peak of the fall surge in mid-November. Colorado is in the red zone for cases, indicating 101 or more new cases per
100,000 population, with the 41st highest rate in the country. Colorado is in the yellow zone for test positivity, indicating a rate between 5.0% and 7.9%, with the
43rd highest rate in the country.
• Colorado has seen an increase in new cases and an increase in test positivity. Health officials consider that the increased cases represent both post-holiday
increased healthcare access by patients as well as reflect increased cases due to holiday gatherings. New and current hospitalizations continued to decline;
current hospitalizations are ~50% below their peak. Deaths declined minimally and were still ~38 per day.
• High-level transmission continues to involve counties throughout the state. The following three counties had the highest number of new cases over the last 3
weeks: 1. Denver County, 2. El Paso County, and 3. Arapahoe County. These counties represent 36.4% of new cases in Colorado.
• 62% of all counties in Colorado have moderate or high levels of community transmission (yellow, orange, or red zones), with 22% having high levels of community
transmission (red zone).
• Surveillance: Two additional isolations of the viral variant associated with increased transmission in the UK (B.1.1.7) were detected last week; samples from a
rapidly growing LTCF outbreak are also being tested. The state announced a BinaxNOW testing program for schools.
• Vaccination: Daily immunization numbers increased after the holidays. Eagle County is beginning a lottery system to help increase equity in vaccine access.
• During the week of Dec 28 - Jan 3, 24% of nursing homes had at least one new resident COVID-19 case, 41% had at least one new staff COVID-19 case, and 18% had
at least one new resident COVID-19 death.
• Colorado had 329 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 67 to support operations activities from FEMA; 4 to support
operations activities from ASPR; 1 to support epidemiology activities from CDC; and 1 to support operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 121 patients with confirmed COVID-19 and 77 patients with suspected COVID-19 were reported as newly admitted each day to
hospitals in Colorado. This is a decrease of 18% in total new COVID-19 hospital admissions.
• As of Jan 8, 381,775 vaccine doses have been distributed to Colorado. 145,164 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased cases,
increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains slope in the fall
and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread, increasing
hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large metros.
Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-19
inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests increasing
and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data suggest
the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the presence of the UK
variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as more
transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible viruses
emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to action
for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient infusion sites
immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate isolation
and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with use of
EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms now; active and
aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public confidence and
maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of individuals vaccinated to
date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy, continued active encouragement by
the Governor, health officials, and community influencers are needed.
• Data from the next week should better clarify the current trend in disease activity after the holidays. We share the sense of urgency of Colorado’s leaders on
speeding up vaccination, as well as share the understanding that the forecast for cases and deaths remains dependent on the continued collective effort of
Colorado’s residents to observe mitigation measures until vaccination levels increase. Continued messaging for residents to maintain their changes in
personal behavior is key to limiting disease and death until the pandemic is ended with immunization. The Governor’s continued personal communication on
these measures remains critical.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that could
limit morbidity and hospitalizations. Continue to prioritize efforts toward marginalized communities that are disproportionately being impacted by COVID-19,
including a strategy that prioritizes allocation of monoclonal antibody preparations to outpatient centers that serve more marginalized populations with
higher levels of COVID-19 risk factors.
• Efforts to identify and reduce asymptomatic transmission should run concurrently with testing of symptomatic persons and contact tracing of cases. The new
school testing program announced by Colorado is commended.
• Mitigation measures in public spaces need careful balancing of risk and economic/social benefit. The fast-food chain outbreak highlights the high-level
transmission that can occur in enclosed space restaurant environments in the absence of effective mitigation of aerosolized virus. Proactive testing must be
part of the mitigation efforts inclusive of universal masking, physical distancing, hand hygiene, and the active promotion of activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in LTCFs as
vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.
The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

COLORADO
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 18,949 53,886 1,744,828


+27%
(RATE PER 100,000) (329) (440) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
7.5% +0.6%* 12.5% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 224,351** 417,166** 9,104,878**


+18%**
(TESTS PER 100,000) (3,896**) (3,403**) (2,774**)

COVID-19 DEATHS 266 629 21,090


-7%
(RATE PER 100,000) (4.6) (5.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
24% N/A*† 22% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
41% N/A*† 40% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
18% N/A*† 13% 16%

TOTAL NEW COVID-19 HOSPITAL 1,391 -18% 3,364 165,234


ADMISSIONS (RATE PER 100 BEDS) (14) (-18%) (14) (23)

NUMBER OF HOSPITALS WITH 9 -1% 70 1,086


SUPPLY SHORTAGES (PERCENT) (10%) (-10%*) (21%) (21%)

NUMBER OF HOSPITALS WITH 4 +0% 41 1,177


STAFF SHORTAGES (PERCENT) (4%) (+0%*) (12%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
381,775 6,629 145,164 3.2%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 89% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

COLORADO
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

COLORADO
STATE REPORT | 01.10.2021

89 hospitals are expected to report in Colorado


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

COLORADO
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Adams
Weld
Garfield
LOCALITIES
3 14
Delta
Montrose
IN RED Greeley
Glenwood Springs
Pitkin
ZONE Montrose
Las Animas
Bent
▲ (+1) ▲ (+6) Elbert
Grand
Gunnison
Park
El Paso
Mesa
Logan
LOCALITIES
5 11
Colorado Springs Montezuma
IN ORANGE Grand Junction
Sterling
Otero
Morgan
ZONE Fort Morgan Routt
▲ (+3) Steamboat Springs
▲ (+5) Prowers
Rio Grande
Archuleta
Clear Creek
Denver
Arapahoe
Jefferson
LOCALITIES
6 15
Denver-Aurora-Lakewood Douglas
Fort Collins Larimer
IN YELLOW Pueblo Pueblo
ZONE Edwards
Breckenridge
Eagle
Broomfield
▼ (-3) Craig ▼ (-5) Summit
Chaffee
Teller
Yuma

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red Counties: Adams, Weld, Garfield, Delta, Montrose, Pitkin, Las Animas, Bent, Elbert, Grand, Gunnison,
Park, Lake, Sedgwick
All Yellow Counties: Denver, Arapahoe, Jefferson, Douglas, Larimer, Pueblo, Eagle, Broomfield, Summit,
Chaffee, Teller, Yuma, Moffat, Conejos, Rio Blanco

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

COLORADO
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

COLORADO
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
CONNECTICUT Issue 30
SUMMARY
• Connecticut has seen a sharp increase in new cases for a second week, suggesting a true increase in transmission rather than post-holiday catchup in
detection and reporting. Connecticut is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 13th highest rate in the
country. Connecticut is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 29th highest rate in the country.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Hartford County, 2. Fairfield County, and 3. New Haven County.
These counties represent 75.2% of new cases in Connecticut.
• 100% of all counties in Connecticut have moderate or high levels of community transmission (yellow, orange, or red zones), with 88% having high levels of
community transmission (red zone).
• Reported new hospitalizations and current hospitalizations plateaued at high levels. Mortality increased; Connecticut reported an average of 47 deaths daily
again last week.
• Surveillance: Many of the outbreaks identified by the state have involved restaurants. The first two cases of the B.1.1.7 variant were detected in residents aged
15-25 years who had recently travelled, one internationally and one to New York state. Connecticut’s COVID-19 Contact Tracing App has been activated by
more than a million users, nearly 1/3 of the state’s population.
• During the week of Dec 28 - Jan 3, 32% of nursing homes had at least one new resident COVID-19 case, 61% had at least one new staff COVID-19 case, and 20%
had at least one new resident COVID-19 death.
• Connecticut had 569 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 2 to support operations activities from FEMA and 16 to
support operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 143 patients with confirmed COVID-19 and 72 patients with suspected COVID-19 were reported as newly admitted each day
to hospitals in Connecticut. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 219,125 vaccine doses have been distributed to Connecticut. 116,277 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased cases,
increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains slope in the fall
and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread, increasing
hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large metros.
Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-19
inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests increasing
and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data suggest
the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the presence of the UK
variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as more
transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible viruses
emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to action
for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient infusion sites
immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate isolation
and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with use of
EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms now; active and
aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public confidence and
maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of individuals vaccinated to
date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy, continued active encouragement by
the Governor, health officials, and community influencers are needed.
• We share the ongoing concern of Connecticut’s leaders that the epidemic could rapidly worsen and that the forecast for cases and deaths remains dependent
on the continued collective effort of Connecticut’s residents. Continued messaging for residents to maintain their changes in personal behavior is key to
limiting disease and death until the pandemic ends with immunization. The Governor’s continued personal communication on these measures remains
critical.
• We applaud the early results of the Connecticut vaccination campaign, especially the rapid completion of the first round in LTCF.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that could
limit morbidity and hospitalizations. The recent report confirming the benefit of convalescent plasma when administered early strengthens the case for
expanded utilization of plasma and monoclonal antibodies. Continue to prioritize efforts toward marginalized communities that are disproportionately being
impacted by COVID-19.
• Proactive testing must be part of the mitigation efforts inclusive of universal masking, physical distancing, hand hygiene, and the active promotion of
activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in LTCFs as
vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Ensure all K-12 schools are following CDC guidelines, including wearing masks and routinely utilizing the BinaxNOW tests. Ensure all universities returning
after winter break implement mandatory weekly testing of all on and off campus students.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

CONNECTICUT
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 20,286 85,599 1,744,828


+56%
(RATE PER 100,000) (569) (577) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
12.8% +0.8%* 8.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 38,353** 640,515** 9,104,878**


-69%**
(TESTS PER 100,000) (1,076**) (4,315**) (2,774**)

COVID-19 DEATHS 329 1,211 21,090


+61%
(RATE PER 100,000) (9.2) (8.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
32% N/A*† 27% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
61% N/A*† 49% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
20% N/A*† 15% 16%

TOTAL NEW COVID-19 HOSPITAL 1,502 -2% 5,332 165,234


ADMISSIONS (RATE PER 100 BEDS) (19) (-2%) (16) (23)

NUMBER OF HOSPITALS WITH 5 -3% 48 1,086


SUPPLY SHORTAGES (PERCENT) (16%) (-38%*) (26%) (21%)

NUMBER OF HOSPITALS WITH 4 -2% 30 1,177


STAFF SHORTAGES (PERCENT) (13%) (-33%*) (16%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
219,125 6,146 116,277 4.1%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 96% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

CONNECTICUT
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

CONNECTICUT
STATE REPORT | 01.10.2021

31 hospitals are expected to report in Connecticut


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

CONNECTICUT
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES

Hartford
LOCALITIES
6 7
Hartford-East Hartford-Middletown
Fairfield
Bridgeport-Stamford-Norwalk
IN RED New Haven-Milford
New Haven
New London
ZONE Norwich-New London
Worcester
Middlesex
▲ (+3) Torrington ▲ (+3) Windham
Litchfield

LOCALITIES
IN ORANGE
ZONE
0 N/A 1 Tolland

▼ (-3) ▼ (-3)

LOCALITIES
IN YELLOW
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

CONNECTICUT
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

CONNECTICUT
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
DELAWARE Issue 30
SUMMARY
• Delaware’s epidemic continued to worsen after apparent stabilization during the holidays. Delaware is in the red zone for cases, indicating 101 or more
new cases per 100,000 population, with the 17th highest rate in the country. Delaware is in the red zone for test positivity, indicating a rate at or above
10.1%, with the 36th highest rate in the country.
• Delaware has seen an increase in new cases and an increase in test positivity.
• All three counties in Delaware have moderate or high levels of community transmission (yellow, orange, or red zones), with 67% having high levels of
community transmission (red zone).
• Mitigation: Intensified mitigation measures, including increased business occupancy restrictions, a stay-at-home advisory, and an indoor mask
mandate took effect on Dec 14; restrictions were eased on restaurants, bars, and sports as of Jan 9.
• During the week of Dec 28 - Jan 3, 37% of nursing homes had at least one new resident COVID-19 case, 63% had at least one new staff COVID-19 case,
and 23% had at least one new resident COVID-19 death.
• Delaware had 559 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 6 to support operations activities from FEMA.
• Between Jan 2 - Jan 8, on average, 50 patients with confirmed COVID-19 and 27 patients with suspected COVID-19 were reported as newly admitted
each day to hospitals in Delaware. This is an increase of 5% in total new COVID-19 hospital admissions.
• As of Jan 8, 65,350 vaccine doses have been distributed to Delaware. 18,482 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased
cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains
slope in the fall and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread,
increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large
metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-
19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests
increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and
vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data
suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the
presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a
much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as
more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible
viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to
action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient
infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate
isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with
use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms
now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of
individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy,
continued active encouragement by the Governor, health officials, and community influencers are needed.
• We share the concern of Delaware’s leaders regarding the increases in cases and hospitalizations after the holidays. We also share their ongoing
concern that the forecast for cases and deaths remains dependent on the continued collective effort of Delaware’s residents. Continued messaging for
residents to maintain their changes in personal behavior is key to limiting disease and death until the pandemic ends with immunization. The
Governor’s continued personal communication on these measures remains critical.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that
could limit morbidity and hospitalizations. The recent report confirming the benefit of convalescent plasma when administered early strengthens the
case for expanded utilization of plasma and monoclonal antibodies. Continue to prioritize efforts toward marginalized communities that are
disproportionately being impacted by COVID-19.
• Proactive testing must be part of the mitigation efforts inclusive of universal masking, physical distancing, hand hygiene, and the active promotion of
activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in
LTCFs as vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Ensure all K-12 schools are following CDC guidelines, including wearing masks and routinely utilizing the BinaxNOW tests. Ensure all universities
returning after winter break implement mandatory weekly testing of all on and off campus students.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

DELAWARE
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 5,439 126,056 1,744,828


+23%
(RATE PER 100,000) (559) (409) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
10.2% +1.0%* 14.2% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 55,770** 1,010,441** 9,104,878**


+1%**
(TESTS PER 100,000) (5,727**) (3,275**) (2,774**)

COVID-19 DEATHS 27 1,971 21,090


-31%
(RATE PER 100,000) (2.8) (6.4) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
37% N/A*† 37% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
63% N/A*† 62% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
23% N/A*† 21% 16%

TOTAL NEW COVID-19 HOSPITAL 545 +5% 18,632 165,234


ADMISSIONS (RATE PER 100 BEDS) (21) (+4%) (27) (23)

NUMBER OF HOSPITALS WITH 0 -1% 77 1,086


SUPPLY SHORTAGES (PERCENT) (0%) (-100%*) (20%) (21%)

NUMBER OF HOSPITALS WITH 1 +0% 92 1,177


STAFF SHORTAGES (PERCENT) (12%) (+0%*) (24%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
65,350 6,711 18,482 2.4%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 91% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

DELAWARE
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

DELAWARE
STATE REPORT | 01.10.2021

8 hospitals are expected to report in Delaware


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

DELAWARE
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES

LOCALITIES
IN RED
ZONE
3 Philadelphia-Camden-Wilmington
Salisbury
Dover
2 Sussex
Kent

■ (+0) ■ (+0)

LOCALITIES
IN ORANGE
ZONE
0 N/A 1 New Castle

■ (+0) ■ (+0)

LOCALITIES
IN YELLOW
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

DELAWARE
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

DELAWARE
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
THE DISTRICT OF COLUMBIA Issue 30
SUMMARY
• The District of Columbia reported near stability of disease activity after sharp changes in recent weeks. The District of Columbia is in the red zone for
cases, indicating 101 or more new cases per 100,000 population, with the 47th highest rate in the country. The District of Columbia is in the yellow zone
for test positivity, indicating a rate between 5.0% and 7.9%, with the 47th highest rate in the country.
• The District of Columbia has seen stability in new cases and stability in test positivity. Current hospitalizations increased, reaching a level last seen in
early June. Deaths decreased.
• The District of Columbia has moderate levels of community transmission (yellow or orange zones).
• Mitigation: DC's ban on indoor dining and other restrictions went into effect on Dec 23 and will remain in place until Jan 15.
• During the week of Dec 28 - Jan 3, 14% of nursing homes had at least one new resident COVID-19 case, 86% had at least one new staff COVID-19 case,
and 7% had at least one new resident COVID-19 death.
• The District of Columbia had 263 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 4 to support operations activities from FEMA.
• Between Jan 2 - Jan 8, on average, 39 patients with confirmed COVID-19 and 89 patients with suspected COVID-19 were reported as newly admitted
each day to hospitals in the District of Columbia. This is an increase of 8% in total new COVID-19 hospital admissions.
• As of Jan 8, 49,250 vaccine doses have been distributed to the District of Columbia. 21,681 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased
cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains
slope in the fall and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread,
increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large
metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-
19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests
increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and
vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data
suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the
presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a
much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as
more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible
viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to
action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient
infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate
isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with
use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms
now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of
individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy,
continued active encouragement by the Mayor, health officials, and community influencers are needed.
• We share the ongoing concern of District leaders regarding the fragility of the current control of the pandemic, especially given the recent mass
demonstrations and the upcoming inauguration. We also share their ongoing conviction that the forecast for cases and deaths remains dependent on
the continued collective effort of the District’s residents. Continued messaging for residents to maintain their changes in personal behavior is key to
limiting disease and death until the pandemic ends with immunization. The Mayor's continued personal communication on these measures remains
critical.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that
could limit morbidity and hospitalizations. The recent report confirming the benefit of convalescent plasma when administered early strengthens the
case for expanded utilization of plasma and monoclonal antibodies. Continue to prioritize efforts toward marginalized communities that are
disproportionately being impacted by COVID-19.
• Proactive testing must be part of the mitigation efforts inclusive of universal masking, physical distancing, hand hygiene, and the active promotion of
activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in
LTCFs as vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Ensure all K-12 schools are following CDC guidelines, including wearing masks and routinely utilizing the BinaxNOW tests. Ensure all universities
returning after winter break implement mandatory weekly testing of all on and off campus students.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

THE DISTRICT OF COLUMBIA


STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 1,855 126,056 1,744,828


+2%
(RATE PER 100,000) (263) (409) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
5.6% +0.3%* 14.2% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 47,775** 1,010,441** 9,104,878**


+10%**
(TESTS PER 100,000) (6,769**) (3,275**) (2,774**)

COVID-19 DEATHS 21 1,971 21,090


-34%
(RATE PER 100,000) (3.0) (6.4) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
14% N/A*† 37% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
86% N/A*† 62% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
7% N/A*† 21% 16%

TOTAL NEW COVID-19 HOSPITAL 897 +8% 18,632 165,234


ADMISSIONS (RATE PER 100 BEDS) (29) (+6%) (27) (23)

NUMBER OF HOSPITALS WITH 1 +0% 77 1,086


SUPPLY SHORTAGES (PERCENT) (9%) (+0%*) (20%) (21%)

NUMBER OF HOSPITALS WITH 0 +0% 92 1,177


STAFF SHORTAGES (PERCENT) (0%) (N/A*) (24%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
49,250 6,978 21,681 3.8%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 74% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

THE DISTRICT OF COLUMBIA


STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

THE DISTRICT OF COLUMBIA


STATE REPORT | 01.10.2021

11 hospitals are expected to report in the District of Columbia


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

THE DISTRICT OF COLUMBIA


STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES

LOCALITIES
IN RED
ZONE
1 Washington-Arlington-Alexandria 0 N/A

■ (+0) ■ (+0)

LOCALITIES
IN ORANGE
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)

LOCALITIES
IN YELLOW
ZONE
0 N/A 1 District of Columbia

■ (+0) ■ (+0)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

THE DISTRICT OF COLUMBIA


STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

THE DISTRICT OF COLUMBIA


STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
FLORIDA Issue 30
SUMMARY
• Florida is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 11th highest rate in the country.
Florida is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 26th highest rate in the country.
• Florida has seen an increase in new cases, test positivity, and hospitalizations and is in full COVID-19 resurgence.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Miami-Dade County, 2. Broward County, and
3. Orange County. These counties represent 34.3% of new cases in Florida.
• 100% of all counties in Florida have moderate or high levels of community transmission (yellow, orange, or red zones), with 96% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 32% of nursing homes had at least one new resident COVID-19 case, 53% had at least one new staff
COVID-19 case, and 10% had at least one new resident COVID-19 death.
• Florida had 586 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 1 to support epidemiology activities
from CDC; 58 to support operations activities from USCG; and 25 to support medical activities from VA.
• Between Jan 2 - Jan 8, on average, 1,137 patients with confirmed COVID-19 and 357 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in Florida. This is an increase of 14% in total new COVID-19 hospital admissions.
• As of Jan 8, 1,355,775 vaccine doses have been distributed to Florida. 402,802 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast,
Mid-Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular
updating of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best
practice. Given persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community
influencers are needed.
• Florida is in full COVID-19 resurgence, which will drive significant fatalities for many weeks and stress the staffing of the hospital system.
• Florida must increase both statewide and local public mitigation. Increase communication around the importance of personal
mitigation with masking, physical distancing, and avoiding family gatherings.
• Ensure aggressive, proactive testing as many more individuals may be asymptomatic and actively spreading virus in the community.
• All K-12 teachers and older students, community colleges, and universities should require weekly testing, as it dramatically decreases
COVID-19 viral spread by identifying and isolating the asymptomatic individuals, as well as symptomatic individuals, and allows for
contact tracing.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

FLORIDA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 125,937 401,743 1,744,828


+66%
(RATE PER 100,000) (586) (600) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
14.0% +1.1%* 16.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 673,569** 1,521,048** 9,104,878**


+5%**
(TESTS PER 100,000) (3,136**) (2,273**) (2,774**)

COVID-19 DEATHS 993 3,680 21,090


+47%
(RATE PER 100,000) (4.6) (5.5) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
32% N/A*† 35% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
53% N/A*† 59% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
10% N/A*† 16% 16%

TOTAL NEW COVID-19 HOSPITAL 10,456 +14% 38,210 165,234


ADMISSIONS (RATE PER 100 BEDS) (20) (+13%) (25) (23)

NUMBER OF HOSPITALS WITH 18 +1% 160 1,086


SUPPLY SHORTAGES (PERCENT) (8%) (+6%*) (17%) (21%)

NUMBER OF HOSPITALS WITH 24 +3% 201 1,177


STAFF SHORTAGES (PERCENT) (11%) (+14%*) (22%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
1,355,775 6,312 402,802 2.3%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 89% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

FLORIDA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

FLORIDA
STATE REPORT | 01.10.2021

213 hospitals are expected to report in Florida


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

FLORIDA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Miami-Fort Lauderdale-Pompano Beach Miami-Dade
Tampa-St. Petersburg-Clearwater Broward
Orlando-Kissimmee-Sanford Orange
LOCALITIES
27 64
Jacksonville Hillsborough
Lakeland-Winter Haven Duval
IN RED North Port-Sarasota-Bradenton Palm Beach
ZONE Cape Coral-Fort Myers
Pensacola-Ferry Pass-Brent
Pinellas
Polk
▲ (+1) Deltona-Daytona Beach-Ormond Beach ▲ (+6) Lee
Tallahassee Pasco
Port St. Lucie Osceola
Ocala Escambia

LOCALITIES
IN ORANGE
ZONE
2 Palm Bay-Melbourne-Titusville
Gainesville
3 Volusia
Brevard
Alachua
■ (+0) ▼ (-4)

LOCALITIES
IN YELLOW
ZONE
0 N/A 0 N/A

▼ (-1) ▼ (-2)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Miami-Fort Lauderdale-Pompano Beach, Tampa-St. Petersburg-Clearwater, Orlando-Kissimmee-Sanford, Jacksonville, Lakeland-Winter Haven,
North Port-Sarasota-Bradenton, Cape Coral-Fort Myers, Pensacola-Ferry Pass-Brent, Deltona-Daytona Beach-Ormond Beach, Tallahassee, Port St. Lucie, Ocala,
Crestview-Fort Walton Beach-Destin, Naples-Marco Island, Panama City, Sebastian-Vero Beach, Punta Gorda, The Villages, Homosassa Springs, Lake City, Palatka,
Sebring-Avon Park, Key West, Clewiston, Okeechobee, Arcadia, Wauchula
All Red Counties: Miami-Dade, Broward, Orange, Hillsborough, Duval, Palm Beach, Pinellas, Polk, Lee, Pasco, Osceola, Escambia, Manatee, Marion, Lake, Sarasota,
Leon, Seminole, St. Johns, Collier, St. Lucie, Clay, Santa Rosa, Okaloosa, Bay, Indian River, Charlotte, Hernando, Nassau, Sumter, Citrus, Martin, Columbia, Walton,
Putnam, Flagler, Highlands, Gadsden, Suwannee, Jackson, Bradford, Monroe, Hendry, Wakulla, Okeechobee, Levy, Holmes, Baker, Washington, DeSoto, Taylor,
Calhoun, Hardee, Gulf, Hamilton, Jefferson, Union, Gilchrist, Liberty, Dixie, Madison, Franklin, Glades, Lafayette

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

FLORIDA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

FLORIDA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
GEORGIA Issue 30
SUMMARY
• Georgia is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 16th highest rate in the country.
Georgia is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 8th highest rate in the country.
• Georgia has seen an increase in new cases despite declines in testing. With an increase in test positivity and dramatic increases in
hospitalizations, Georgia is in full pandemic resurgence.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Gwinnett County, 2. Fulton County, and 3.
Cobb County. These counties represent 24.7% of new cases in Georgia.
• 98% of all counties in Georgia have moderate or high levels of community transmission (yellow, orange, or red zones), with 94% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 36% of nursing homes had at least one new resident COVID-19 case, 58% had at least one new staff
COVID-19 case, and 12% had at least one new resident COVID-19 death.
• Georgia had 559 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 31 to support operations activities from
FEMA; 9 to support operations activities from ASPR; 11 to support epidemiology activities from CDC; and 4 to support operations
activities from USCG.
• Between Jan 2 - Jan 8, on average, 796 patients with confirmed COVID-19 and 215 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in Georgia. This is an increase of 13% in total new COVID-19 hospital admissions.
• As of Jan 8, 687,425 vaccine doses have been distributed to Georgia. 119,118 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-
Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating
of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Georgia is in full pandemic resurgence and will experience continued increases in new COVID admissions and fatalities. Ensure aggressive
utilization of monoclonal antibodies in outpatient settings and that every hospital has active infusion sites available.
• Significantly increase public mitigation and increase communication around the importance of personal mitigation with masking,
physical distancing, and avoiding family gatherings.
• Ensure aggressive, proactive testing as many more individuals may be asymptomatic and actively spreading virus in the community.
• All K-12 teachers and older students, community colleges, and universities should require weekly testing, as it dramatically decreases
COVID-19 viral spread by identifying and isolating the asymptomatic individuals, as well as symptomatic individuals, and allows for
contact tracing.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

GEORGIA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 59,337 401,743 1,744,828


+12%
(RATE PER 100,000) (559) (600) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
20.4% +0.6%* 16.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 82,659** 1,521,048** 9,104,878**


-58%**
(TESTS PER 100,000) (779**) (2,273**) (2,774**)

COVID-19 DEATHS 358 3,680 21,090


+9%
(RATE PER 100,000) (3.4) (5.5) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
36% N/A*† 35% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
58% N/A*† 59% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
12% N/A*† 16% 16%

TOTAL NEW COVID-19 HOSPITAL 7,074 +13% 38,210 165,234


ADMISSIONS (RATE PER 100 BEDS) (36) (+13%) (25) (23)

NUMBER OF HOSPITALS WITH 20 +0% 160 1,086


SUPPLY SHORTAGES (PERCENT) (14%) (+0%*) (17%) (21%)

NUMBER OF HOSPITALS WITH 42 +2% 201 1,177


STAFF SHORTAGES (PERCENT) (30%) (+5%*) (22%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
687,425 6,474 119,118 1.5%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 90% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

GEORGIA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

GEORGIA
STATE REPORT | 01.10.2021

140 hospitals are expected to report in Georgia


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

GEORGIA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Atlanta-Sandy Springs-Alpharetta Gwinnett
Augusta-Richmond County Fulton
Gainesville Cobb
LOCALITIES
37 149
Warner Robins DeKalb
Athens-Clarke County Cherokee
IN RED Dalton Hall
ZONE Savannah
Macon-Bibb County
Henry
Forsyth
▼ (-1) Columbus ▼ (-3) Richmond
Chattanooga Houston
Albany Columbia
Jefferson Clayton

LOCALITIES
IN ORANGE
ZONE
2 Valdosta
Hinesville
4 Lowndes
Cook
Long
Schley
▲ (+2) ▲ (+2)

LOCALITIES
IN YELLOW
ZONE
0 N/A 3 Warren
Randolph
Baker
▼ (-1) ▲ (+2)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Atlanta-Sandy Springs-Alpharetta, Augusta-Richmond County, Gainesville, Warner Robins, Athens-Clarke County, Dalton, Savannah, Macon-Bibb County, Columbus,
Chattanooga, Albany, Jefferson, Rome, Dublin, Brunswick, Waycross, Calhoun, Douglas, LaGrange, Cedartown, Vidalia, Cornelia, Tifton, Thomasville, Thomaston, Milledgeville, Statesboro, St.
Marys, Jesup, Moultrie, Toccoa, Summerville, Americus, Fitzgerald, Bainbridge, Cordele, Eufaula
All Red Counties: Gwinnett, Fulton, Cobb, DeKalb, Cherokee, Hall, Henry, Forsyth, Richmond, Houston, Columbia, Clayton, Paulding, Whitfield, Chatham, Muscogee, Bartow, Bibb, Douglas,
Coweta, Walton, Clarke, Jackson, Barrow, Floyd, Newton, Carroll, Fayette, Laurens, Walker, Spalding, Gordon, Dougherty, Rockdale, Catoosa, Troup, Polk, Glynn, Habersham, Oconee, Murray,
Tift, Coffee, Thomas, Upson, Ware, Pickens, Bulloch, Toombs, White, Madison, Camden, Baldwin, Dawson, Wayne, Lumpkin, Colquitt, Lee, Butts, Hart, Effingham, Peach, Stephens, Gilmer,
Harris, Pike, Bryan, Franklin, Emanuel, Monroe, Dodge, Pierce, Chattooga, Lamar, Jones, Grady, Worth, McDuffie, Greene, Rabun, Tattnall, Haralson, Mitchell, Union, Berrien, Ben Hill, Sumter,
Decatur, Meriwether, Oglethorpe, Appling, Liberty, Putnam, Burke, Morgan, Crisp, Banks, Elbert, Bleckley, Jasper, Jeff Davis, Washington, Fannin, Bacon, Jefferson, Johnson, Dade,
Montgomery, Brantley, Turner, Telfair, Charlton, Irwin, Towns, Hancock, Treutlen, Twiggs, Pulaski, Wilkinson, Brooks, Atkinson, Miller, Macon, Dooly, Clinch, Wilkes, Crawford, Screven, Evans,
Candler, Taylor, Heard, Seminole, Early, McIntosh, Jenkins, Lincoln, Calhoun, Terrell, Talbot, Wheeler, Chattahoochee, Marion, Glascock, Stewart, Webster, Clay, Taliaferro, Quitman

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

GEORGIA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

GEORGIA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
HAWAII Issue 30
SUMMARY
• Hawaii is in the orange zone for cases, indicating between 51 and 100 new cases per 100,000 population, with the lowest rate in the country.
Hawaii is in the green zone for test positivity, indicating a rate at or below 4.9%, with the lowest rate in the country.
• Hawaii has seen an increase in new cases and stability in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Honolulu County, 2. Maui County, and 3. Hawaii
County. These counties represent 99.3% of new cases in Hawaii.
• No counties in Hawaii have moderate or high levels of community transmission (yellow, orange, or red zones).
• During the week of Dec 28 - Jan 3, 5% of nursing homes had at least one new resident COVID-19 case, 8% had at least one new staff COVID-19
case, and none had at least one new resident COVID-19 death.
• Hawaii had 82 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 15 to support operations activities from
FEMA; 2 to support epidemiology activities from CDC; and 19 to support operations activities from USCG.
• The federal government has supported surge testing in Kauai, Maui, and Lanai.
• Between Jan 2 - Jan 8, on average, 11 patients with confirmed COVID-19 and 15 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Hawaii. This is an increase of 19% in total new COVID-19 hospital admissions.
• As of Jan 8, 95,700 vaccine doses have been distributed to Hawaii. 27,375 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the
Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our
large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000
total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and
Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of
monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given
that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we
must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help
identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on
a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should
have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination
sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should
instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the
number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent
vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• The increases in cases, test positivity, and hospitalizations are concerning. Hawaii must do all that it can to prevent importation of virus and
new variants from the mainland.
• Because Hawaii still has an opportunity to mitigate, sensitive surveillance should be enhanced; increased surveillance (wastewater, proactive
testing of at-risk individuals, and genotypic) will help guide programmatic interventions and pivots.
• Ensure that contact tracing is comprehensive and scaled adequately to keep pace with epidemic; use previous recommendations to limit
workload and enhance capacity as needed.
• Ensure that all schools and IHEs that are planning to reopen have capacity to test students and teachers (regardless of symptoms) with rapid
turnaround times.
• Maintain requirements for negative testing before arrival and effective quarantine of all tourists. If adequate surveillance data about virus
variants becomes available, consider using these data to limit tourism from states where variants have emerged.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

HAWAII
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 1,158 369,307 1,744,828


+32%
(RATE PER 100,000) (82) (720) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
3.7% +0.3%* 18.7% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 33,021** 1,533,674** 9,104,878**


+27%**
(TESTS PER 100,000) (2,332**) (2,990**) (2,774**)

COVID-19 DEATHS 14 4,076 21,090


+250%
(RATE PER 100,000) (1.0) (7.9) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
5% N/A*† 20% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
8% N/A*† 32% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
0% N/A*† 10% 16%

TOTAL NEW COVID-19 HOSPITAL 183 +19% 28,479 165,234


ADMISSIONS (RATE PER 100 BEDS) (7) (+19%) (31) (23)

NUMBER OF HOSPITALS WITH 7 +0% 105 1,086


SUPPLY SHORTAGES (PERCENT) (27%) (+0%*) (20%) (21%)

NUMBER OF HOSPITALS WITH 2 +0% 235 1,177


STAFF SHORTAGES (PERCENT) (8%) (+0%*) (44%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
95,700 6,759 27,375 2.5%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 82% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

HAWAII
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

HAWAII
STATE REPORT | 01.10.2021

26 hospitals are expected to report in Hawaii


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

HAWAII
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES

LOCALITIES
IN RED
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)

LOCALITIES
IN ORANGE
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)

LOCALITIES
IN YELLOW
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

HAWAII
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

HAWAII
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
IDAHO Issue 30
SUMMARY
• Idaho is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 31st highest rate in the country. Idaho is in
the red zone for test positivity, indicating a rate at or above 10.1%, with the 6th highest rate in the country.
• Idaho has seen an increase in new cases and stability in test positivity. Test positivity increased in 21 counties, most notably in Washington,
Madison, Adams, and Oneida counties.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Ada County, 2. Kootenai County, and 3. Canyon
County. These counties represent 59.6% of new cases in Idaho.
• 82% of all counties in Idaho have moderate or high levels of community transmission (yellow, orange, or red zones), with 70% having high levels
of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 23% of nursing homes had at least one new resident COVID-19 case, 50% had at least one new staff COVID-19
case, and 8% had at least one new resident COVID-19 death. Life Care Centers reported ongoing outbreaks in at least 3 facilities.
• Idaho had 402 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 9 to support operations activities from FEMA.
• The federal government has supported surge testing in Idaho Falls, ID.
• Between Jan 2 - Jan 8, on average, 48 patients with confirmed COVID-19 and 7 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Idaho. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 108,825 vaccine doses have been distributed to Idaho. 25,335 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the
Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid acceleration
phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our
large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total
COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and
Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal
antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic
data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility,
and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and
mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation;
without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could
quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and
where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a
call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have
outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites
with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put
in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number
of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine
hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Limited surveillance and reduction in testing remain the critical concerns in Idaho and expanding both should be a top priority; expansion of
genomic testing will allow early detection of emergence of virus variants, which should direct programmatic efforts.
• Incorporate new concerns about virus variants in public health messaging that emphasizes the critical importance – now more than ever – of
mask wearing and social distancing; work with local leaders to enforce local mitigation ordinances.
• Ensure that contact tracing is comprehensive and scaled adequately to keep pace with epidemic; use previous recommendations to limit
workload and enhance capacity as needed.
• Ensure that all schools and IHEs that are planning to reopen have capacity to test students and teachers (regardless of symptoms) with rapid
turnaround times.
• Continue development of mid-range (6-12 weeks) contingency plans if hospitalizations increase and ensure all facilities throughout the state
have up-to-date treatment protocols that include recent recommendations on appropriate use of convalescent plasma and immune modulating
therapies.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

IDAHO
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 7,184 39,189 1,744,828


+23%
(RATE PER 100,000) (402) (273) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
21.9% -0.2%* 10.0% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 31,258** 288,163** 9,104,878**


+16%**
(TESTS PER 100,000) (1,749**) (2,008**) (2,774**)

COVID-19 DEATHS 87 431 21,090


+0%
(RATE PER 100,000) (4.9) (3.0) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
23% N/A*† 18% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
50% N/A*† 33% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
8% N/A*† 10% 16%

TOTAL NEW COVID-19 HOSPITAL 380 +3% 3,059 165,234


ADMISSIONS (RATE PER 100 BEDS) (12) (+3%) (13) (23)

NUMBER OF HOSPITALS WITH 2 +0% 39 1,086


SUPPLY SHORTAGES (PERCENT) (5%) (+0%*) (18%) (21%)

NUMBER OF HOSPITALS WITH 4 +0% 18 1,177


STAFF SHORTAGES (PERCENT) (10%) (+0%*) (8%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
108,825 6,089 25,335 1.9%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 73% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

IDAHO
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

IDAHO
STATE REPORT | 01.10.2021

41 hospitals are expected to report in Idaho


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

IDAHO
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Boise Ada
Coeur d'Alene Kootenai
Idaho Falls Canyon
LOCALITIES
12 31
Pocatello Bonneville
Twin Falls Bannock
IN RED Sandpoint Twin Falls
ZONE Rexburg
Burley
Bonner
Madison
■ (+0) Lewiston ■ (+0) Nez Perce
Ontario Jefferson
Moscow Payette
Logan Latah

LOCALITIES
IN ORANGE
ZONE
3 Blackfoot
Mountain Home
Jackson
4 Bingham
Elmore
Oneida
Lincoln
▲ (+1) ▲ (+2)

LOCALITIES
IN YELLOW
ZONE
1 Hailey 1 Teton

■ (+0) ■ (+0)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red Counties: Ada, Kootenai, Canyon, Bonneville, Bannock, Twin Falls, Bonner, Madison, Nez Perce, Jefferson, Payette, Latah, Cassia,
Minidoka, Valley, Jerome, Gem, Idaho, Shoshone, Boundary, Washington, Benewah, Franklin, Adams, Owyhee, Gooding, Caribou, Fremont, Bear
Lake, Lewis, Butte

Red CBSAs: Boise CBSA is comprised of Ada County, ID; Boise County, ID; Canyon County, ID; Gem County, ID; and Owyhee County, ID. Coeur
d'Alene CBSA is comprised of Kootenai County, ID. Idaho Falls CBSA is comprised of Bonneville County, ID; Butte County, ID; and Jefferson
County, ID. Pocatello CBSA is comprised of Bannock County, ID and Power County, ID. Twin Falls CBSA is comprised of Jerome County, ID and
Twin Falls County, ID. Sandpoint CBSA is comprised of Bonner County, ID. Rexburg CBSA is comprised of Fremont County, ID and Madison
County, ID. Burley CBSA is comprised of Cassia County, ID and Minidoka County, ID. Lewiston CBSA is comprised of Nez Perce County, ID and
Asotin County, WA. Ontario CBSA is comprised of Payette County, ID and Malheur County, OR. Moscow CBSA is comprised of Latah County, ID.
Logan CBSA is comprised of Franklin County, ID and Cache County, UT.
Orange CBSAs: Blackfoot CBSA is comprised of Bingham County, ID. Mountain Home CBSA is comprised of Elmore County, ID. Jackson CBSA is
comprised of Teton County, ID and Teton County, WY.
Yellow CBSAs: Hailey CBSA is comprised of Blaine County, ID and Camas County, ID.

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

IDAHO
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

IDAHO
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
ILLINOIS Issue 30
SUMMARY
• Illinois saw a seventh week of gradual improvement in hospitalizations although remains at high levels of disease transmission, hospitalizations, and deaths.
Illinois is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 30th highest rate in the country. Illinois is in the red zone
for test positivity, indicating a rate at or above 10.1%, with the 34th highest rate in the country.
• Illinois has seen an increase in new cases and stability in test positivity. Weekly cases increased sharply although health officials attribute this to post-holiday
resumption of testing. Current hospitalizations decreased for a seventh week with a ~40% fall from their recent peak. Deaths remain high.
• Although improving, high viral transmission continues to involve the entire state with all counties still reporting >100 cases per 100,000 population. The
following three counties had the highest number of new cases over the last 3 weeks: 1. Cook County, 2. DuPage County, and 3. Will County. These counties
represent 48.2% of new cases in Illinois.
• 88% of all counties in Illinois have moderate or high levels of community transmission (yellow, orange, or red zones), with 61% having high levels of
community transmission (red zone).
• Mitigation: The state has indicated it may ease restrictions after next week if disease trends are favorable.
• During the week of Dec 28 - Jan 3, 26% of nursing homes had at least one new resident COVID-19 case, 42% had at least one new staff COVID-19 case, and 19%
had at least one new resident COVID-19 death.
• Illinois had 426 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 80 to support operations activities from FEMA; 5 to support
operations activities from ASPR; 1 to support epidemiology activities from CDC; and 8 to support operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 399 patients with confirmed COVID-19 and 427 patients with suspected COVID-19 were reported as newly admitted each
day to hospitals in Illinois. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 769,700 vaccine doses have been distributed to Illinois. 234,051 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased cases,
increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains slope in the fall
and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread, increasing
hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large metros.
Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-19
inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests increasing
and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data suggest
the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the presence of the UK
variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as more
transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible viruses
emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to action
for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient infusion sites
immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate isolation
and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with use of
EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms now; active and
aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public confidence and
maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of individuals vaccinated to
date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy, continued active encouragement by
the Governor, health officials, and community influencers are needed.
• We share the measured optimism of Illinois’s leaders on current trends given the trend in hospitalization. However, cases and deaths remain high, and we
share the ongoing concern that the forecast for cases and deaths remains dependent on the continued collective effort of Illinois’s residents. Continued
messaging for residents to maintain their changes in personal behavior is key to limiting disease and death until the pandemic ends with immunization. The
Governor’s continued personal communication on these measures remains critical.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that could
limit morbidity and hospitalizations. The recent report confirming the benefit of convalescent plasma when administered early strengthens the case for
expanded utilization of plasma and monoclonal antibodies. Continue to prioritize efforts toward marginalized communities that are disproportionately being
impacted by COVID-19, including a strategy that prioritizes allocation of monoclonal antibody preparations to outpatient centers that serve more
marginalized populations with higher levels of COVID-19 risk factors.
• Mitigation measures in public spaces remain critical and need careful balancing of risk and economic/social benefit. Wide variation in implementation of
mitigation measures across jurisdictions diminishes the effectiveness of these measures.
• Proactive testing must be part of the mitigation efforts inclusive of universal masking, physical distancing, hand hygiene, and the active promotion of
activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in LTCFs as
vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Ensure all K-12 schools are following CDC guidelines, including wearing masks and routinely utilizing the BinaxNOW tests. Ensure all universities returning
after winter break implement mandatory weekly testing of all on and off campus students.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.
The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

ILLINOIS
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 53,932 220,780 1,744,828


+66%
(RATE PER 100,000) (426) (420) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
10.7% +0.0%* 11.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 358,054** 1,504,419** 9,104,878**


+10%**
(TESTS PER 100,000) (2,826**) (2,863**) (2,774**)

COVID-19 DEATHS 1,132 3,714 21,090


+38%
(RATE PER 100,000) (8.9) (7.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
26% N/A*† 27% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
42% N/A*† 45% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
19% N/A*† 19% 16%

TOTAL NEW COVID-19 HOSPITAL 5,778 -3% 22,662 165,234


ADMISSIONS (RATE PER 100 BEDS) (20) (-3%) (19) (23)

NUMBER OF HOSPITALS WITH 37 +0% 192 1,086


SUPPLY SHORTAGES (PERCENT) (20%) (+0%*) (22%) (21%)

NUMBER OF HOSPITALS WITH 22 +5% 185 1,177


STAFF SHORTAGES (PERCENT) (12%) (+29%*) (21%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
769,700 6,074 234,051 2.4%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 83% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

ILLINOIS
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

ILLINOIS
STATE REPORT | 01.10.2021

188 hospitals are expected to report in Illinois


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

ILLINOIS
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Chicago-Naperville-Elgin Cook
St. Louis DuPage
Rockford Will
LOCALITIES
14 62
Bloomington Lake
Davenport-Moline-Rock Island Kane
IN RED Charleston-Mattoon Madison
ZONE Rochelle
Sterling
St. Clair
McHenry
▼ (-1) Mount Vernon ▲ (+3) Winnebago
Effingham Peoria
Fort Madison-Keokuk Tazewell
Paducah McLean
Vermilion
Rock Island
Kankakee
Peoria
LOCALITIES
7 15
Marion
Carbondale-Marion
Stephenson
IN ORANGE Danville
Kankakee
Bond
ZONE Centralia
Ford
McDonough
▼ (-1) Freeport
Macomb
▼ (-1) Wabash
Greene
Menard
Jo Daviess
Sangamon
Adams
LaSalle
Springfield
LOCALITIES
7 13
Macon
Ottawa
Knox
IN YELLOW Quincy
Decatur
Christian
ZONE Galesburg
Logan
Fayette
▲ (+2) Taylorville
Lincoln
▼ (-4) Edgar
Warren
Piatt
Massac

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Chicago-Naperville-Elgin, St. Louis, Rockford, Bloomington, Davenport-Moline-Rock Island, Charleston-Mattoon, Rochelle, Sterling, Mount
Vernon, Effingham, Fort Madison-Keokuk, Paducah, Burlington, Cape Girardeau
All Red Counties: Cook, DuPage, Will, Lake, Kane, Madison, St. Clair, McHenry, Winnebago, Peoria, Tazewell, McLean, Kendall, Williamson, Montgomery,
Perry, DeKalb, Franklin, Ogle, Clinton, Boone, Monroe, Whiteside, Coles, Jefferson, Randolph, Grundy, Effingham, Woodford, Jackson, Macoupin,
Lawrence, Saline, Union, Jersey, Bureau, Iroquois, Clark, Richland, Washington, White, Douglas, Pike, De Witt, Wayne, Hancock, Mason, Shelby, Moultrie,
Cumberland, Jasper, Mercer, Hamilton, Carroll, Edwards, Gallatin, Marshall, Stark, Pulaski, Pope, Henderson, Putnam
All Orange Counties: Vermilion, Rock Island, Kankakee, Marion, Stephenson, Bond, Ford, McDonough, Wabash, Greene, Menard, Jo Daviess, Hardin,
Scott, Alexander
All Yellow Counties: Sangamon, Adams, LaSalle, Macon, Knox, Christian, Logan, Fayette, Edgar, Warren, Piatt, Massac, Clay

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

ILLINOIS
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

ILLINOIS
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
INDIANA Issue 30
SUMMARY
• Indiana’s epidemic appeared to plateau last week with continued extremely high levels of viral transmission. Indiana is in the red zone for cases, indicating
101 or more new cases per 100,000 population, with the 22nd highest rate in the country. Indiana is in the red zone for test positivity, indicating a rate at or
above 10.1%, with the 15th highest rate in the country.
• Indiana has seen an increase in new cases and stability in test positivity with both indicators remaining extremely high. New and current hospitalizations
stabilized at high levels last week. Daily deaths remained high as well.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Marion County, 2. Lake County, and 3. Hamilton County. These
counties represent 25.6% of new cases in Indiana.
• 100% of all counties in Indiana have moderate or high levels of community transmission (yellow, orange, or red zones), with 95% having high levels of
community transmission (red zone).
• Mitigation measures: With the recent improvement, the state lifted a ban on elective surgeries.
• During the week of Dec 28 - Jan 3, 30% of nursing homes had at least one new resident COVID-19 case, 46% had at least one new staff COVID-19 case, and
22% had at least one new resident COVID-19 death.
• Indiana had 517 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 5 to support operations activities from FEMA.
• Between Jan 2 - Jan 8, on average, 389 patients with confirmed COVID-19 and 162 patients with suspected COVID-19 were reported as newly admitted each
day to hospitals in Indiana. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 430,025 vaccine doses have been distributed to Indiana. 137,933 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased cases,
increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains slope in the fall
and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread, increasing
hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large metros.
Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-19
inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests
increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data
suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the presence
of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a much more rapid
transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as more
transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible viruses
emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to
action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient
infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate
isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with use
of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms now;
active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public confidence
and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of individuals
vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy, continued active
encouragement by the Governor, health officials, and community influencers are needed.
• We share the caution of Indiana’s leaders that while the situation has improved in the last month, the reserve of treatment capacity remains limited and the
near-term forecast for cases and deaths remains dependent on the collective effort of Hoosiers to follow the guidelines. Continued messaging for residents
to maintain their changes in personal behavior is key to limiting disease and death until the pandemic ends with immunization. The Governor’s continued
personal communication on these measures remains critical.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that could
limit morbidity and hospitalizations. The recent report confirming the benefit of convalescent plasma when administered early strengthens the case for
expanded utilization of plasma and monoclonal antibodies. Continue to prioritize efforts toward marginalized communities that are disproportionately
being impacted by COVID-19, including a strategy that prioritizes allocation of monoclonal antibody preparations to outpatient centers that serve more
marginalized populations with higher levels of COVID-19 risk factors.
• Proactive testing must be part of the mitigation efforts inclusive of universal masking, physical distancing, hand hygiene, and the active promotion of
activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in LTCFs as
vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Ensure all K-12 schools are following CDC guidelines, including wearing masks and routinely utilizing the BinaxNOW tests. Ensure all universities returning
after winter break implement mandatory weekly testing of all on and off campus students.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

INDIANA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 34,821 220,780 1,744,828


+18%
(RATE PER 100,000) (517) (420) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
17.5% +0.0%* 11.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 155,859** 1,504,419** 9,104,878**


-7%**
(TESTS PER 100,000) (2,315**) (2,863**) (2,774**)

COVID-19 DEATHS 521 3,714 21,090


-13%
(RATE PER 100,000) (7.7) (7.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
30% N/A*† 27% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
46% N/A*† 45% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
22% N/A*† 19% 16%

TOTAL NEW COVID-19 HOSPITAL 3,862 +2% 22,662 165,234


ADMISSIONS (RATE PER 100 BEDS) (23) (+2%) (19) (23)

NUMBER OF HOSPITALS WITH 14 +0% 192 1,086


SUPPLY SHORTAGES (PERCENT) (11%) (+0%*) (22%) (21%)

NUMBER OF HOSPITALS WITH 29 +2% 185 1,177


STAFF SHORTAGES (PERCENT) (24%) (+7%*) (21%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
430,025 6,387 137,933 2.7%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 76% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

INDIANA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

INDIANA
STATE REPORT | 01.10.2021

122 hospitals are expected to report in Indiana


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

INDIANA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Indianapolis-Carmel-Anderson Marion
Chicago-Naperville-Elgin Lake
Evansville Hamilton
LOCALITIES
38 87
Fort Wayne Allen
Louisville/Jefferson County Vanderburgh
IN RED Lafayette-West Lafayette Hendricks
ZONE South Bend-Mishawaka
Terre Haute
Johnson
St. Joseph
▲ (+1) Elkhart-Goshen ▼ (-2) Tippecanoe
Michigan City-La Porte Porter
Jasper Clark
Kokomo Madison

LOCALITIES
IN ORANGE
ZONE
1 Decatur 1 Adams

■ (+0) ▲ (+1)

LOCALITIES
IN YELLOW
ZONE
2 Bloomington
Wabash
4 Monroe
Clay
Wabash
Brown
■ (+0) ▲ (+1)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Indianapolis-Carmel-Anderson, Chicago-Naperville-Elgin, Evansville, Fort Wayne, Louisville/Jefferson County, Lafayette-West Lafayette, South Bend-Mishawaka,
Terre Haute, Elkhart-Goshen, Michigan City-La Porte, Jasper, Kokomo, Cincinnati, Muncie, Warsaw, Marion, New Castle, Columbus, Richmond, Bedford, Kendallville, Frankfort,
Angola, Crawfordsville, Logansport, Huntington, Plymouth, Seymour, Auburn, Peru, Madison, Vincennes, Greensburg, Washington, Connersville, Scottsburg, Bluffton, North
Vernon
All Red Counties: Marion, Lake, Hamilton, Allen, Vanderburgh, Hendricks, Johnson, Tippecanoe, St. Joseph, Porter, Clark, Madison, Elkhart, Vigo, LaPorte, Howard, Hancock,
Delaware, Dubois, Warrick, Boone, Floyd, Kosciusko, Grant, Henry, Morgan, Bartholomew, Wayne, Dearborn, Lawrence, Shelby, Noble, Harrison, Clinton, Steuben, Montgomery,
Cass, Huntington, Gibson, Ripley, Marshall, Jackson, DeKalb, Putnam, White, Whitley, Miami, Greene, Jefferson, Posey, Spencer, Jasper, Knox, Rush, Decatur, Owen, Washington,
Daviess, Fayette, Orange, Fountain, Vermillion, Scott, Carroll, Wells, Sullivan, Jennings, Franklin, Tipton, Pike, LaGrange, Perry, Fulton, Randolph, Starke, Blackford, Pulaski,
Warren, Parke, Union, Martin, Crawford, Jay, Switzerland, Benton, Ohio, Newton

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

INDIANA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

INDIANA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
IOWA Issue 30
SUMMARY
• Iowa is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 37th highest rate in the country. Iowa is
in the red zone for test positivity, indicating a rate at or above 10.1%, with the 23rd highest rate in the country.
• Iowa has seen an increase in new cases and an increase in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Polk County, 2. Scott County, and 3. Linn
County. These counties represent 25.0% of new cases in Iowa.
• 98% of all counties in Iowa have moderate or high levels of community transmission (yellow, orange, or red zones), with 85% having high
levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 15% of nursing homes had at least one new resident COVID-19 case, 38% had at least one new staff
COVID-19 case, and 9% had at least one new resident COVID-19 death.
• Iowa had 373 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Between Jan 2 - Jan 8, on average, 73 patients with confirmed COVID-19 and 25 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Iowa. This is a decrease of 11% in total new COVID-19 hospital admissions.
• As of Jan 8, 191,675 vaccine doses have been distributed to Iowa. 80,621 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000
total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic,
and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of
monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible,
we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and
on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital
should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of
the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Mitigation that Iowa implemented in November was effective to rapidly decrease hospitalizations and prevent deaths.
• With the uptick in cases and positivity, aggressive targeted testing in counties with the highest increases is critical now to prevent surges
similar to those experienced in the fall.
• Early and limited data from returning university students and staff indicate COVID presence at universities; mandatory, weekly testing will
identify asymptomatic cases and can prevent transmission into the community.
• In K-12 schools, establish public health protocols to conduct active testing for teachers and students in districts with high positivity and
cases. In accordance with CDC guidelines, masks should be worn by students and teachers.
• With the high percentage of LTCF sites having COVID-positive staff, continue weekly testing of all staff until residents and staff are fully
vaccinated.
• Ensure all Tribal communities have expanded access to testing, vaccination plans and protocols, and sufficient capacity to contact trace,
isolate, and quarantine. Support Tribal communities in their efforts to protect themselves.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

IOWA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 11,782 55,547 1,744,828


+35%
(RATE PER 100,000) (373) (393) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
14.2% +1.3%* 16.9% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 62,306** 216,870** 9,104,878**


+26%**
(TESTS PER 100,000) (1,975**) (1,534**) (2,774**)

COVID-19 DEATHS 227 1,013 21,090


+47%
(RATE PER 100,000) (7.2) (7.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
15% N/A*† 21% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
38% N/A*† 43% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
9% N/A*† 12% 16%

TOTAL NEW COVID-19 HOSPITAL 686 -11% 6,085 165,234


ADMISSIONS (RATE PER 100 BEDS) (9) (-10%) (17) (23)

NUMBER OF HOSPITALS WITH 26 +4% 114 1,086


SUPPLY SHORTAGES (PERCENT) (22%) (+18%*) (25%) (21%)

NUMBER OF HOSPITALS WITH 6 +2% 75 1,177


STAFF SHORTAGES (PERCENT) (5%) (+50%*) (17%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
191,675 6,075 80,621 3.3%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 87% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

IOWA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

IOWA
STATE REPORT | 01.10.2021

119 hospitals are expected to report in Iowa


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

IOWA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Des Moines-West Des Moines Polk
Cedar Rapids Scott
Davenport-Moline-Rock Island Linn
LOCALITIES
21 84
Waterloo-Cedar Falls Black Hawk
Iowa City Dallas
IN RED Omaha-Council Bluffs Woodbury
ZONE Ames
Sioux City
Pottawattamie
Dubuque
■ (+0) Dubuque ▲ (+1) Story
Clinton Warren
Pella Clinton
Fort Madison-Keokuk Marion

Johnson
Webster
LOCALITIES
3 9
Mahaska
IN ORANGE Mason City
Fort Dodge
Poweshiek
Shelby
ZONE Oskaloosa Mills
■ (+0) ■ (+0) Pocahontas
Davis
Van Buren

LOCALITIES
IN YELLOW
ZONE
0 N/A 4 Cerro Gordo
Keokuk
Decatur
Greene
■ (+0) ▲ (+1)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Des Moines-West Des Moines, Cedar Rapids, Davenport-Moline-Rock Island, Waterloo-Cedar Falls, Iowa City, Omaha-Council Bluffs, Ames,
Sioux City, Dubuque, Pella, Clinton, Fort Madison-Keokuk, Burlington, Muscatine, Storm Lake, Ottumwa, Marshalltown, Fairfield, Carroll, Spirit Lake,
Spencer
All Red Counties: Polk, Scott, Linn, Black Hawk, Dallas, Woodbury, Pottawattamie, Dubuque, Story, Warren, Marion, Clinton, Jasper, Lee, Boone, Des
Moines, Muscatine, Washington, Buena Vista, Wapello, Marshall, Sioux, Fayette, Jefferson, Carroll, Plymouth, Crawford, Butler, Madison, Monroe, Kossuth,
Harrison, Cherokee, Henry, Clayton, Lucas, Bremer, Allamakee, Dickinson, Grundy, Buchanan, Mitchell, Hamilton, Clarke, Hancock, Emmet, Cedar, Jones,
Clay, O'Brien, Tama, Montgomery, Jackson, Appanoose, Franklin, Wright, Hardin, Howard, Louisa, Benton, Lyon, Humboldt, Guthrie, Cass, Delaware,
Floyd, Adair, Page, Worth, Iowa, Chickasaw, Palo Alto, Union, Winnebago, Sac, Monona, Taylor, Wayne, Ringgold, Adams, Ida, Audubon, Fremont, Osceola

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

IOWA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

IOWA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
KANSAS Issue 30
SUMMARY
• Kansas is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 24th highest rate in the country.
Kansas is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 18th highest rate in the country.
• Kansas has seen a decrease in new cases and an increase in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Sedgwick County, 2. Johnson County, and 3.
Shawnee County. These counties represent 44.9% of new cases in Kansas.
• 80% of all counties in Kansas have moderate or high levels of community transmission (yellow, orange, or red zones), with 70% having high
levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 25% of nursing homes had at least one new resident COVID-19 case, 51% had at least one new staff
COVID-19 case, and 18% had at least one new resident COVID-19 death.
• Kansas had 487 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Between Jan 2 - Jan 8, on average, 129 patients with confirmed COVID-19 and 62 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Kansas. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 191,225 vaccine doses have been distributed to Kansas. 58,841 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000
total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic,
and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of
monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible,
we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and
on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital
should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of
the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Mitigation that Kansas implemented in November was effective to rapidly decrease hospitalizations and prevent deaths.
• With the uptick in cases, positivity, and hospitalizations, aggressive targeted testing in counties with the highest increases is critical now to
prevent surges similar to those experienced in the fall.
• Early and limited data from returning university students and staff indicate COVID presence at universities; mandatory, weekly testing will
identify asymptomatic cases and can prevent transmission into the community.
• In K-12 schools, establish public health protocols to conduct active testing for teachers and students in districts with high positivity and
cases. In accordance with CDC guidelines, masks should be worn by students and teachers.
• With the high percentage of LTCF sites having COVID-positive staff, continue weekly testing of all staff until residents and staff are fully
vaccinated.
• Ensure all Tribal communities have expanded access to testing, vaccination plans and protocols, and sufficient capacity to contact trace,
isolate, and quarantine. Support Tribal communities in their efforts to protect themselves.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

KANSAS
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 14,201 55,547 1,744,828


-17%
(RATE PER 100,000) (487) (393) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
16.6% +2.0%* 16.9% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 66,233** 216,870** 9,104,878**


-15%**
(TESTS PER 100,000) (2,273**) (1,534**) (2,774**)

COVID-19 DEATHS 269 1,013 21,090


-27%
(RATE PER 100,000) (9.2) (7.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
25% N/A*† 21% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
51% N/A*† 43% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
18% N/A*† 12% 16%

TOTAL NEW COVID-19 HOSPITAL 1,337 +3% 6,085 165,234


ADMISSIONS (RATE PER 100 BEDS) (17) (+2%) (17) (23)

NUMBER OF HOSPITALS WITH 28 -2% 114 1,086


SUPPLY SHORTAGES (PERCENT) (22%) (-7%*) (25%) (21%)

NUMBER OF HOSPITALS WITH 17 +3% 75 1,177


STAFF SHORTAGES (PERCENT) (13%) (+21%*) (17%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
191,225 6,563 58,841 2.7%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 80% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

KANSAS
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

KANSAS
STATE REPORT | 01.10.2021

128 hospitals are expected to report in Kansas


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

KANSAS
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Kansas City Sedgwick
Wichita Johnson
Topeka Shawnee
LOCALITIES
20 73
Manhattan Wyandotte
Salina Butler
IN RED Lawrence Saline
ZONE Hutchinson
Coffeyville
Douglas
Reno
■ (+0) Winfield ▲ (+2) Montgomery
Pittsburg Leavenworth
Parsons Cowley
Ottawa Crawford

LOCALITIES
0 6
Pawnee
Thomas
IN ORANGE N/A
Nemaha
ZONE Cloud
Trego
▼ (-1) ▼ (-1) Clark

LOCALITIES
1 5
Atchison
IN YELLOW Atchison
Republic
Kingman
ZONE Kearny
▲ (+1) ■ (+0) Haskell

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Kansas City, Wichita, Topeka, Manhattan, Salina, Lawrence, Hutchinson, Coffeyville, Winfield, Pittsburg, Parsons, Ottawa,
Emporia, McPherson, Dodge City, Great Bend, Hays, St. Joseph, Liberal, Garden City
All Red Counties: Sedgwick, Johnson, Shawnee, Wyandotte, Butler, Saline, Douglas, Reno, Montgomery, Leavenworth, Cowley,
Crawford, Labette, Harvey, Miami, Riley, Geary, Franklin, Cherokee, Neosho, Lyon, Sumner, Pottawatomie, McPherson, Dickinson, Ford,
Barton, Jefferson, Bourbon, Ellis, Allen, Rice, Osage, Wilson, Marion, Anderson, Linn, Jackson, Seward, Doniphan, Brown, Wabaunsee,
Ellsworth, Mitchell, Rooks, Morris, Coffey, Clay, Greenwood, Finney, Pratt, Chautauqua, Ottawa, Russell, Harper, Barber, Washington,
Phillips, Osborne, Cheyenne, Lincoln, Elk, Meade, Rush, Smith, Woodson, Marshall, Stafford, Jewell, Graham, Wichita, Morton, Gray

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

KANSAS
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

KANSAS
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
KENTUCKY Issue 30
SUMMARY
• Kentucky is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 7th highest rate in the country.
Kentucky is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 17th highest rate in the country.
• Kentucky has seen an increase in new cases and stability in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Jefferson County, 2. Fayette County, and 3.
Kenton County. These counties represent 25.7% of new cases in Kentucky.
• 98% of all counties in Kentucky have moderate or high levels of community transmission (yellow, orange, or red zones), with 90% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 30% of nursing homes had at least one new resident COVID-19 case, 50% had at least one new staff
COVID-19 case, and 24% had at least one new resident COVID-19 death.
• Kentucky had 692 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• The federal government has supported surge testing in Louisville, KY and will begin in Covington, KY next week.
• Between Jan 2 - Jan 8, on average, 423 patients with confirmed COVID-19 and 110 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in Kentucky. This is a decrease of 6% in total new COVID-19 hospital admissions.
• As of Jan 8, 267,750 vaccine doses have been distributed to Kentucky. 94,443 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast,
Mid-Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular
updating of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best
practice. Given persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community
influencers are needed.
• Hospitalizations remain at their highest levels even with mask requirements in place. Reexamine capacity thresholds for all indoor
public spaces, particularly in those areas with the highest increases.
• In K-12 schools, establish public health protocols to conduct active testing for teachers and students in districts with high positivity and
cases. In accordance with CDC guidelines, masks should be worn by students and teachers.
• With 50% of LTCF sites having COVID-positive staff, continue weekly testing of all staff until residents and staff are fully vaccinated.
• Ensure reporting is maintained to identify when new measures are needed and determine the effects of mitigation.
• Ensure all universities returning after winter break move to mandatory weekly testing of all on and off campus students. Immediately
identifying and isolating asymptomatic individuals will prevent community spread.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

KENTUCKY
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 30,896 401,743 1,744,828


+106%
(RATE PER 100,000) (692) (600) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
17.4% +0.4%* 16.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 121,115** 1,521,048** 9,104,878**


+1%**
(TESTS PER 100,000) (2,711**) (2,273**) (2,774**)

COVID-19 DEATHS 234 3,680 21,090


+49%
(RATE PER 100,000) (5.2) (5.5) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
30% N/A*† 35% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
50% N/A*† 59% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
24% N/A*† 16% 16%

TOTAL NEW COVID-19 HOSPITAL 3,729 -6% 38,210 165,234


ADMISSIONS (RATE PER 100 BEDS) (30) (-6%) (25) (23)

NUMBER OF HOSPITALS WITH 3 +1% 160 1,086


SUPPLY SHORTAGES (PERCENT) (3%) (+50%*) (17%) (21%)

NUMBER OF HOSPITALS WITH 5 +3% 201 1,177


STAFF SHORTAGES (PERCENT) (5%) (+150%*) (22%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
267,750 5,993 94,443 2.7%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 87% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

KENTUCKY
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

KENTUCKY
STATE REPORT | 01.10.2021

98 hospitals are expected to report in Kentucky


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

KENTUCKY
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Louisville/Jefferson County Jefferson
Cincinnati Fayette
Lexington-Fayette Kenton
LOCALITIES
24 108
Bowling Green Warren
London Boone
IN RED Owensboro Daviess
ZONE Huntington-Ashland
Elizabethtown-Fort Knox
Hardin
Oldham
■ (+0) Danville ▲ (+13) Christian
Clarksville Campbell
Richmond-Berea Boyle
Paducah Madison

LOCALITIES
0 5
Whitley
IN ORANGE N/A
Lewis
Adair
ZONE Pendleton
▼ (-1) ▼ (-2) Robertson

LOCALITIES
1 5
Pulaski
IN YELLOW Somerset
Russell
Leslie
ZONE Casey
▲ (+1) ▼ (-6) Elliott

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Louisville/Jefferson County, Cincinnati, Lexington-Fayette, Bowling Green, London, Owensboro, Huntington-Ashland, Elizabethtown-Fort Knox, Danville,
Clarksville, Richmond-Berea, Paducah, Frankfort, Mayfield, Madisonville, Bardstown, Evansville, Mount Sterling, Glasgow, Murray, Central City, Campbellsville, Middlesborough,
Maysville
All Red Counties: Jefferson, Fayette, Kenton, Warren, Boone, Daviess, Hardin, Oldham, Christian, Campbell, Boyle, Madison, Laurel, Pike, Bullitt, Boyd, Graves, McCracken,
Hopkins, Greenup, Nelson, Henderson, Shelby, Scott, Marshall, Knox, Clay, Wayne, Harlan, Morgan, Calloway, Floyd, Muhlenberg, Jessamine, Mercer, Franklin, Bell, Letcher,
Carter, Barren, McCreary, Lincoln, Anderson, Logan, Clark, Bourbon, Ohio, Rowan, Montgomery, Taylor, Meade, Lawrence, Allen, Harrison, Woodford, Clinton, Grant, Perry,
Johnson, Simpson, Grayson, Rockcastle, Fleming, Todd, Marion, Garrard, Breckinridge, Breathitt, Mason, Henry, Webster, Jackson, Spencer, Trigg, Butler, Hancock, Monroe,
Larue, Carroll, Washington, Hart, Union, Estill, Green, Martin, McLean, Bath, Powell, Knott, Cumberland, Nicholas, Owen, Metcalfe, Crittenden, Livingston, Edmonson, Carlisle,
Menifee, Trimble, Lyon, Owsley, Bracken, Wolfe, Magoffin, Lee, Gallatin, Ballard, Fulton

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

KENTUCKY
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

KENTUCKY
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
LOUISIANA Issue 30
SUMMARY
• Louisiana is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 14th highest rate in the country.
Louisiana is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 27th highest rate in the country.
• Louisiana has seen an increase in new cases and an increase in test positivity despite increases in testing rates. These increases coupled
with rapidly rising hospitalizations suggest full pandemic resurgence.
• The following three parishes had the highest number of new cases over the last 3 weeks: 1. Jefferson Parish, 2. Orleans Parish, and 3. East
Baton Rouge Parish. These parishes represent 24.6% of new cases in Louisiana.
• 100% of all parishes in Louisiana have moderate or high levels of community transmission (yellow, orange, or red zones), with 86%
having high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 32% of nursing homes had at least one new resident COVID-19 case, 55% had at least one new staff
COVID-19 case, and 13% had at least one new resident COVID-19 death.
• Louisiana had 563 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 3 to support operations activities from
FEMA and 47 to support operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 263 patients with confirmed COVID-19 and 18 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in Louisiana. This is an increase of 21% in total new COVID-19 hospital admissions.
• As of Jan 8, 299,325 vaccine doses have been distributed to Louisiana. 78,608 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-
Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating
of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Louisiana is in full pandemic resurgence and in addition to aggressive mitigation and testing, must increase the utilization of monoclonal
antibodies in outpatient settings, including settings linked to emergency rooms.
• Significantly increase public mitigation and increase communication around the importance of personal mitigation with masking,
physical distancing, and avoiding family gatherings.
• Ensure aggressive, proactive testing as many more individuals may be asymptomatic and actively spreading virus in the community.
• All K-12 teachers and older students, community colleges, and universities should require weekly testing, as it dramatically decreases
COVID-19 viral spread by identifying and isolating the asymptomatic individuals, as well as symptomatic individuals, and allows for
contact tracing.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

LOUISIANA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 26,167 243,956 1,744,828


+39%
(RATE PER 100,000) (563) (571) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
13.8% +0.8%* 18.4% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 146,323** 853,979** 9,104,878**


+4%**
(TESTS PER 100,000) (3,148**) (1,999**) (2,774**)

COVID-19 DEATHS 347 2,639 21,090


+62%
(RATE PER 100,000) (7.5) (6.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
32% N/A*† 31% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
55% N/A*† 52% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
13% N/A*† 15% 16%

TOTAL NEW COVID-19 HOSPITAL 1,967 +21% 25,494 165,234


ADMISSIONS (RATE PER 100 BEDS) (15) (+20%) (27) (23)

NUMBER OF HOSPITALS WITH 68 -1% 211 1,086


SUPPLY SHORTAGES (PERCENT) (45%) (-1%*) (24%) (21%)

NUMBER OF HOSPITALS WITH 38 -1% 283 1,177


STAFF SHORTAGES (PERCENT) (25%) (-3%*) (32%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
299,325 6,438 78,608 2.2%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 88% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating parish-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

LOUISIANA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP PARISHES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating parish-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

LOUISIANA
STATE REPORT | 01.10.2021

150 hospitals are expected to report in Louisiana


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

LOUISIANA
STATE REPORT | 01.10.2021
COVID-19 PARISH AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) PARISHES


New Orleans-Metairie Jefferson
Baton Rouge Orleans
Lafayette East Baton Rouge
LOCALITIES
17 55
Shreveport-Bossier City St. Tammany
Monroe Caddo
IN RED Houma-Thibodaux Lafayette
ZONE Lake Charles
Alexandria
Ouachita
Calcasieu
▲ (+1) Hammond ▲ (+1) Bossier
Opelousas Rapides
Minden Livingston
Natchitoches Terrebonne

LOCALITIES
0 5
Sabine
IN ORANGE N/A
Allen
Jackson
ZONE LaSalle
▼ (-2) ▼ (-2) Winn

LOCALITIES
IN YELLOW
ZONE
2 Ruston
Jennings
4 Lincoln
Jefferson Davis
Assumption
East Feliciana
▲ (+1) ▲ (+2)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: New Orleans-Metairie, Baton Rouge, Lafayette, Shreveport-Bossier City, Monroe, Houma-Thibodaux, Lake Charles,
Alexandria, Hammond, Opelousas, Minden, Natchitoches, Morgan City, Bogalusa, Fort Polk South, DeRidder, Natchez
All Red Parishes: Jefferson, Orleans, East Baton Rouge, St. Tammany, Caddo, Lafayette, Ouachita, Calcasieu, Bossier, Rapides,
Livingston, Terrebonne, Ascension, Tangipahoa, Lafourche, St. Landry, Iberia, St. Charles, Vermilion, Acadia, St. Martin, Webster,
Natchitoches, St. Mary, St. Bernard, Washington, Vernon, St. John the Baptist, Avoyelles, Beauregard, Morehouse, Grant, Iberville,
Evangeline, Union, De Soto, West Baton Rouge, Plaquemines, Claiborne, Pointe Coupee, St. James, Richland, Franklin, Concordia,
Bienville, Madison, West Carroll, Catahoula, Caldwell, St. Helena, East Carroll, West Feliciana, Red River, Cameron, Tensas

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating parish-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 parishes based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating parish-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

LOUISIANA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating parish-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

LOUISIANA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating parish-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
MAINE Issue 30
SUMMARY
• Maine is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 46th highest rate in the country. Maine is
in the yellow zone for test positivity, indicating a rate between 5.0% and 7.9%, with the 45th highest rate in the country.
• Maine has seen stability in new cases and an increase in test positivity. Ten counties reported an increase in cases and 9 counties (most
notably Oxford, Piscataquis, Somerset, Sagadahoc, and York counties) reported an increase in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Cumberland County, 2. York County, and 3.
Penobscot County. These counties represent 62.7% of new cases in Maine.
• 62% of all counties in Maine have moderate or high levels of community transmission (yellow, orange, or red zones), with 6% having high
levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 16% of nursing homes had at least one new resident COVID-19 case, 32% had at least one new staff COVID-
19 case, and 11% had at least one new resident COVID-19 death.
• Maine had 281 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 2 to support operations activities from FEMA.
• Between Jan 2 - Jan 8, on average, 17 patients with confirmed COVID-19 and 26 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Maine. This is an increase of 11% in total new COVID-19 hospital admissions.
• As of Jan 8, 96,475 vaccine doses have been distributed to Maine. 41,429 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the
Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our
large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000
total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and
Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of
monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given
that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we
must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help
identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on
a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should
have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination
sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should
instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the
number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent
vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Case rates, test positivity, and hospitalizations indicate increasing transmission in Maine, which will require intensification of testing,
surveillance, community messaging, and contact tracing.
• Enhanced surveillance (wastewater, routine testing of at-risk individuals, and genomic) will allow early identification of outbreaks and earlier
and more productive targeting of mitigation efforts.
• Public health messages should incorporate new concerns about emergence of a more transmissible virus, and should underscore critical
need for face-masking and distancing (now more then ever). Mainers should be made aware of any vaccine requirements.
• Leverage current vaccine allocation successes by creating an online tool that will allow people to schedule their shots; this can be deployed
when distribution becomes more predictable with advanced notification to state.
• Ensure that all schools and IHEs that are planning to reopen have protocols and the capacity for regular testing of students and teachers
(including those without symptoms).
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

MAINE
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 3,774 85,599 1,744,828


+2%
(RATE PER 100,000) (281) (577) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
6.1% +0.6%* 8.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 38,824** 640,515** 9,104,878**


+13%**
(TESTS PER 100,000) (2,888**) (4,315**) (2,774**)

COVID-19 DEATHS 74 1,211 21,090


+90%
(RATE PER 100,000) (5.5) (8.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
16% N/A*† 27% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
32% N/A*† 49% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
11% N/A*† 15% 16%

TOTAL NEW COVID-19 HOSPITAL 299 +11% 5,332 165,234


ADMISSIONS (RATE PER 100 BEDS) (10) (+11%) (16) (23)

NUMBER OF HOSPITALS WITH 10 +0% 48 1,086


SUPPLY SHORTAGES (PERCENT) (29%) (+0%*) (26%) (21%)

NUMBER OF HOSPITALS WITH 3 +2% 30 1,177


STAFF SHORTAGES (PERCENT) (9%) (+200%*) (16%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
96,475 7,177 41,429 3.8%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 97% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

MAINE
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs)
through 1/6/2021.
COVID-19 Issue 30

MAINE
STATE REPORT | 01.10.2021

34 hospitals are expected to report in Maine


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

MAINE
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES

LOCALITIES
IN RED
ZONE
0 N/A 1 Oxford

■ (+0) ■ (+0)

LOCALITIES
IN ORANGE
ZONE
1 Lewiston-Auburn 1 Androscoggin

■ (+0) ■ (+0)

Cumberland
LOCALITIES
3 8
York
Penobscot
IN YELLOW Portland-South Portland
Bangor
Kennebec
ZONE Augusta-Waterville
Aroostook
Somerset
▲ (+1) ▲ (+4) Sagadahoc
Piscataquis

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs) through
1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

MAINE
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs) through
1/6/2021; week one month before is 12/3 - 12/9.
COVID-19 Issue 30

MAINE
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
MARYLAND Issue 30
SUMMARY
• Maryland showed signs of a post-holiday increase although resumption of routine testing and reporting post-holidays may be contributing. Maryland is in the
red zone for cases, indicating 101 or more new cases per 100,000 population, with the 42nd highest rate in the country. Maryland is in the red zone for test
positivity, indicating a rate at or above 10.1%, with the 37th highest rate in the country.
• Maryland has seen an increase in new cases and stability in test positivity. The average daily number of cases increased to >2,700. New hospitalizations
increased slightly while current hospitalizations gradually increased to a new peak. Deaths remained ~40 per day.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Prince George's County, 2. Montgomery County, and 3. Baltimore
County. These counties represent 44.0% of new cases in Maryland.
• 100% of all counties in Maryland have moderate or high levels of community transmission (yellow, orange, or red zones), with 67% having high levels of
community transmission (red zone).
• During the week of Dec 28 - Jan 3, 30% of nursing homes had at least one new resident COVID-19 case, 54% had at least one new staff COVID-19 case, and 12%
had at least one new resident COVID-19 death.
• Maryland had 321 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 15 to support operations activities from FEMA; 3 to support
operations activities from ASPR; and 14 to support operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 230 patients with confirmed COVID-19 and 321 patients with suspected COVID-19 were reported as newly admitted each
day to hospitals in Maryland. This is an increase of 6% in total new COVID-19 hospital admissions.
• As of Jan 8, 371,425 vaccine doses have been distributed to Maryland. 114,731 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased cases,
increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains slope in the fall
and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread, increasing
hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large metros.
Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-19
inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests increasing
and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data suggest
the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the presence of the UK
variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as more
transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible viruses
emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to action
for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient infusion sites
immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate isolation
and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with use of
EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms now; active and
aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public confidence and
maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of individuals vaccinated to
date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy, continued active encouragement by
the Governor, health officials, and community influencers are needed.
• We share the caution of Maryland’s leaders that the apparent stabilization of the severe upsurge may be replaced by a resumption of case increases; the near-
term forecast for cases and deaths is dependent on the collective effort of Marylanders to observe mitigation measures. Continued messaging for residents to
maintain their changes in personal behavior is key to limiting disease and death until the pandemic ends with immunization. The Governor’s continued
personal communication on these measures remains critical.
• The announced changes to the roll-out of the COVID immunization program, including prioritizing shipments to facilities demonstrating the ability to
effectively administer vaccine, are commended.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that could
limit morbidity and hospitalizations. Maryland’s efforts to establish regional infusion centers are commended; however, the number remains inadequate to
ensure easy access by all who could benefit.
• Continue to prioritize efforts toward marginalized communities that are disproportionately being impacted by COVID-19, including a strategy that prioritizes
allocation of monoclonal antibody preparations to outpatient centers that serve more marginalized populations with higher levels of COVID-19 risk factors.
• Mitigation measures in public spaces remain critical and need careful balancing of risk and economic/social benefit. Proactive testing must be part of the
mitigation efforts inclusive of universal masking, physical distancing, hand hygiene, and the active promotion of activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in LTCFs as
vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Ensure all K-12 schools are following CDC guidelines, including wearing masks and routinely utilizing the BinaxNOW tests. Ensure all universities returning
after winter break implement mandatory weekly testing of all on and off campus students.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

MARYLAND
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 19,387 126,056 1,744,828


+14%
(RATE PER 100,000) (321) (409) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
10.2% -0.2%* 14.2% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 251,586** 1,010,441** 9,104,878**


-1%**
(TESTS PER 100,000) (4,161**) (3,275**) (2,774**)

COVID-19 DEATHS 276 1,971 21,090


-1%
(RATE PER 100,000) (4.6) (6.4) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
30% N/A*† 37% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
54% N/A*† 62% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
12% N/A*† 21% 16%

TOTAL NEW COVID-19 HOSPITAL 3,855 +6% 18,632 165,234


ADMISSIONS (RATE PER 100 BEDS) (39) (+5%) (27) (23)

NUMBER OF HOSPITALS WITH 6 +0% 77 1,086


SUPPLY SHORTAGES (PERCENT) (13%) (+0%*) (20%) (21%)

NUMBER OF HOSPITALS WITH 3 +1% 92 1,177


STAFF SHORTAGES (PERCENT) (7%) (+50%*) (24%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
371,425 6,143 114,731 2.4%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 96% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

MARYLAND
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

MARYLAND
STATE REPORT | 01.10.2021

45 hospitals are expected to report in Maryland


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

MARYLAND
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Prince George's
Baltimore
Washington-Arlington-Alexandria Anne Arundel
LOCALITIES
8 16
Hagerstown-Martinsburg Washington
Salisbury Carroll
IN RED Philadelphia-Camden-Wilmington Wicomico
ZONE California-Lexington Park
Cumberland
Cecil
St. Mary's
▲ (+2) Easton ▲ (+4) Allegany
Cambridge Worcester
Calvert
Queen Anne's

LOCALITIES
1 6
Montgomery
Frederick
IN ORANGE Baltimore-Columbia-Towson
Howard
ZONE Harford
Charles
▼ (-1) ▼ (-2) Caroline

LOCALITIES
IN YELLOW
ZONE
0 N/A 2 Baltimore City
Kent

▼ (-1) ▼ (-2)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red Counties: Prince George's, Baltimore, Anne Arundel, Washington, Carroll, Wicomico, Cecil, St. Mary's,
Allegany, Worcester, Calvert, Queen Anne's, Somerset, Talbot, Dorchester, Garrett

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

MARYLAND
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

MARYLAND
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
MASSACHUSETTS Issue 30
SUMMARY
• Massachusetts is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 8th highest rate in the country.
Massachusetts is in the orange zone for test positivity, indicating a rate between 8.0% and 10.0%, with the 41st highest rate in the country.
• Massachusetts has seen an increase in new cases and stability in test positivity. All counties had an increase in cases, and 7 counties had an
increase in test positivity, most notably Nantucket, Dukes, Bristol, and Hampden counties.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Middlesex County, 2. Essex County, and 3. Worcester
County. These counties represent 45.0% of new cases in Massachusetts.
• 93% of all counties in Massachusetts have moderate or high levels of community transmission (yellow, orange, or red zones), with 29% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 28% of nursing homes had at least one new resident COVID-19 case, 49% had at least one new staff COVID-19
case, and 15% had at least one new resident COVID-19 death.
• Massachusetts had 646 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 141 to support operations activities from
FEMA; 4 to support operations activities from ASPR; and 19 to support operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 259 patients with confirmed COVID-19 and 135 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Massachusetts. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 449,625 vaccine doses have been distributed to Massachusetts. 151,430 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the
Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our
large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000
total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and
Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of
monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given
that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must
be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation;
without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could
quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and
where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on
a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should
have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination
sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead
be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the
number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent
vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• The very high level of transmission and likely increasing circulation of more transmissible variants require additional efforts to expand
surveillance, intensify public health messaging, and increase timely contact tracing to keep pace with the epidemic.
• Public health messaging should include concerns about emergent viral variants to promote strict face-masking and social distancing (and
reporting of non-compliant businesses).
• Increased wastewater and genomic surveillance will help detect increased transmission and spread of variants early and allow targeting of
mitigation efforts.
• Ensure testing returns to pre-holiday levels and is easily available to all communities, particularly those that have more limited access to care.
• Ensure equitable distribution of resources, accounting for the need in communities with larger populations of those at risk for more severe
disease, and ensure all facilities have the most up-to-date treatment protocols, including appropriate use of immune modulating agents and
convalescent plasma.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

MASSACHUSETTS
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 44,543 85,599 1,744,828


+34%
(RATE PER 100,000) (646) (577) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
8.1% -0.3%* 8.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 436,451** 640,515** 9,104,878**


+1%**
(TESTS PER 100,000) (6,332**) (4,315**) (2,774**)

COVID-19 DEATHS 562 1,211 21,090


+22%
(RATE PER 100,000) (8.2) (8.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
28% N/A*† 27% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
49% N/A*† 49% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
15% N/A*† 15% 16%

TOTAL NEW COVID-19 HOSPITAL 2,759 -2% 5,332 165,234


ADMISSIONS (RATE PER 100 BEDS) (18) (-4%) (16) (23)

NUMBER OF HOSPITALS WITH 5 +0% 48 1,086


SUPPLY SHORTAGES (PERCENT) (8%) (+0%*) (26%) (21%)

NUMBER OF HOSPITALS WITH 8 +1% 30 1,177


STAFF SHORTAGES (PERCENT) (12%) (+14%*) (16%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
449,625 6,523 151,430 2.7%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 87% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

MASSACHUSETTS
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

MASSACHUSETTS
STATE REPORT | 01.10.2021

64 hospitals are expected to report in Massachusetts


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

MASSACHUSETTS
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES

LOCALITIES
IN RED
ZONE
1 Worcester 4 Essex
Bristol
Hampden
Nantucket
▲ (+1) ▲ (+2)

LOCALITIES
IN ORANGE
ZONE
2 Providence-Warwick
Springfield
2 Worcester
Plymouth

▼ (-2) ▼ (-2)

Middlesex
LOCALITIES
4 7
Suffolk
Boston-Cambridge-Newton
IN YELLOW Barnstable Town
Norfolk
Barnstable
ZONE Pittsfield
Vineyard Haven
Hampshire
▲ (+3) ▲ (+2) Berkshire
Dukes

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

MASSACHUSETTS
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

MASSACHUSETTS
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
MICHIGAN Issue 30
SUMMARY
• Michigan saw evidence for a resurgence with an increase in cases and deaths. Michigan is in the red zone for cases, indicating 101 or more new cases per
100,000 population, with the 43rd highest rate in the country. Michigan is in the orange zone for test positivity, indicating a rate between 8.0% and 10.0%, with
the 39th highest rate in the country.
• Michigan has seen an increase in new cases and an increase in test positivity.
• New hospitalizations were stable, while current hospitalizations continued to slowly decline.
• High-level viral transmission remained widespread throughout the state; ten counties reported <100 cases per 100,000 residents. The following three counties
had the highest number of new cases over the last 3 weeks: 1. Wayne County, 2. Oakland County, and 3. Macomb County. These counties represent 32.0% of
new cases in Michigan.
• 84% of all counties in Michigan have moderate or high levels of community transmission (yellow, orange, or red zones), with 46% having high levels of
community transmission (red zone).
• Immunization: Thousands of Michigan's frontline workers have declined the vaccine, contributing to the slowed roll-out.
• During the week of Dec 28 - Jan 3, 23% of nursing homes had at least one new resident COVID-19 case, 44% had at least one new staff COVID-19 case, and 18%
had at least one new resident COVID-19 death.
• Michigan had 311 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 8 to support operations activities from FEMA and 7 to support
operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 284 patients with confirmed COVID-19 and 111 patients with suspected COVID-19 were reported as newly admitted each
day to hospitals in Michigan. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 662,550 vaccine doses have been distributed to Michigan. 156,251 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased cases,
increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains slope in the fall
and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread, increasing
hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large metros.
Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-19
inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests increasing
and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data suggest
the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the presence of the UK
variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as more
transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible viruses
emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to action
for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient infusion sites
immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate isolation
and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with use of
EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms now; active and
aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public confidence and
maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of individuals vaccinated to
date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy, continued active encouragement by
the Governor, health officials, and community influencers are needed.
• Although holiday reporting instability makes it difficult to fully assess disease trends, we share the caution of Michigan’s leaders that despite the improving
hospital census, the recent upticks in cases may be evidence of a post-holiday worsening. This week’s data should help clarify this. In the near-term, the
forecast for cases and deaths remains dependent on the collective effort of Michiganders to follow the guidelines. Continued messaging for residents to
maintain their changes in personal behavior is key to limiting disease and death until the pandemic ends with immunization. The Governor’s continued
personal communication on these measures remains critical.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that could
limit morbidity and hospitalizations. The recent report confirming the benefit of convalescent plasma when administered early strengthens the case for
expanded utilization of plasma and monoclonal antibodies. Continue to prioritize efforts toward marginalized communities that are disproportionately being
impacted by COVID-19, including a strategy that prioritizes allocation of monoclonal antibody preparations to outpatient centers that serve more
marginalized populations with higher levels of COVID-19 risk factors.
• Mitigation measures in public spaces remain critical and need careful balancing of risk and economic/social benefit. Proactive testing must be part of
mitigation efforts inclusive of universal masking, physical distancing, hand hygiene, and the active promotion of activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in LTCFs as
vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Ensure all K-12 schools are following CDC guidelines, including wearing masks and routinely utilizing the BinaxNOW tests. Ensure all universities returning
after winter break implement mandatory weekly testing of all on and off campus students.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

MICHIGAN
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 31,067 220,780 1,744,828


+54%
(RATE PER 100,000) (311) (420) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
9.8% +0.9%* 11.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 255,517** 1,504,419** 9,104,878**


+2%**
(TESTS PER 100,000) (2,559**) (2,863**) (2,774**)

COVID-19 DEATHS 896 3,714 21,090


+49%
(RATE PER 100,000) (9.0) (7.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
23% N/A*† 27% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
44% N/A*† 45% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
18% N/A*† 19% 16%

TOTAL NEW COVID-19 HOSPITAL 2,769 +0% 22,662 165,234


ADMISSIONS (RATE PER 100 BEDS) (14) (-1%) (19) (23)

NUMBER OF HOSPITALS WITH 34 +1% 192 1,086


SUPPLY SHORTAGES (PERCENT) (26%) (+3%*) (22%) (21%)

NUMBER OF HOSPITALS WITH 23 -1% 185 1,177


STAFF SHORTAGES (PERCENT) (18%) (-4%*) (21%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
662,550 6,634 156,251 2.0%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 93% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

MICHIGAN
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

MICHIGAN
STATE REPORT | 01.10.2021

131 hospitals are expected to report in Michigan


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

MICHIGAN
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Detroit-Warren-Dearborn Macomb
Grand Rapids-Kentwood Kent
Kalamazoo-Portage Ottawa
LOCALITIES
14 38
Saginaw Kalamazoo
Niles Saginaw
IN RED Adrian Livingston
ZONE Traverse City
Bay City
St. Clair
Berrien
▲ (+8) Midland ▲ (+18) Lenawee
Sturgis Bay
Hillsdale Eaton
South Bend-Mishawaka Grand Traverse
Wayne
Lansing-East Lansing Oakland
Flint Genesee
LOCALITIES
10 18
Ann Arbor Washtenaw
Monroe Ingham
IN ORANGE Holland Monroe
ZONE Muskegon
Mount Pleasant
Allegan
Muskegon
▼ (-2) Houghton ▼ (-9) Clinton
Marinette Ionia
Ludington Isabella
Houghton
Jackson
Calhoun
Branch
Jackson
LOCALITIES
7 14
Chippewa
Battle Creek
Montcalm
IN YELLOW Coldwater
Sault Ste. Marie
Sanilac
ZONE Iron Mountain
Dickinson
Mecosta
▼ (-3) Big Rapids
Escanaba
▼ (-5) Delta
Manistee
Otsego
Montmorency

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Detroit-Warren-Dearborn, Grand Rapids-Kentwood, Kalamazoo-Portage, Saginaw, Niles, Adrian, Traverse City, Bay City,
Midland, Sturgis, Hillsdale, South Bend-Mishawaka, Cadillac, Alpena
All Red Counties: Macomb, Kent, Ottawa, Kalamazoo, Saginaw, Livingston, St. Clair, Berrien, Lenawee, Bay, Eaton, Grand Traverse,
Midland, St. Joseph, Hillsdale, Van Buren, Lapeer, Shiawassee, Tuscola, Cass, Barry, Newaygo, Huron, Alpena, Menominee, Clare,
Gladwin, Wexford, Missaukee, Oceana, Osceola, Benzie, Iosco, Cheboygan, Crawford, Oscoda, Alcona, Keweenaw
All Orange Counties: Wayne, Oakland, Genesee, Washtenaw, Ingham, Monroe, Allegan, Muskegon, Clinton, Ionia, Isabella, Houghton,
Mason, Antrim, Ogemaw, Leelanau, Roscommon, Presque Isle
All Yellow Counties: Jackson, Calhoun, Branch, Chippewa, Montcalm, Sanilac, Dickinson, Mecosta, Delta, Manistee, Otsego,
Montmorency, Arenac, Kalkaska

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

MICHIGAN
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

MICHIGAN
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
MINNESOTA Issue 30
SUMMARY
• After several weeks of declines, Minnesota reported an increase in cases and deaths although holiday-related reporting instability may still be affecting trends
as normal services resume. Minnesota is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 44th highest rate in the
country. Minnesota is in the yellow zone for test positivity, indicating a rate between 5.0% and 7.9%, with the 44th highest rate in the country.
• Minnesota has seen an increase in new cases and stability in test positivity (+0.4%). Current hospitalizations (7-day average) fell for a seventh week; although
still high, current hospitalizations are now nearly 60% off their peak. Deaths increased with COVID claiming ~44 lives per day.
• Viral transmission remains high throughout the state. The following three counties had the highest number of new cases over the last 3 weeks: 1. Hennepin
County, 2. Ramsey County, and 3. Dakota County. These counties represent 37.9% of new cases in Minnesota.
• 77% of all counties in Minnesota have moderate or high levels of community transmission (yellow, orange, or red zones), with 13% having high levels of
community transmission (red zone).
• Surveillance: Minnesota has confirmed the presence of 5 cases of the B.1.1.7 variant in a sampling of cases from the 2nd half of December, indicating
substantial circulation.
• During the week of Dec 28 - Jan 3, 18% of nursing homes had at least one new resident COVID-19 case, 36% had at least one new staff COVID-19 case, and 13%
had at least one new resident COVID-19 death.
• Minnesota had 295 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 7 to support operations activities from FEMA; 15 to support
medical activities from ASPR; and 1 to support operations activities from USCG.
• The federal government has supported surge testing, pending a new location in January.
• Between Jan 2 - Jan 8, on average, 104 patients with confirmed COVID-19 and 52 patients with suspected COVID-19 were reported as newly admitted each day
to hospitals in Minnesota. This is a decrease of 8% in total new COVID-19 hospital admissions.
• As of Jan 8, 381,325 vaccine doses have been distributed to Minnesota. 110,427 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased cases,
increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains slope in the fall
and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread, increasing
hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large metros.
Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-19
inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests increasing
and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data suggest
the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the presence of the UK
variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as more
transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible viruses
emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to action
for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient infusion sites
immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate isolation
and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with use of
EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms now; active and
aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public confidence and
maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of individuals vaccinated to
date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy, continued active encouragement by
the Governor, health officials, and community influencers are needed.
• We share the caution of Minnesota’s leaders that the state is at an inflection point following multiple weeks of improvement but with a recent increase in
cases and slight upward trend in test positivity. With the presence of the B.1.1.7 variant and efforts to ease restrictions, the near-term forecast for cases and
deaths remains dependent on the collective effort of Minnesotans to follow the guidelines. Continued messaging for residents to maintain their changes in
personal behavior is key to limiting disease and death until the pandemic ends with immunization. The Governor’s continued personal communication on
these measures remains critical.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that could
limit morbidity and hospitalizations. The recent report confirming the benefit of convalescent plasma when administered early strengthens the case for
expanded utilization of plasma and monoclonal antibodies. Continue to prioritize efforts toward marginalized communities that are disproportionately being
impacted by COVID-19, including a strategy that prioritizes allocation of monoclonal antibody preparations to outpatient centers that serve more
marginalized populations with higher levels of COVID-19 risk factors.
• Proactive testing must be part of the mitigation efforts inclusive of universal masking, physical distancing, hand hygiene, and the active promotion of
activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in LTCFs as
vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Ensure all K-12 schools are following CDC guidelines, including wearing masks and routinely utilizing the BinaxNOW tests. Ensure all universities returning
after winter break implement mandatory weekly testing of all on and off campus students.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.
The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

MINNESOTA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 16,642 220,780 1,744,828


+53%
(RATE PER 100,000) (295) (420) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
6.6% +0.4%* 11.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 269,304** 1,504,419** 9,104,878**


+5%**
(TESTS PER 100,000) (4,775**) (2,863**) (2,774**)

COVID-19 DEATHS 306 3,714 21,090


+12%
(RATE PER 100,000) (5.4) (7.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
18% N/A*† 27% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
36% N/A*† 45% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
13% N/A*† 19% 16%

TOTAL NEW COVID-19 HOSPITAL 1,090 -8% 22,662 165,234


ADMISSIONS (RATE PER 100 BEDS) (11) (-9%) (19) (23)

NUMBER OF HOSPITALS WITH 37 -2% 192 1,086


SUPPLY SHORTAGES (PERCENT) (28%) (-5%*) (22%) (21%)

NUMBER OF HOSPITALS WITH 22 +2% 185 1,177


STAFF SHORTAGES (PERCENT) (17%) (+10%*) (21%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
381,325 6,761 110,427 2.5%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 84% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

MINNESOTA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

MINNESOTA
STATE REPORT | 01.10.2021

130 hospitals are expected to report in Minnesota


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

MINNESOTA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Chisago
Pine
Freeborn
LOCALITIES
3 11
Waseca
IN RED Albert Lea
Fairmont
Faribault
Martin
ZONE Worthington Nobles
▲ (+1) ▲ (+1) Wadena
Murray
Roseau
Pipestone
Dakota
Anoka
Olmsted
LOCALITIES
4 15
Scott
Faribault-Northfield Rice
IN ORANGE Red Wing Goodhue
ZONE Marshall
Hutchinson
Lyon
McLeod
▲ (+3) ▲ (+3) Houston
Le Sueur
Cass
Hubbard
Minneapolis-St. Paul-Bloomington Hennepin
Rochester Ramsey
Duluth Washington
LOCALITIES
14 41
St. Cloud St. Louis
Mankato Stearns
IN YELLOW Brainerd Wright
ZONE Alexandria
Fergus Falls
Sherburne
Carver
▼ (-4) Winona ■ (+0) Blue Earth
Austin Clay
Bemidji Benton
La Crosse-Onalaska Douglas

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Yellow CBSAs: Minneapolis-St. Paul-Bloomington, Rochester, Duluth, St. Cloud, Mankato, Brainerd, Alexandria, Fergus Falls, Winona,
Austin, Bemidji, La Crosse-Onalaska, New Ulm, Owatonna
All Orange Counties: Dakota, Anoka, Olmsted, Scott, Rice, Goodhue, Lyon, McLeod, Houston, Le Sueur, Cass, Hubbard, Sibley, Jackson,
Lac qui Parle
All Yellow Counties: Hennepin, Ramsey, Washington, St. Louis, Stearns, Wright, Sherburne, Carver, Blue Earth, Clay, Benton, Douglas,
Otter Tail, Winona, Crow Wing, Isanti, Mower, Beltrami, Wabasha, Morrison, Nicollet, Brown, Steele, Dodge, Mille Lacs, Meeker, Renville,
Redwood, Chippewa, Aitkin, Kanabec, Rock, Grant, Cottonwood, Pennington, Pope, Clearwater, Marshall, Lincoln, Big Stone, Watonwan

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

MINNESOTA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

MINNESOTA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
MISSISSIPPI Issue 30
SUMMARY
• Mississippi is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 23rd highest rate in the
country. Mississippi is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 16th highest rate in the country.
• Mississippi has seen stability in new cases and an increase in test positivity. Hospitalizations remain at a high plateau.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. DeSoto County, 2. Harrison County, and 3.
Hinds County. These counties represent 19.2% of new cases in Mississippi.
• 98% of all counties in Mississippi have moderate or high levels of community transmission (yellow, orange, or red zones), with 87%
having high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 31% of nursing homes had at least one new resident COVID-19 case, 54% had at least one new staff
COVID-19 case, and 15% had at least one new resident COVID-19 death.
• Mississippi had 513 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 1 to support operations activities from
FEMA.
• Between Jan 2 - Jan 8, on average, 161 patients with confirmed COVID-19 and 43 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in Mississippi. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 159,625 vaccine doses have been distributed to Mississippi. 34,406 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-
Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating
of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Stable cases are most likely related to low testing. Rising numbers of LTCFs with positive staff members and high levels of
hospitalizations suggest significant ongoing community spread.
• Significantly increase public mitigation and increase communication around the importance of personal mitigation with masking,
physical distancing, and avoiding family gatherings.
• Ensure aggressive, proactive testing as many more individuals may be asymptomatic and actively spreading virus in the community.
• All K-12 teachers and older students, community colleges, and universities should require weekly testing, as it dramatically decreases
COVID-19 viral spread by identifying and isolating the asymptomatic individuals, as well as symptomatic individuals, and allows for
contact tracing.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

MISSISSIPPI
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 15,279 401,743 1,744,828


+8%
(RATE PER 100,000) (513) (600) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
17.4% +0.6%* 16.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 28,334** 1,521,048** 9,104,878**


+2%**
(TESTS PER 100,000) (952**) (2,273**) (2,774**)

COVID-19 DEATHS 283 3,680 21,090


+11%
(RATE PER 100,000) (9.5) (5.5) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
31% N/A*† 35% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
54% N/A*† 59% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
15% N/A*† 16% 16%

TOTAL NEW COVID-19 HOSPITAL 1,429 -1% 38,210 165,234


ADMISSIONS (RATE PER 100 BEDS) (18) (+0%) (25) (23)

NUMBER OF HOSPITALS WITH 28 +1% 160 1,086


SUPPLY SHORTAGES (PERCENT) (29%) (+4%*) (17%) (21%)

NUMBER OF HOSPITALS WITH 16 +0% 201 1,177


STAFF SHORTAGES (PERCENT) (17%) (+0%*) (22%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
159,625 5,363 34,406 1.5%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 89% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

MISSISSIPPI
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

MISSISSIPPI
STATE REPORT | 01.10.2021

96 hospitals are expected to report in Mississippi


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

MISSISSIPPI
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Jackson DeSoto
Gulfport-Biloxi Harrison
Memphis Hinds
LOCALITIES
22 71
Tupelo Rankin
Hattiesburg Jackson
IN RED Laurel Lee
ZONE Columbus
Meridian
Madison
Lowndes
▲ (+1) Starkville ▲ (+4) Jones
Greenville Lauderdale
Vicksburg Forrest
Picayune Lamar

LOCALITIES
IN ORANGE
ZONE
1 Brookhaven 4 Lincoln
Attala
Calhoun
Montgomery
■ (+0) ▼ (-3)

LOCALITIES
0 5
Simpson
IN YELLOW N/A
Winston
Walthall
ZONE Greene
▼ (-1) ■ (+0) Wilkinson

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Jackson, Gulfport-Biloxi, Memphis, Tupelo, Hattiesburg, Laurel, Columbus, Meridian, Starkville, Greenville, Vicksburg,
Picayune, Oxford, Cleveland, Greenwood, Corinth, Indianola, McComb, West Point, Clarksdale, Grenada, Natchez
All Red Counties: DeSoto, Harrison, Hinds, Rankin, Jackson, Lee, Madison, Lowndes, Jones, Lauderdale, Forrest, Lamar, Washington,
Warren, Union, Pearl River, Lafayette, Bolivar, Monroe, Pontotoc, Oktibbeha, Hancock, Panola, Marshall, Alcorn, Itawamba, Neshoba,
Leake, Prentiss, Sunflower, Leflore, Tippah, Pike, Jasper, Scott, Marion, Tate, Chickasaw, Covington, Newton, Wayne, Clay, Coahoma,
Tishomingo, Stone, Grenada, Copiah, George, Adams, Webster, Yalobusha, Smith, Noxubee, Tallahatchie, Clarke, Perry, Benton,
Claiborne, Amite, Holmes, Franklin, Choctaw, Humphreys, Tunica, Jefferson Davis, Kemper, Carroll, Lawrence, Quitman, Jefferson,
Sharkey

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

MISSISSIPPI
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

MISSISSIPPI
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
MISSOURI Issue 30
SUMMARY
• Missouri is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 38th highest rate in the country.
Missouri is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 13th highest rate in the country.
• Missouri has seen an increase in new cases and an increase in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. St. Louis County, 2. Jackson County, and 3.
St. Charles County. These counties represent 38.9% of new cases in Missouri.
• 92% of all counties in Missouri have moderate or high levels of community transmission (yellow, orange, or red zones), with 85% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 27% of nursing homes had at least one new resident COVID-19 case, 44% had at least one new staff
COVID-19 case, and 12% had at least one new resident COVID-19 death.
• Missouri had 369 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 96 to support operations activities from
FEMA and 5 to support operations activities from ASPR.
• Between Jan 2 - Jan 8, on average, 271 patients with confirmed COVID-19 and 225 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in Missouri. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 406,150 vaccine doses have been distributed to Missouri. 124,721 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast,
Mid-Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular
updating of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best
practice. Given persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community
influencers are needed.
• New admissions remain at the highest levels. Establish mask requirements statewide and capacity thresholds for all indoor public
spaces, particularly in those areas with the highest increases.
• In K-12 schools, establish public health protocols to conduct active testing for teachers and students in districts with high positivity and
cases. In accordance with CDC guidelines, masks should be worn by students and teachers.
• With nearly 50% of LTCF sites having COVID-positive staff, continue weekly testing of all staff until residents and staff are fully
vaccinated.
• Ensure all universities returning after winter break move to mandatory weekly testing of all on and off campus students. Immediately
identifying and isolating asymptomatic individuals will prevent community spread.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

MISSOURI
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 22,662 55,547 1,744,828


+20%
(RATE PER 100,000) (369) (393) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
18.6% +0.8%* 16.9% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 54,371** 216,870** 9,104,878**


+1%**
(TESTS PER 100,000) (886**) (1,534**) (2,774**)

COVID-19 DEATHS 413 1,013 21,090


+63%
(RATE PER 100,000) (6.7) (7.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
27% N/A*† 21% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
44% N/A*† 43% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
12% N/A*† 12% 16%

TOTAL NEW COVID-19 HOSPITAL 3,468 +1% 6,085 165,234


ADMISSIONS (RATE PER 100 BEDS) (22) (-1%) (17) (23)

NUMBER OF HOSPITALS WITH 27 +0% 114 1,086


SUPPLY SHORTAGES (PERCENT) (23%) (+0%*) (25%) (21%)

NUMBER OF HOSPITALS WITH 31 +3% 75 1,177


STAFF SHORTAGES (PERCENT) (27%) (+11%*) (17%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
406,150 6,617 124,721 2.6%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 87% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

MISSOURI
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs)
through 1/6/2021.
COVID-19 Issue 30

MISSOURI
STATE REPORT | 01.10.2021

115 hospitals are expected to report in Missouri


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

MISSOURI
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


St. Louis St. Louis
Kansas City Jackson
Springfield St. Charles
LOCALITIES
25 98
Columbia Greene
Joplin Jefferson
IN RED Jefferson City St. Louis City
ZONE St. Joseph
Cape Girardeau
Boone
Jasper
▲ (+1) Fort Leonard Wood ▲ (+10) Franklin
Sedalia Christian
Branson Clay
Poplar Bluff Cass

LOCALITIES
IN ORANGE
ZONE
1 Farmington 4 St. Francois
Camden
Gasconade
Holt
▼ (-1) ▼ (-4)

LOCALITIES
IN YELLOW
ZONE
1 Quincy 4 Polk
Cooper
Gentry
Shannon
■ (+0) ■ (+0)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: St. Louis, Kansas City, Springfield, Columbia, Joplin, Jefferson City, St. Joseph, Cape Girardeau, Fort Leonard Wood, Sedalia, Branson, Poplar Bluff,
Mexico, Rolla, Kirksville, West Plains, Warrensburg, Hannibal, Lebanon, Sikeston, Marshall, Kennett, Maryville, Moberly, Fort Madison-Keokuk
All Red Counties: St. Louis, Jackson, St. Charles, Greene, Jefferson, St. Louis City, Boone, Jasper, Franklin, Christian, Clay, Cass, Cole, Cape Girardeau, Buchanan,
Pulaski, Callaway, Lincoln, Pettis, Platte, Taney, Webster, Newton, Audrain, Phelps, Howell, Johnson, Crawford, Adair, Butler, Lafayette, Vernon, Laclede, Scott,
Lawrence, Saline, Warren, Ray, Marion, Miller, Stone, Washington, Wright, Barry, Clinton, Dunklin, Bates, Nodaway, McDonald, Randolph, Ste. Genevieve, Texas,
Madison, Livingston, Henry, Andrew, Benton, Pike, Macon, Morgan, New Madrid, Osage, Perry, Moniteau, Stoddard, Douglas, Ralls, Oregon, Carroll, Grundy, Barton,
Iron, DeKalb, Harrison, Pemiscot, Wayne, Dent, Cedar, Caldwell, Montgomery, Daviess, Ripley, Monroe, Mississippi, Sullivan, Lewis, St. Clair, Ozark, Bollinger,
Chariton, Linn, Howard, Schuyler, Carter, Dade, Shelby, Mercer, Reynolds

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs) through
1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

MISSOURI
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs) through
1/6/2021; week one month before is 12/3 - 12/9.
COVID-19 Issue 30

MISSOURI
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
MONTANA Issue 30
SUMMARY
• Montana is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 36th highest rate in the country. Montana
is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 28th highest rate in the country.
• Montana has seen an increase in new cases and an increase in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Gallatin County, 2. Yellowstone County, and 3. Lewis
and Clark County. These counties represent 37.7% of new cases in Montana.
• 61% of all counties in Montana have moderate or high levels of community transmission (yellow, orange, or red zones), with 52% having high
levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 11% of nursing homes had at least one new resident COVID-19 case, 33% had at least one new staff COVID-19
case, and 9% had at least one new resident COVID-19 death.
• Montana had 376 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 3 to support operations activities from FEMA; 1
to support testing activities from CDC; 11 to support epidemiology activities from CDC; and 2 to support operations activities from CDC.
• The federal government has supported surge testing, pending a new location for January.
• Between Jan 2 - Jan 8, on average, 40 patients with confirmed COVID-19 and 25 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Montana. This is an increase of 8% in total new COVID-19 hospital admissions.
• As of Jan 8, 71,950 vaccine doses have been distributed to Montana. 31,444 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the
Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid acceleration
phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our
large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total
COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and
Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal
antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic
data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility,
and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and
mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation;
without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could
quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and
where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a
call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have
outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites
with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put
in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number
of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine
hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Increasing cases and test positivity, especially in the context of an overall decrease in test volume, suggests that transmission is increasing; this
will require expansion of effective public health messaging, more sensitive surveillance, and increased contact tracing capacity.
• Public health messaging should incorporate concerns about new viral variants to promote universal face masking and social distancing; in places
with local ordinances, residents should have a process to report non-compliance.
• All schools and IHEs with plans to reopen in person should have capacity and protocols for testing of students and teachers, including those
without symptoms.
• All facilities should have up-to-date treatment protocols that incorporate the latest recommendations on use of immune modulators and
convalescent plasma and hospitals should have contingency expansion plans over the next 6-12 weeks.
• Ensure all Tribal communities have sufficient testing and contact tracing capacity and are incorporated into plans for equitable distribution of
therapeutics and vaccines.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

MONTANA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 4,014 53,886 1,744,828


+51%
(RATE PER 100,000) (376) (440) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
12.9% +1.7%* 12.5% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 24,773** 417,166** 9,104,878**


+12%**
(TESTS PER 100,000) (2,318**) (3,403**) (2,774**)

COVID-19 DEATHS 89 629 21,090


+93%
(RATE PER 100,000) (8.3) (5.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
11% N/A*† 22% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
33% N/A*† 40% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
9% N/A*† 13% 16%

TOTAL NEW COVID-19 HOSPITAL 459 +8% 3,364 165,234


ADMISSIONS (RATE PER 100 BEDS) (16) (+8%) (14) (23)

NUMBER OF HOSPITALS WITH 17 -2% 70 1,086


SUPPLY SHORTAGES (PERCENT) (27%) (-11%*) (21%) (21%)

NUMBER OF HOSPITALS WITH 12 -3% 41 1,177


STAFF SHORTAGES (PERCENT) (19%) (-20%*) (12%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
71,950 6,731 31,444 3.7%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 76% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

MONTANA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

MONTANA
STATE REPORT | 01.10.2021

64 hospitals are expected to report in Montana


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

MONTANA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Gallatin
Yellowstone
Lewis and Clark
Billings
LOCALITIES
7 29
Flathead
Bozeman
Missoula
IN RED Helena
Kalispell
Cascade
ZONE Missoula
Silver Bow
Ravalli
▲ (+1) Great Falls
Butte-Silver Bow
▲ (+10) Lake
Lincoln
Hill
Jefferson

LOCALITIES
IN ORANGE
ZONE
0 N/A 3 Fergus
Chouteau
Deer Lodge
■ (+0) ▲ (+1)

LOCALITIES
IN YELLOW
ZONE
0 N/A 2 Big Horn
Glacier

▼ (-1) ▼ (-5)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red Counties: Gallatin, Yellowstone, Lewis and Clark, Flathead, Missoula, Cascade, Silver Bow, Ravalli, Lake,
Lincoln, Hill, Jefferson, Richland, Sanders, Park, Dawson, Beaverhead, Madison, Stillwater, Rosebud, Mineral,
Phillips, Valley, Carbon, Broadwater, Roosevelt, Powell, Teton, Granite

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

MONTANA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

MONTANA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
NEBRASKA Issue 30
SUMMARY
• Nebraska is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 40th highest rate in the country.
Nebraska is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 12th highest rate in the country.
• Nebraska has seen stability in new cases and stability in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Douglas County, 2. Lancaster County, and 3.
Sarpy County. These counties represent 62.9% of new cases in Nebraska.
• 63% of all counties in Nebraska have moderate or high levels of community transmission (yellow, orange, or red zones), with 59% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 14% of nursing homes had at least one new resident COVID-19 case, 37% had at least one new staff
COVID-19 case, and 8% had at least one new resident COVID-19 death.
• Nebraska had 357 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Between Jan 2 - Jan 8, on average, 55 patients with confirmed COVID-19 and 30 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in Nebraska. This is an increase of 8% in total new COVID-19 hospital admissions.
• As of Jan 8, 143,700 vaccine doses have been distributed to Nebraska. 68,297 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-
Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating
of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• With the uptick in cases and positivity, aggressive targeted testing in counties with the highest increases is critical now to prevent surges
similar to those experienced in the fall.
• Early and limited data from returning university students and staff indicate COVID presence at universities; mandatory, weekly testing
will identify asymptomatic cases and can prevent transmission into the community.
• In K-12 schools, establish public health protocols to conduct active testing for teachers and students in districts with high positivity and
cases. In accordance with CDC guidelines, masks should be worn by students and teachers.
• With the high percentage of LTCF sites having COVID-positive staff, continue weekly testing of all staff until residents and staff are fully
vaccinated.
• Ensure all Tribal communities have expanded access to testing, vaccination plans and protocols, and sufficient capacity to contact trace,
isolate, and quarantine. Support Tribal communities in their efforts to protect themselves.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

NEBRASKA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 6,902 55,547 1,744,828


+5%
(RATE PER 100,000) (357) (393) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
19.4% +0.1%* 16.9% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 33,960** 216,870** 9,104,878**


+19%**
(TESTS PER 100,000) (1,756**) (1,534**) (2,774**)

COVID-19 DEATHS 104 1,013 21,090


-9%
(RATE PER 100,000) (5.4) (7.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
14% N/A*† 21% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
37% N/A*† 43% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
8% N/A*† 12% 16%

TOTAL NEW COVID-19 HOSPITAL 594 +8% 6,085 165,234


ADMISSIONS (RATE PER 100 BEDS) (13) (+12%) (17) (23)

NUMBER OF HOSPITALS WITH 33 +0% 114 1,086


SUPPLY SHORTAGES (PERCENT) (36%) (+0%*) (25%) (21%)

NUMBER OF HOSPITALS WITH 21 +2% 75 1,177


STAFF SHORTAGES (PERCENT) (23%) (+11%*) (17%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
143,700 7,428 68,297 4.7%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 90% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

NEBRASKA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

NEBRASKA
STATE REPORT | 01.10.2021

92 hospitals are expected to report in Nebraska


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

NEBRASKA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Omaha-Council Bluffs Douglas
Lincoln Lancaster
Grand Island Sarpy
LOCALITIES
12 55
Fremont Hall
Kearney Dodge
IN RED Norfolk Cass
ZONE North Platte
Lexington
Buffalo
Lincoln
▼ (-1) Hastings ▲ (+3) Saunders
Sioux City Dawson
Columbus Adams
Beatrice Madison

LOCALITIES
IN ORANGE
ZONE
1 Scottsbluff 3 Dakota
Scotts Bluff
Webster
▲ (+1) ▲ (+1)

LOCALITIES
IN YELLOW
ZONE
0 N/A 1 Richardson

■ (+0) ▲ (+1)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red Counties: Douglas, Lancaster, Sarpy, Hall, Dodge, Cass, Buffalo, Lincoln, Saunders, Dawson, Adams,
Madison, Washington, Platte, Gage, Red Willow, Cuming, Seward, Otoe, Phelps, Saline, Johnson, Cheyenne,
Knox, Merrick, Chase, Keith, Nemaha, Custer, York, Holt, Hamilton, Colfax, Thurston, Box Butte, Clay, Thayer,
Boone, Wayne, Pierce, Jefferson, Dawes, Stanton, Perkins, Butler, Furnas, Morrill, Valley, Fillmore, Antelope,
Cedar, Frontier, Dundy, Nuckolls, Pawnee

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

NEBRASKA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

NEBRASKA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
NEVADA Issue 30
SUMMARY
• Nevada is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 20th highest rate in the country. Nevada is in
the red zone for test positivity, indicating a rate at or above 10.1%, with the 3rd highest rate in the country.
• Nevada has seen an increase in new cases and an increase in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Clark County, 2. Washoe County, and 3. Carson City.
These counties represent 93.6% of new cases in Nevada.
• 82% of all counties in Nevada have moderate or high levels of community transmission (yellow, orange, or red zones), with 71% having high levels
of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 38% of nursing homes had at least one new resident COVID-19 case, 56% had at least one new staff COVID-19
case, and 17% had at least one new resident COVID-19 death.
• Nevada had 539 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 10 to support operations activities from FEMA; 9 to
support medical activities from ASPR; and 5 to support operations activities from ASPR.
• Between Jan 2 - Jan 8, on average, 110 patients with confirmed COVID-19 and 66 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Nevada. An average of 62% of facilities reported each day during this time period. The change in the number of
admissions may be incomplete.
• As of Jan 8, 187,375 vaccine doses have been distributed to Nevada. 44,656 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased
cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains
slope in the fall and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral
spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large
metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total
COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast
suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies,
and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic
data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility,
and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and
mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation;
without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly
worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more
transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a
call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have
outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate
isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites
with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put
in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of
individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy,
continued active encouragement by the Governor, health officials, and community influencers are needed.
• With the uptick in cases and positivity, aggressive targeted testing in counties with the highest increases is critical now to prevent surges similar to
those experienced in the fall.
• Early and limited data from returning university students and staff indicate COVID presence at universities; mandatory, weekly testing will identify
asymptomatic cases and can prevent transmission into the community.
• In K-12 schools, establish public health protocols to conduct active testing for teachers and students in districts with high positivity and cases. In
accordance with CDC guidelines, masks should be worn by students and teachers.
• With nearly 60% of LTCF sites having COVID-positive staff, continue weekly testing of all staff until residents and staff are fully vaccinated.
• At the monoclonal antibody infusion site in Las Vegas, ask patients if they are willing to publicly describe how they felt after receiving monoclonal
antibodies. The public still is not aware of the benefits of this therapeutic.
• Ensure all Tribal communities have expanded access to testing, vaccination plans and protocols, and sufficient capacity to contact trace, isolate,
and quarantine. Support Tribal communities in their efforts to protect themselves.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

NEVADA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 16,615 369,307 1,744,828


+28%
(RATE PER 100,000) (539) (720) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
22.5% +0.6%* 18.7% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 81,827** 1,533,674** 9,104,878**


+6%**
(TESTS PER 100,000) (2,657**) (2,990**) (2,774**)

COVID-19 DEATHS 251 4,076 21,090


+24%
(RATE PER 100,000) (8.1) (7.9) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
38% N/A*† 20% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
56% N/A*† 32% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
17% N/A*† 10% 16%

TOTAL NEW COVID-19 HOSPITAL 1,228 N/A 28,479 165,234


ADMISSIONS (RATE PER 100 BEDS) (17) (N/A) (31) (23)

NUMBER OF HOSPITALS WITH 6 +0% 105 1,086


SUPPLY SHORTAGES (PERCENT) (13%) (+0%*) (20%) (21%)

NUMBER OF HOSPITALS WITH 14 +2% 235 1,177


STAFF SHORTAGES (PERCENT) (30%) (+17%*) (44%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
187,375 6,083 44,656 1.9%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous data. 79%
of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions. An average of 62% of facilities reported
each day during this time period. The change in the number of admissions may be incomplete.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of 16:56 EST
on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

NEVADA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

NEVADA
STATE REPORT | 01.10.2021

47 hospitals are expected to report in Nevada


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

NEVADA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Clark
Washoe
Las Vegas-Henderson-Paradise
Carson City
Reno
LOCALITIES
9 12
Pershing
Carson City
Douglas
IN RED Gardnerville Ranchos
Fernley
Lyon
ZONE Elko
Elko
Nye
■ (+0) Pahrump
Fallon
▼ (-1) Churchill
Humboldt
Winnemucca
Lincoln
Eureka

LOCALITIES
IN ORANGE
ZONE
0 N/A 2 White Pine
Mineral

■ (+0) ▲ (+2)

LOCALITIES
IN YELLOW
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

NEVADA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

NEVADA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
NEW HAMPSHIRE Issue 30
SUMMARY
• New Hampshire’s viral surge appeared to worsen with increased cases and deaths. New Hampshire is in the red zone for cases, indicating 101 or more new
cases per 100,000 population, with the 27th highest rate in the country. New Hampshire is in the red zone for test positivity, indicating a rate at or above
10.1%, with the 20th highest rate in the country.
• New Hampshire has seen an increase in new cases and a decrease in test positivity. Current hospitalizations rose, setting a new record, before falling back
substantially by week’s end. Deaths continued to increase, averaging 12 – 13 deaths per day.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Hillsborough County, 2. Rockingham County, and 3. Merrimack
County. These counties represent 71.1% of new cases in New Hampshire.
• 100% of all counties in New Hampshire have moderate or high levels of community transmission (yellow, orange, or red zones), with 80% having high levels
of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 24% of nursing homes had at least one new resident COVID-19 case, 47% had at least one new staff COVID-19 case, and
12% had at least one new resident COVID-19 death.
• New Hampshire had 450 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 8 to support operations activities from FEMA; 10 to support
medical activities from ASPR; and 3 to support operations activities from ASPR.
• Between Jan 2 - Jan 8, on average, 37 patients with confirmed COVID-19 and 26 patients with suspected COVID-19 were reported as newly admitted each
day to hospitals in New Hampshire. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 89,375 vaccine doses have been distributed to New Hampshire. 41,868 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased cases,
increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains slope in the fall
and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread, increasing
hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large metros.
Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-19
inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests
increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data
suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the presence
of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a much more rapid
transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as more
transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible viruses
emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to
action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient
infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate
isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with use
of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms now;
active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public confidence
and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of individuals
vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy, continued active
encouragement by the Governor, health officials, and community influencers are needed.
• We share the ongoing concern of New Hampshire’s leaders that the epidemiological situation remains fragile with the near-term forecast for cases and
deaths dependent on the collective effort of Granite Staters to follow the guidelines. Continued messaging for residents to maintain their changes in
personal behavior is key to limiting disease and death until the pandemic ends with immunization. The Governor’s continued personal communication on
these measures remains critical.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that could
limit morbidity and hospitalizations. The recent report confirming the benefit of convalescent plasma when administered early strengthens the case for
expanded utilization of plasma and monoclonal antibodies.
• Continue to prioritize efforts toward marginalized communities that are disproportionately being impacted by COVID-19, including a strategy that
prioritizes allocation of monoclonal antibody preparations to outpatient centers that serve more marginalized populations with higher levels of COVID-19
risk factors.
• Proactive testing must be part of the mitigation efforts inclusive of universal masking, physical distancing, hand hygiene, and the active promotion of
activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in LTCFs as
vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Ensure all K-12 schools are following CDC guidelines, including wearing masks and routinely utilizing the BinaxNOW tests. Ensure all universities returning
after winter break implement mandatory weekly testing of all on and off campus students.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

NEW HAMPSHIRE
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 6,124 85,599 1,744,828


+19%
(RATE PER 100,000) (450) (577) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
15.4% -0.9%* 8.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 18,602** 640,515** 9,104,878**


-4%**
(TESTS PER 100,000) (1,368**) (4,315**) (2,774**)

COVID-19 DEATHS 87 1,211 21,090


+26%
(RATE PER 100,000) (6.4) (8.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
24% N/A*† 27% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
47% N/A*† 49% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
12% N/A*† 15% 16%

TOTAL NEW COVID-19 HOSPITAL 440 -4% 5,332 165,234


ADMISSIONS (RATE PER 100 BEDS) (16) (-4%) (16) (23)

NUMBER OF HOSPITALS WITH 9 -1% 48 1,086


SUPPLY SHORTAGES (PERCENT) (35%) (-10%*) (26%) (21%)

NUMBER OF HOSPITALS WITH 9 +3% 30 1,177


STAFF SHORTAGES (PERCENT) (35%) (+50%*) (16%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
89,375 6,573 41,868 3.8%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 92% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

NEW HAMPSHIRE
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

NEW HAMPSHIRE
STATE REPORT | 01.10.2021

26 hospitals are expected to report in New Hampshire


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

NEW HAMPSHIRE
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Hillsborough
LOCALITIES
4 8
Rockingham
Manchester-Nashua Merrimack
IN RED Concord Strafford
ZONE Laconia
Keene
Belknap
Cheshire
▼ (-1) ▼ (-2) Carroll
Sullivan

LOCALITIES
IN ORANGE
ZONE
1 Berlin 2 Grafton
Coos

■ (+0) ▲ (+2)

LOCALITIES
IN YELLOW
ZONE
2 Boston-Cambridge-Newton
Lebanon
0 N/A

▲ (+1) ■ (+0)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

NEW HAMPSHIRE
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

NEW HAMPSHIRE
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
NEW JERSEY Issue 30
SUMMARY
• New Jersey is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 25th highest rate in the
country. New Jersey is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 30th highest rate in the country.
• New Jersey has seen an increase in new cases and stability in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Bergen County, 2. Middlesex County, and 3.
Hudson County. These counties represent 35.8% of new cases in New Jersey.
• 100% of all counties in New Jersey have moderate or high levels of community transmission (yellow, orange, or red zones), with 95%
having high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 28% of nursing homes had at least one new resident COVID-19 case, 44% had at least one new staff
COVID-19 case, and 14% had at least one new resident COVID-19 death.
• New Jersey had 486 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 54 to support operations activities from
FEMA and 20 to support operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 418 patients with confirmed COVID-19 and 191 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in New Jersey. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 572,250 vaccine doses have been distributed to New Jersey. 156,021 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-
Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating
of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• With the uptick in cases and positivity, aggressive targeted testing in counties with the highest increases is critical now to prevent surges
similar to those experienced in the fall.
• Early and limited data from returning university students and staff indicate COVID presence at universities; mandatory, weekly testing
will identify asymptomatic cases and can prevent transmission into the community.
• In K-12 schools, establish public health protocols to conduct active testing for teachers and students in districts with high positivity and
cases. In accordance with CDC guidelines, masks should be worn by students and teachers.
• With the high percentage of LTCF sites having COVID-positive staff, continue weekly testing of all staff until residents and staff are fully
vaccinated.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

NEW JERSEY
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 43,136 148,765 1,744,828


+32%
(RATE PER 100,000) (486) (525) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
12.8% +0.5%* 10.9% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 236,384** 1,118,603** 9,104,878**


-10%**
(TESTS PER 100,000) (2,661**) (3,948**) (2,774**)

COVID-19 DEATHS 596 1,726 21,090


+5%
(RATE PER 100,000) (6.7) (6.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
28% N/A*† 38% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
44% N/A*† 57% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
14% N/A*† 17% 16%

TOTAL NEW COVID-19 HOSPITAL 4,259 +4% 13,917 165,234


ADMISSIONS (RATE PER 100 BEDS) (21) (+1%) (18) (23)

NUMBER OF HOSPITALS WITH 19 -2% 70 1,086


SUPPLY SHORTAGES (PERCENT) (26%) (-10%*) (23%) (21%)

NUMBER OF HOSPITALS WITH 9 -1% 17 1,177


STAFF SHORTAGES (PERCENT) (12%) (-10%*) (5%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
572,250 6,442 156,021 2.2%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous data. 91%
of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1. Probable cases were allocated to
their respective county on 1/7. We look forward to continuing to work to improve data quality.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of 16:56 EST
on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

NEW JERSEY
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. Probable cases were allocated to their respective county on 1/7. We look
forward to continuing to work to improve data quality.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

NEW JERSEY
STATE REPORT | 01.10.2021

74 hospitals are expected to report in New Jersey


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

NEW JERSEY
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Bergen
Middlesex
Hudson
LOCALITIES
6 20
New York-Newark-Jersey City Ocean
Philadelphia-Camden-Wilmington Monmouth
IN RED Atlantic City-Hammonton Essex
ZONE Trenton-Princeton
Vineland-Bridgeton
Union
Camden
▲ (+1) Allentown-Bethlehem-Easton ▲ (+3) Passaic
Morris
Burlington
Atlantic

LOCALITIES
IN ORANGE
ZONE
1 Ocean City 1 Cape May

■ (+0) ▼ (-2)

LOCALITIES
IN YELLOW
ZONE
0 N/A 0 N/A

▼ (-1) ▼ (-1)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red Counties: Bergen, Middlesex, Hudson, Ocean, Monmouth, Essex, Union, Camden, Passaic, Morris,
Burlington, Atlantic, Gloucester, Somerset, Mercer, Cumberland, Sussex, Warren, Hunterdon, Salem

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have incomplete data due to
delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. Probable cases were allocated to their respective county on 1/7. We look forward to
continuing to work to improve data quality.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore, the values may
not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8. Probable cases were allocated to their respective county on 1/7. We look
forward to continuing to work to improve data quality.
COVID-19 Issue 30

NEW JERSEY
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11. Probable cases were allocated
to their respective county on 1/7. We look forward to continuing to work to improve data quality.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

NEW JERSEY
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore, the values
may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11. Probable cases were allocated to their respective
county on 1/7. We look forward to continuing to work to improve data quality.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
NEW MEXICO Issue 30
SUMMARY
• New Mexico is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 28th highest rate in the
country. New Mexico is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 31st highest rate in the country.
• New Mexico has seen an increase in new cases and an increase in test positivity with evidence of early post-holiday resurgence.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Bernalillo County, 2. San Juan County, and 3.
Doña Ana County. These counties represent 48.8% of new cases in New Mexico.
• 88% of all counties in New Mexico have moderate or high levels of community transmission (yellow, orange, or red zones), with 67%
having high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 23% of nursing homes had at least one new resident COVID-19 case, 41% had at least one new staff
COVID-19 case, and 7% had at least one new resident COVID-19 death.
• New Mexico had 444 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 3 to support operations activities from
FEMA; 1 to support operations activities from ASPR; and 2 to support medical activities from CDC.
• The federal government has supported surge testing, pending a new location in Deming next week.
• Between Jan 2 - Jan 8, on average, 104 patients with confirmed COVID-19 and 28 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in New Mexico. This is a decrease of 13% in total new COVID-19 hospital admissions.
• As of Jan 8, 145,025 vaccine doses have been distributed to New Mexico. 56,366 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-
Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating
of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Although New Mexico was showing evidence of significant improvement over the past week, unfortunately the state is entering a post-
holiday resurgence.
• Significantly increase public mitigation and increase communication around the importance of personal mitigation with masking,
physical distancing, and avoiding family gatherings.
• Ensure aggressive, proactive testing as many more individuals may be asymptomatic and actively spreading virus in the community.
• All K-12 teachers and older students, community colleges, and universities should require weekly testing as it dramatically decreases
COVID-19 viral spread by identifying and isolating the asymptomatic individuals, as well as symptomatic individuals, and allows for
contact tracing.
• Ensure access to testing, monoclonal antibody infusions, and vaccination for all Tribal Nations.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

NEW MEXICO
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 9,315 243,956 1,744,828


+24%
(RATE PER 100,000) (444) (571) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
12.1% +1.9%* 18.4% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 45,355** 853,979** 9,104,878**


+14%**
(TESTS PER 100,000) (2,163**) (1,999**) (2,774**)

COVID-19 DEATHS 208 2,639 21,090


+7%
(RATE PER 100,000) (9.9) (6.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
23% N/A*† 31% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
41% N/A*† 52% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
7% N/A*† 15% 16%

TOTAL NEW COVID-19 HOSPITAL 925 -13% 25,494 165,234


ADMISSIONS (RATE PER 100 BEDS) (24) (-13%) (27) (23)

NUMBER OF HOSPITALS WITH 6 -1% 211 1,086


SUPPLY SHORTAGES (PERCENT) (13%) (-14%*) (24%) (21%)

NUMBER OF HOSPITALS WITH 20 +1% 283 1,177


STAFF SHORTAGES (PERCENT) (43%) (+5%*) (32%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
145,025 6,916 56,366 3.5%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 86% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

NEW MEXICO
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

NEW MEXICO
STATE REPORT | 01.10.2021

47 hospitals are expected to report in New Mexico


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

NEW MEXICO
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Albuquerque Bernalillo
Farmington San Juan
Las Cruces Doña Ana
LOCALITIES
16 22
Gallup Sandoval
Roswell McKinley
IN RED Santa Fe Chaves
ZONE Hobbs
Carlsbad-Artesia
Santa Fe
Lea
▲ (+6) Española ▲ (+6) Eddy
Clovis Valencia
Grants Rio Arriba
Silver City Curry

LOCALITIES
IN ORANGE
ZONE
1 Alamogordo 4 Otero
Socorro
Colfax
Guadalupe
▼ (-1) ■ (+0)

LOCALITIES
IN YELLOW
ZONE
2 Las Vegas
Los Alamos
3 San Miguel
Los Alamos
Quay
▼ (-3) ▼ (-3)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Albuquerque, Farmington, Las Cruces, Gallup, Roswell, Santa Fe, Hobbs, Carlsbad-Artesia,
Española, Clovis, Grants, Silver City, Portales, Deming, Taos, Ruidoso
All Red Counties: Bernalillo, San Juan, Doña Ana, Sandoval, McKinley, Chaves, Santa Fe, Lea, Eddy, Valencia,
Rio Arriba, Curry, Cibola, Grant, Roosevelt, Luna, Taos, Lincoln, Sierra, Torrance, Hidalgo, De Baca

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

NEW MEXICO
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

NEW MEXICO
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
NEW YORK Issue 30
SUMMARY
• New York is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 19th highest rate in the country. New
York is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 35th highest rate in the country.
• New York has seen an increase in new cases and an increase in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Suffolk County, 2. Queens County, and 3. Kings
County. These counties represent 31.7% of new cases in New York.
• 97% of all counties in New York have moderate or high levels of community transmission (yellow, orange, or red zones), with 68% having high
levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 45% of nursing homes had at least one new resident COVID-19 case, 65% had at least one new staff COVID-
19 case, and 19% had at least one new resident COVID-19 death. Dozens of facilities reported large (>10 cases among staff or resident)
outbreaks.
• New York had 543 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 75 to support operations activities from
FEMA; 4 to support operations activities from ASPR; 1 to support testing activities from CDC; and 27 to support operations activities from
USCG.
• Between Jan 2 - Jan 8, on average, 1,031 patients with confirmed COVID-19 and 281 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in New York. This is an increase of 9% in total new COVID-19 hospital admissions.
• As of Jan 8, 1,208,900 vaccine doses have been distributed to New York. 434,802 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the
Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our
large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000
total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and
Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of
monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given
that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we
must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help
identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on
a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should
have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination
sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should
instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the
number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent
vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• The increasing transmission, despite an overall decrease in testing volume, and the confirmation of circulating viral variants is highly
concerning and will require intensified public health messaging, enhanced surveillance, and expansion of timely contact tracing.
• Messaging should incorporate concerns about a more transmissible virus and the need for universal face-masking and social distancing
outside of the home, with procedures to report non-compliant businesses.
• Enhancements in wastewater surveillance, routine surveillance of at-risk individuals, and genomic surveillance could help target resources,
mitigation efforts, and mid-range planning (e.g., hospital expansion plans).
• Ensure equitable distribution of vaccine and therapeutics, accounting for communities with increased numbers of persons at risk for severe
disease, and ensure all facilities have up-to-date treatment protocols, including appropriate use of convalescent plasma and immune
modulating therapies (after state review).
• Ensure dedicated efforts to track outbreaks and interventions at LTCFs, with clear repercussions for non-compliance to CMS guidance.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

NEW YORK
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 105,629 148,765 1,744,828


+27%
(RATE PER 100,000) (543) (525) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
10.4% +0.9%* 10.9% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 882,219** 1,118,603** 9,104,878**


-9%**
(TESTS PER 100,000) (4,535**) (3,948**) (2,774**)

COVID-19 DEATHS 1,130 1,726 21,090


+14%
(RATE PER 100,000) (5.8) (6.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
45% N/A*† 38% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
65% N/A*† 57% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
19% N/A*† 17% 16%

TOTAL NEW COVID-19 HOSPITAL 9,183 +9% 13,917 165,234


ADMISSIONS (RATE PER 100 BEDS) (19) (+11%) (18) (23)

NUMBER OF HOSPITALS WITH 13 +1% 70 1,086


SUPPLY SHORTAGES (PERCENT) (7%) (+8%*) (23%) (21%)

NUMBER OF HOSPITALS WITH 8 +1% 17 1,177


STAFF SHORTAGES (PERCENT) (5%) (+14%*) (5%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
1,208,900 6,214 434,802 2.8%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 90% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

NEW YORK
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

NEW YORK
STATE REPORT | 01.10.2021

174 hospitals are expected to report in New York


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

NEW YORK
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


New York-Newark-Jersey City Suffolk
Rochester Queens
Albany-Schenectady-Troy Nassau
LOCALITIES
15 42
Syracuse Bronx
Poughkeepsie-Newburgh-Middletown Westchester
IN RED Utica-Rome Monroe
ZONE Binghamton
Auburn
Richmond
Onondaga
▲ (+4) Jamestown-Dunkirk-Fredonia ▲ (+10) Oneida
Batavia Orange
Corning Albany
Olean Rockland
Kings
Erie
Buffalo-Cheektowaga Ulster
LOCALITIES
7 11
Kingston St. Lawrence
IN ORANGE Ogdensburg-Massena
Watertown-Fort Drum
Jefferson
Chemung
ZONE Elmira Clinton
■ (+0) Plattsburgh
Seneca Falls
▼ (-4) Orleans
Chenango
Seneca
Essex

New York
LOCALITIES
3 7
Warren
IN YELLOW Glens Falls
Hudson
Columbia
Washington
ZONE Oneonta Otsego
▼ (-3) ▼ (-2) Delaware
Hamilton

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: New York-Newark-Jersey City, Rochester, Albany-Schenectady-Troy, Syracuse, Poughkeepsie-Newburgh-
Middletown, Utica-Rome, Binghamton, Auburn, Jamestown-Dunkirk-Fredonia, Batavia, Corning, Olean, Amsterdam,
Cortland, Gloversville
All Red Counties: Suffolk, Queens, Nassau, Bronx, Westchester, Monroe, Richmond, Onondaga, Oneida, Orange, Albany,
Rockland, Dutchess, Niagara, Saratoga, Schenectady, Broome, Rensselaer, Cayuga, Chautauqua, Ontario, Putnam,
Herkimer, Oswego, Genesee, Steuben, Wayne, Cattaraugus, Livingston, Madison, Montgomery, Sullivan, Wyoming, Greene,
Cortland, Fulton, Allegany, Lewis, Tioga, Schoharie, Yates, Schuyler

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

NEW YORK
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

NEW YORK
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
NORTH CAROLINA Issue 30
SUMMARY
• North Carolina is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 10th highest rate in the country.
North Carolina is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 19th highest rate in the country.
• North Carolina has seen an increase in new cases and an increase in test positivity; 96 counties reported an increase in cases and 70 reported
an increase in test positivity, most notably Camden, Clay, and Tyrell.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Mecklenburg County, 2. Wake County, and 3.
Guilford County. These counties represent 23.7% of new cases in North Carolina.
• 100% of all counties in North Carolina have moderate or high levels of community transmission (yellow, orange, or red zones), with 91% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 37% of nursing homes had at least one new resident COVID-19 case, 61% had at least one new staff COVID-19
case, and 19% had at least one new resident COVID-19 death.
• North Carolina had 603 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 3 to support operations activities from FEMA; 7
to support operations activities from USCG; and 1 to support operations activities from VA.
• The federal government has supported surge testing in Guilford County.
• Between Jan 2 - Jan 8, on average, 439 patients with confirmed COVID-19 and 292 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in North Carolina. This is an increase of 10% in total new COVID-19 hospital admissions.
• As of Jan 8, 649,150 vaccine doses have been distributed to North Carolina. 178,136 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the
Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our
large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000
total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and
Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of
monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given
that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must
be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation;
without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could
quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and
where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on
a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should
have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination
sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead
be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the
number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent
vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• The increasing transmission and possibility of circulating viral variants is highly concerning and will require intensified public health
messaging, enhanced surveillance, and expansion of timely contact tracing.
• Messaging should incorporate concerns about a more transmissible virus and the need for universal face-masking and social distancing outside
of the home, with procedures to report non-compliant businesses.
• Enhancements in wastewater surveillance, routine surveillance of at-risk individuals, and genomic surveillance could help target resources,
mitigation efforts, and mid-range planning (e.g., hospital expansion plans).
• Ensure equitable distribution of vaccine and therapeutics, accounting for communities with increased numbers of persons at risk for severe
disease, and ensure all facilities have up-to-date treatment protocols, including appropriate use of convalescent plasma and immune
modulating therapies.
• Ensure dedicated efforts to track outbreaks and interventions at LTCFs, with clear repercussions for non-compliance to CMS guidance.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

NORTH CAROLINA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 63,229 401,743 1,744,828


+40%
(RATE PER 100,000) (603) (600) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
15.5% +1.3%* 16.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 319,848** 1,521,048** 9,104,878**


+24%**
(TESTS PER 100,000) (3,050**) (2,273**) (2,774**)

COVID-19 DEATHS 581 3,680 21,090


+50%
(RATE PER 100,000) (5.5) (5.5) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
37% N/A*† 35% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
61% N/A*† 59% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
19% N/A*† 16% 16%

TOTAL NEW COVID-19 HOSPITAL 5,117 +10% 38,210 165,234


ADMISSIONS (RATE PER 100 BEDS) (24) (+10%) (25) (23)

NUMBER OF HOSPITALS WITH 15 +2% 160 1,086


SUPPLY SHORTAGES (PERCENT) (13%) (+15%*) (17%) (21%)

NUMBER OF HOSPITALS WITH 6 +1% 201 1,177


STAFF SHORTAGES (PERCENT) (5%) (+20%*) (22%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
649,150 6,189 178,136 2.2%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 90% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

NORTH CAROLINA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

NORTH CAROLINA
STATE REPORT | 01.10.2021

112 hospitals are expected to report in North Carolina


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

NORTH CAROLINA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Charlotte-Concord-Gastonia Mecklenburg
Raleigh-Cary Wake
Winston-Salem Guilford
LOCALITIES
36 91
Greensboro-High Point Forsyth
Hickory-Lenoir-Morganton Gaston
IN RED Asheville Union
ZONE Fayetteville
Greenville
Cumberland
Cabarrus
▲ (+2) Wilmington ▲ (+4) Buncombe
Jacksonville Johnston
Burlington Catawba
Lumberton Pitt

Durham
LOCALITIES
3 8
Wayne
Orange
IN ORANGE Durham-Chapel Hill
Goldsboro
Watauga
ZONE Boone
Greene
Warren
▼ (-2) ▲ (+1) Graham
Jones

LOCALITIES
IN YELLOW
ZONE
0 N/A 1 Chatham

■ (+0) ▼ (-4)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Charlotte-Concord-Gastonia, Raleigh-Cary, Winston-Salem, Greensboro-High Point, Hickory-Lenoir-Morganton, Asheville, Fayetteville, Greenville, Wilmington,
Jacksonville, Burlington, Lumberton, Shelby, Rocky Mount, New Bern, Pinehurst-Southern Pines, Forest City, Mount Airy, Myrtle Beach-Conway-North Myrtle Beach, Wilson,
Albemarle, Roanoke Rapids, North Wilkesboro, Washington, Marion, Sanford, Cullowhee, Kinston, Elizabeth City, Morehead City, Henderson, Rockingham, Virginia Beach-
Norfolk-Newport News, Kill Devil Hills, Laurinburg, Brevard
All Red Counties: Mecklenburg, Wake, Guilford, Forsyth, Gaston, Union, Cumberland, Cabarrus, Buncombe, Johnston, Catawba, Pitt, Davidson, Iredell, Rowan, Onslow,
Alamance, Robeson, Randolph, Cleveland, New Hanover, Caldwell, Henderson, Lincoln, Burke, Moore, Rutherford, Craven, Harnett, Surry, Brunswick, Wilson, Nash, Stanly,
Rockingham, Wilkes, Columbus, Beaufort, Franklin, McDowell, Sampson, Lee, Lenoir, Haywood, Halifax, Granville, Pender, Alexander, Carteret, Stokes, Duplin, Davie, Vance,
Yadkin, Pasquotank, Jackson, Macon, Hoke, Richmond, Person, Montgomery, Edgecombe, Martin, Bladen, Dare, Scotland, Anson, Ashe, Transylvania, Cherokee, Caswell,
Hertford, Polk, Swain, Avery, Yancey, Currituck, Bertie, Madison, Northampton, Hyde, Alleghany, Chowan, Perquimans, Washington, Mitchell, Clay, Camden, Gates, Pamlico,
Tyrrell

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

NORTH CAROLINA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

NORTH CAROLINA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
NORTH DAKOTA Issue 30
SUMMARY
• North Dakota is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 48th highest rate in the
country. North Dakota is in the green zone for test positivity, indicating a rate at or below 4.9%, with the 50th highest rate in the country.
• North Dakota has seen stability in new cases and test positivity, but some counties are showing early post-holiday increases; these must
be aggressively addressed.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Cass County, 2. Burleigh County, and 3. Ward
County. These counties represent 41.8% of new cases in North Dakota.
• 21% of all counties in North Dakota have moderate or high levels of community transmission (yellow, orange, or red zones), with 6%
having high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 23% of nursing homes had at least one new resident COVID-19 case, 40% had at least one new staff
COVID-19 case, and 7% had at least one new resident COVID-19 death.
• North Dakota had 219 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Between Jan 2 - Jan 8, on average, 16 patients with confirmed COVID-19 and 13 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in North Dakota. This is a decrease of 5% in total new COVID-19 hospital admissions.
• As of Jan 8, 43,950 vaccine doses have been distributed to North Dakota. 29,954 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-
Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating
of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• North Dakota remains mostly stable, but there are concerning signs in several counties that should be aggressively mitigated before
another surge develops.
• In those counties, significantly increase public mitigation and increase communication around the importance of personal mitigation
with masking, physical distancing, and avoiding family gatherings.
• Ensure aggressive, proactive testing as many more individuals may be asymptomatic and actively spreading virus in the community.
• All K-12 teachers and older students, community colleges, and universities should require weekly testing, as it dramatically decreases
COVID-19 viral spread by identifying and isolating the asymptomatic individuals, as well as symptomatic individuals, and allows for
contact tracing.
• Ensure access to testing, monoclonal antibody infusions, and vaccination for all Tribal Nations.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

NORTH DAKOTA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 1,669 53,886 1,744,828


+7%
(RATE PER 100,000) (219) (440) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
3.9% +0.4%* 12.5% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 23,835** 417,166** 9,104,878**


+7%**
(TESTS PER 100,000) (3,128**) (3,403**) (2,774**)

COVID-19 DEATHS 43 629 21,090


-4%
(RATE PER 100,000) (5.6) (5.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
23% N/A*† 22% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
40% N/A*† 40% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
7% N/A*† 13% 16%

TOTAL NEW COVID-19 HOSPITAL 207 -5% 3,364 165,234


ADMISSIONS (RATE PER 100 BEDS) (10) (-5%) (14) (23)

NUMBER OF HOSPITALS WITH 12 +0% 70 1,086


SUPPLY SHORTAGES (PERCENT) (25%) (+0%*) (21%) (21%)

NUMBER OF HOSPITALS WITH 16 +0% 41 1,177


STAFF SHORTAGES (PERCENT) (33%) (+0%*) (12%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
43,950 5,767 29,954 5.1%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 88% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

NORTH DAKOTA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

NORTH DAKOTA
STATE REPORT | 01.10.2021

48 hospitals are expected to report in North Dakota


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

NORTH DAKOTA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES

LOCALITIES
IN RED
ZONE
0 N/A 3 Rolette
LaMoure
Foster
■ (+0) ▼ (-1)

LOCALITIES
IN ORANGE
ZONE
0 N/A 3 Walsh
Emmons
McHenry
■ (+0) ▲ (+1)

LOCALITIES
1 5
Williams
IN YELLOW Williston
Dickey
Benson
ZONE Mountrail
▼ (-2) ■ (+0) Nelson

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

NORTH DAKOTA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

NORTH DAKOTA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
OHIO Issue 30
SUMMARY
• Ohio is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 21st highest rate in the country. Ohio
is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 21st highest rate in the country.
• Ohio has seen an increase in new cases, an increase in test positivity, and rising hospitalizations.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Franklin County, 2. Cuyahoga County, and 3.
Hamilton County. These counties represent 27.3% of new cases in Ohio.
• 100% of all counties in Ohio have moderate or high levels of community transmission (yellow, orange, or red zones), with 98% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 36% of nursing homes had at least one new resident COVID-19 case, 56% had at least one new staff
COVID-19 case, and 23% had at least one new resident COVID-19 death.
• Ohio had 532 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 5 to support operations activities from
FEMA and 4 to support operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 559 patients with confirmed COVID-19 and 420 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in Ohio. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 646,450 vaccine doses have been distributed to Ohio. 223,424 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-
Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating
of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Ohio was becoming more stable; however, we see significant evidence of deterioration post-holidays with rising cases and a slight uptick
in hospitalizations.
• To prevent full resurgence, Ohio must significantly increase public mitigation and increase communication around the importance of
personal mitigation with masking, physical distancing, and avoiding family gatherings.
• Ensure aggressive, proactive testing as many more individuals may be asymptomatic and actively spreading virus in the community.
• All K-12 teachers and older students, community colleges, and universities should require weekly testing, as it dramatically decreases
COVID-19 viral spread by identifying and isolating the asymptomatic individuals, as well as symptomatic individuals, and allows for
contact tracing.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

OHIO
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 62,223 220,780 1,744,828


+33%
(RATE PER 100,000) (532) (420) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
14.5% +0.7%* 11.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 287,085** 1,504,419** 9,104,878**


+5%**
(TESTS PER 100,000) (2,456**) (2,863**) (2,774**)

COVID-19 DEATHS 582 3,714 21,090


+14%
(RATE PER 100,000) (5.0) (7.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
36% N/A*† 27% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
56% N/A*† 45% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
23% N/A*† 19% 16%

TOTAL NEW COVID-19 HOSPITAL 6,855 +2% 22,662 165,234


ADMISSIONS (RATE PER 100 BEDS) (24) (+2%) (19) (23)

NUMBER OF HOSPITALS WITH 32 +5% 192 1,086


SUPPLY SHORTAGES (PERCENT) (17%) (+19%*) (22%) (21%)

NUMBER OF HOSPITALS WITH 47 -2% 185 1,177


STAFF SHORTAGES (PERCENT) (25%) (-4%*) (21%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
646,450 5,530 223,424 2.5%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 84% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

OHIO
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

OHIO
STATE REPORT | 01.10.2021

187 hospitals are expected to report in Ohio


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

OHIO
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Columbus Franklin
Cleveland-Elyria Cuyahoga
Cincinnati Hamilton
LOCALITIES
46 86
Dayton-Kettering Montgomery
Toledo Summit
IN RED Akron Lucas
ZONE Canton-Massillon
Youngstown-Warren-Boardman
Stark
Butler
▲ (+1) Mansfield ■ (+0) Warren
Springfield Lorain
Lima Clermont
Zanesville Lake

LOCALITIES
IN ORANGE
ZONE
0 N/A 1 Fairfield

▼ (-1) ▼ (-1)

LOCALITIES
IN YELLOW
ZONE
0 N/A 1 Mahoning

■ (+0) ▲ (+1)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Columbus, Cleveland-Elyria, Cincinnati, Dayton-Kettering, Toledo, Akron, Canton-Massillon, Youngstown-Warren-Boardman, Mansfield, Springfield, Lima,
Zanesville, Sandusky, New Philadelphia-Dover, Salem, Wooster, Portsmouth, Chillicothe, Findlay, Fremont, Huntington-Ashland, Norwalk, Weirton-Steubenville, Sidney,
Marietta, Marion, Mount Vernon, Ashland, Tiffin, Wheeling, Ashtabula, Bucyrus-Galion, Wapakoneta, Greenville, Defiance, Wilmington, Urbana, Bellefontaine, Athens, Cambridge,
Jackson, Washington Court House, Celina, Coshocton, Point Pleasant, Van Wert
All Red Counties: Franklin, Cuyahoga, Hamilton, Montgomery, Summit, Lucas, Stark, Butler, Warren, Lorain, Clermont, Lake, Delaware, Licking, Medina, Greene, Trumbull,
Wood, Richland, Clark, Portage, Miami, Allen, Muskingum, Pickaway, Erie, Tuscarawas, Columbiana, Wayne, Scioto, Ross, Hancock, Sandusky, Geauga, Union, Lawrence, Huron,
Jefferson, Shelby, Washington, Marion, Knox, Ashland, Seneca, Belmont, Brown, Ashtabula, Fulton, Crawford, Auglaize, Darke, Ottawa, Defiance, Clinton, Williams, Madison,
Champaign, Logan, Athens, Guernsey, Highland, Jackson, Fayette, Morrow, Preble, Perry, Wyandot, Putnam, Mercer, Henry, Coshocton, Gallia, Hardin, Adams, Van Wert, Carroll,
Hocking, Holmes, Monroe, Pike, Harrison, Paulding, Meigs, Noble, Vinton, Morgan

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs) through
1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

OHIO
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs) through
1/6/2021; week one month before is 12/3 - 12/9.
COVID-19 Issue 30

OHIO
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
OKLAHOMA Issue 30
SUMMARY
• Oklahoma is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 4th highest rate in the country.
Oklahoma is in the red zone for test positivity, indicating a rate at or above 10.1%, with the highest rate in the country.
• Oklahoma has seen an increase in new cases and an increase in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Oklahoma County, 2. Tulsa County, and 3. Cleveland
County. These counties represent 38.9% of new cases in Oklahoma.
• 97% of all counties in Oklahoma have moderate or high levels of community transmission (yellow, orange, or red zones), with 97% having high
levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 33% of nursing homes had at least one new resident COVID-19 case, 54% had at least one new staff COVID-19
case, and 20% had at least one new resident COVID-19 death.
• Oklahoma had 749 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 2 to support operations activities from FEMA and
1 to support epidemiology activities from CDC.
• Between Jan 2 - Jan 8, on average, 391 patients with confirmed COVID-19 and 81 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Oklahoma. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 297,625 vaccine doses have been distributed to Oklahoma. 103,020 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the
Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid acceleration
phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our
large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total
COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and
Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal
antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic
data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility,
and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and
mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation;
without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could
quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and
where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a
call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have
outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites
with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put
in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number
of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine
hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• The COVID-19 pandemic spread is unyielding in Oklahoma, impacting hospitals and staff. Effective mitigation is needed statewide. Oklahomans
must know that even though vaccines are coming, they will not immediately stop this current wave, which started weeks ago and continues to
surge. Have community leaders talk to their peers about vigilance and vaccination. Effective mitigation efforts in the Heartland have included
statewide mask requirements, limited indoor dining, and bar closures. These mitigation efforts reduced hospitalizations within 6 weeks.
• Early and limited data from returning university students and staff indicate COVID presence at universities; mandatory, weekly testing will
identify asymptomatic cases and can prevent transmission into the community.
• In K-12 schools, establish public health protocols to conduct active testing for teachers and students in districts with high positivity and cases. In
accordance with CDC guidelines, masks should be worn by students and teachers.
• With the high percentage of LTCF sites having COVID-positive staff, continue weekly testing of all staff until residents and staff are fully
vaccinated.
• Ensure all Tribal communities have expanded access to testing, vaccination plans and protocols, and sufficient capacity to contact trace, isolate,
and quarantine. Support Tribal communities in their efforts to protect themselves.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

OKLAHOMA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 29,650 243,956 1,744,828


+61%
(RATE PER 100,000) (749) (571) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
25.6% +0.7%* 18.4% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 43,871** 853,979** 9,104,878**


+17%**
(TESTS PER 100,000) (1,109**) (1,999**) (2,774**)

COVID-19 DEATHS 214 2,639 21,090


+33%
(RATE PER 100,000) (5.4) (6.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
33% N/A*† 31% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
54% N/A*† 52% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
20% N/A*† 15% 16%

TOTAL NEW COVID-19 HOSPITAL 3,307 +3% 25,494 165,234


ADMISSIONS (RATE PER 100 BEDS) (34) (+2%) (27) (23)

NUMBER OF HOSPITALS WITH 41 -2% 211 1,086


SUPPLY SHORTAGES (PERCENT) (31%) (-5%*) (24%) (21%)

NUMBER OF HOSPITALS WITH 45 -2% 283 1,177


STAFF SHORTAGES (PERCENT) (34%) (-4%*) (32%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
297,625 7,521 103,020 3.4%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 84% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

OKLAHOMA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs)
through 1/6/2021.
COVID-19 Issue 30

OKLAHOMA
STATE REPORT | 01.10.2021

132 hospitals are expected to report in Oklahoma


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

OKLAHOMA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Oklahoma City Oklahoma
Tulsa Tulsa
Lawton Cleveland
LOCALITIES
22 75
Ardmore Canadian
Muskogee Rogers
IN RED Stillwater Wagoner
ZONE Shawnee
Ponca City
Comanche
Muskogee
■ (+0) Tahlequah ▲ (+2) Payne
Duncan Pottawatomie
Durant Carter
Ada Creek

LOCALITIES
IN ORANGE
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)

LOCALITIES
IN YELLOW
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Oklahoma City, Tulsa, Lawton, Ardmore, Muskogee, Stillwater, Shawnee, Ponca City, Tahlequah, Duncan, Durant, Enid,
Ada, McAlester, Bartlesville, Miami, Weatherford, Fort Smith, Elk City, Woodward, Guymon, Altus
All Red Counties: Oklahoma, Tulsa, Cleveland, Canadian, Rogers, Wagoner, Comanche, Muskogee, Payne, Pottawatomie, Carter, Creek,
Kay, Cherokee, Stephens, Bryan, Garfield, Pontotoc, Le Flore, Pittsburg, Grady, Delaware, Osage, McClain, Mayes, Washington, Ottawa,
Logan, Garvin, Custer, Okmulgee, Sequoyah, Adair, McCurtain, Caddo, Lincoln, Seminole, Murray, Beckham, Kingfisher, McIntosh,
Woodward, Pawnee, Choctaw, Craig, Woods, Marshall, Atoka, Love, Johnston, Okfuskee, Noble, Pushmataha, Texas, Nowata, Jackson,
Haskell, Washita, Latimer, Hughes, Blaine, Jefferson, Alfalfa, Coal, Tillman, Major, Grant, Kiowa, Cotton, Dewey, Greer, Harmon, Roger
Mills, Beaver, Harper

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs) through
1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

OKLAHOMA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs) through
1/6/2021; week one month before is 12/3 - 12/9.
COVID-19 Issue 30

OKLAHOMA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
OREGON Issue 30
SUMMARY
• Oregon is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 50th highest rate in the country. Oregon is in
the orange zone for test positivity, indicating a rate between 8.0% and 10.0%, with the 40th highest rate in the country.
• Oregon has seen stability in new cases and an increase in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Multnomah County, 2. Washington County, and 3.
Marion County. These counties represent 43.3% of new cases in Oregon.
• 78% of all counties in Oregon have moderate or high levels of community transmission (yellow, orange, or red zones), with 33% having high levels
of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 21% of nursing homes had at least one new resident COVID-19 case, 33% had at least one new staff COVID-19
case, and 11% had at least one new resident COVID-19 death.
• Oregon had 178 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 16 to support operations activities from FEMA; 1 to
support epidemiology activities from CDC; and 8 to support operations activities from USCG.
• The federal government has supported surge testing in several cities across the state.
• Between Jan 2 - Jan 8, on average, 64 patients with confirmed COVID-19 and 91 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Oregon. This is a decrease of 6% in total new COVID-19 hospital admissions.
• As of Jan 8, 262,300 vaccine doses have been distributed to Oregon. 66,933 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased
cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains
slope in the fall and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral
spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large
metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total
COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast
suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies,
and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic
data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility,
and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and
mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation;
without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly
worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more
transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a
call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have
outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate
isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites
with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put
in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of
individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy,
continued active encouragement by the Governor, health officials, and community influencers are needed.
• An increase in cases, despite a decrease in the overall volume of testing (since Nov), and the increased test positivity raise concerns about
increasing transmission in Oregon; this will require more urgent public health messaging, enhanced surveillance, and expansion of contact tracing.
• Public health messaging should incorporate concerns about more transmissible viral variants to urgently emphasize need for universal face
masking and social distancing outside of the home; procedures to report non-compliance of local businesses should be widely promulgated.
• Enhanced surveillance (quantitative wastewater, routine testing of at-risk individuals, and genomic surveillance) will provide early warning of local
increases in transmission and emergence/spread of viral variants. This will permit targeting of resources and efforts to identify areas that are likely
to require expansion of clinical services.
• Ensure all schools and IHEs that are planning to reopen have the resources and plans to test all students and teachers, including those without
symptoms, and protocols to monitor and enforce face-masking and distancing.
• Ensure equitable distribution of vaccines and therapeutics, accounting for communities with increased numbers of individuals at-risk for severe
disease; ensure all facilities have up-to-date treatment protocols, including appropriate use of convalescent plasma and immune modulating
therapies.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

OREGON
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 7,508 39,189 1,744,828


-2%
(RATE PER 100,000) (178) (273) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
8.9% +0.7%* 10.0% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 109,597** 288,163** 9,104,878**


-1%**
(TESTS PER 100,000) (2,598**) (2,008**) (2,774**)

COVID-19 DEATHS 85 431 21,090


+25%
(RATE PER 100,000) (2.0) (3.0) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
21% N/A*† 18% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
33% N/A*† 33% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
11% N/A*† 10% 16%

TOTAL NEW COVID-19 HOSPITAL 1,087 -6% 3,059 165,234


ADMISSIONS (RATE PER 100 BEDS) (16) (-6%) (13) (23)

NUMBER OF HOSPITALS WITH 17 -6% 39 1,086


SUPPLY SHORTAGES (PERCENT) (27%) (-26%*) (18%) (21%)

NUMBER OF HOSPITALS WITH 3 +2% 18 1,177


STAFF SHORTAGES (PERCENT) (5%) (+200%*) (8%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
262,300 6,218 66,933 2.0%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 79% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

OREGON
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

OREGON
STATE REPORT | 01.10.2021

63 hospitals are expected to report in Oregon


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

OREGON
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Marion
Jackson
Salem Umatilla
LOCALITIES
8 12
Hermiston-Pendleton Deschutes
Medford Klamath
IN RED Bend Polk
ZONE Klamath Falls
Ontario
Jefferson
Malheur
▲ (+4) Hood River ▲ (+5) Hood River
Prineville Crook
Morrow
Harney

Multnomah
LOCALITIES
3 7
Washington
IN ORANGE Portland-Vancouver-Hillsboro
Grants Pass
Clackamas
Yamhill
ZONE Astoria Josephine
▼ (-2) ▼ (-2) Clatsop
Baker

Linn
Coos
LOCALITIES
5 9
Albany-Lebanon Wasco
IN YELLOW Coos Bay
The Dalles
Columbia
Lincoln
ZONE Newport Tillamook
▲ (+1) La Grande
▲ (+2) Union
Lake
Sherman

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

OREGON
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

OREGON
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
PENNSYLVANIA Issue 30
SUMMARY
• Pennsylvania is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 29th highest rate in the country. Pennsylvania
is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 25th highest rate in the country.
• Pennsylvania has seen an increase in new cases and stability in test positivity; 47 counties reported an increase in cases, and 40 reported an increase in test
positivity, most notably Clinton, Forest, Northumberland, Cameron, Crawford, and Lehigh counties.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Allegheny County, 2. Philadelphia County, and 3. Montgomery
County. These counties represent 22.3% of new cases in Pennsylvania.
• 100% of all counties in Pennsylvania have moderate or high levels of community transmission (yellow, orange, or red zones), with 94% having high levels of
community transmission (red zone).
• During the week of Dec 28 - Jan 3, 40% of nursing homes had at least one new resident COVID-19 case, 66% had at least one new staff COVID-19 case, and
26% had at least one new resident COVID-19 death.
• Pennsylvania had 439 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 41 to support operations activities from FEMA; 8 to support
operations activities from ASPR; 1 to support epidemiology activities from CDC; 4 to support operations activities from USCG; and 9 to support medical
activities from VA.
• Between Jan 2 - Jan 8, on average, 589 patients with confirmed COVID-19 and 592 patients with suspected COVID-19 were reported as newly admitted each
day to hospitals in Pennsylvania. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 812,550 vaccine doses have been distributed to Pennsylvania. 226,478 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased cases,
increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains slope in the fall
and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread, increasing
hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large metros.
Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-19
inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests
increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data
suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the presence
of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a much more rapid
transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as more
transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible viruses
emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to
action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient
infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate
isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with use
of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms now;
active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public confidence
and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of individuals
vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy, continued active
encouragement by the Governor, health officials, and community influencers are needed.
• Given the decrease in volume of testing over the past two months, test positivity, and hospitalization may be the best indicators of transmission, and the
high level of transmission along with increasing reports of viral variants across the Northeast, are concerning and require intensified public health
messaging, enhanced surveillance, and expanded and more efficient contact tracing efforts.
• Enhanced surveillance (quantitative wastewater, routine testing of at-risk individuals, and genomic surveillance) will provide early warning of local
increases in transmission and emergence/spread of viral variants. This will permit targeting of resources and efforts to identify areas that are likely to
require expansion of clinical services.
• In areas where hospitals are stretched (or forecasted to be stretched in the near future), ensure nearby LTCFs are sufficiently capacitated to help off-load
chronic patients, with resources to upgrade to skilled nursing as needed.
• Ensure all schools and IHEs that are planning to reopen have the resources and plans to test all students and teachers, including those without symptoms,
and protocols to monitor and enforce face-masking and distancing.
• Ensure equitable distribution of vaccines and therapeutics, accounting for communities with increased numbers of individuals at-risk for severe disease;
ensure all facilities have up-to-date treatment protocols, including appropriate use of convalescent plasma and immune modulating therapies.
• The Pennsylvania ban on indoor dining and other high-risk indoor activities should be extended until at least Jan 25th, after MLK Day and Inauguration Day
to avoid gathering during these events.
• The State Correctional Institution at Dallas should prohibit guest visitation of inmates and test correctional officers and workers for COVID, as those who
are symptomatic can still spread the disease. Ensure/enforce strict mitigation interventions (social distancing, masking, and hand washing).
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

PENNSYLVANIA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 56,143 126,056 1,744,828


+12%
(RATE PER 100,000) (439) (409) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
14.0% +0.3%* 14.2% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 350,633** 1,010,441** 9,104,878**


+1%**
(TESTS PER 100,000) (2,739**) (3,275**) (2,774**)

COVID-19 DEATHS 1,221 1,971 21,090


-8%
(RATE PER 100,000) (9.5) (6.4) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
40% N/A*† 37% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
66% N/A*† 62% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
26% N/A*† 21% 16%

TOTAL NEW COVID-19 HOSPITAL 8,269 -2% 18,632 165,234


ADMISSIONS (RATE PER 100 BEDS) (26) (-3%) (27) (23)

NUMBER OF HOSPITALS WITH 32 +6% 77 1,086


SUPPLY SHORTAGES (PERCENT) (17%) (+23%*) (20%) (21%)

NUMBER OF HOSPITALS WITH 33 +7% 92 1,177


STAFF SHORTAGES (PERCENT) (18%) (+27%*) (24%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
812,550 6,347 226,478 2.2%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 90% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

PENNSYLVANIA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

PENNSYLVANIA
STATE REPORT | 01.10.2021

184 hospitals are expected to report in Pennsylvania


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

PENNSYLVANIA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Philadelphia-Camden-Wilmington Allegheny
Pittsburgh Montgomery
Allentown-Bethlehem-Easton Bucks
LOCALITIES
37 63
Scranton--Wilkes-Barre Lancaster
Harrisburg-Carlisle York
IN RED Lancaster Delaware
ZONE York-Hanover
Reading
Berks
Lehigh
▲ (+1) Erie ▼ (-1) Westmoreland
Pottsville Northampton
Chambersburg-Waynesboro Chester
Lebanon Luzerne

LOCALITIES
IN ORANGE
ZONE
0 N/A 4 Philadelphia
Jefferson
Tioga
Sullivan
▼ (-1) ▲ (+2)

LOCALITIES
IN YELLOW
ZONE
0 N/A 0 N/A

■ (+0) ▼ (-1)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Philadelphia-Camden-Wilmington, Pittsburgh, Allentown-Bethlehem-Easton, Scranton--Wilkes-Barre, Harrisburg-Carlisle, Lancaster, York-Hanover,
Reading, Erie, Pottsville, Chambersburg-Waynesboro, Lebanon, Williamsport, Altoona, Johnstown, East Stroudsburg, Gettysburg, Somerset, Sunbury, Youngstown-
Warren-Boardman, DuBois, Bloomsburg-Berwick, State College, New Castle, Meadville, Huntingdon, Lewisburg, Bradford, Oil City, Warren, Lewistown, Indiana, Lock
Haven, Sayre, St. Marys, Selinsgrove, New York-Newark-Jersey City
All Red Counties: Allegheny, Montgomery, Bucks, Lancaster, York, Delaware, Berks, Lehigh, Westmoreland, Northampton, Chester, Luzerne, Erie, Dauphin, Butler,
Schuylkill, Cumberland, Fayette, Washington, Lackawanna, Franklin, Beaver, Lebanon, Lycoming, Blair, Cambria, Monroe, Adams, Somerset, Northumberland,
Mercer, Clearfield, Centre, Carbon, Armstrong, Lawrence, Columbia, Crawford, Wayne, Huntingdon, Union, McKean, Venango, Warren, Mifflin, Indiana, Greene,
Clinton, Bradford, Perry, Elk, Bedford, Snyder, Clarion, Pike, Montour, Juniata, Susquehanna, Fulton, Wyoming, Potter, Forest, Cameron

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

PENNSYLVANIA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

PENNSYLVANIA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
RHODE ISLAND Issue 30
SUMMARY
• Rhode Island is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the highest rate in the country. Rhode
Island is in the orange zone for test positivity, indicating a rate between 8.0% and 10.0%, with the 42nd highest rate in the country.
• Rhode Island has seen an increase in new cases and stability in test positivity; 3 counties reported an increase in test positivity, most notably
Providence and Kent counties.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Providence County, 2. Kent County, and 3.
Washington County. These counties represent 73.7% of new cases in Rhode Island.
• 80% of all counties in Rhode Island have moderate or high levels of community transmission (yellow, orange, or red zones), with none having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 38% of nursing homes had at least one new resident COVID-19 case, 59% had at least one new staff COVID-19
case, and 15% had at least one new resident COVID-19 death.
• Rhode Island had 912 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 2 to support operations activities from FEMA.
• Between Jan 2 - Jan 8, on average, 31 patients with confirmed COVID-19 were reported as newly admitted each day to hospitals in Rhode Island.
This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 72,175 vaccine doses have been distributed to Rhode Island. 30,264 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the
Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid acceleration
phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our
large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total
COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and
Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal
antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic
data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility,
and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and
mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation;
without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could
quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and
where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a
call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have
outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites
with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put
in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number
of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine
hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Increasing cases indicate that transmission is increasing; this will require expansion of effective public health messaging, more sensitive
surveillance, and increased contact tracing capacity.
• Public health messaging should incorporate concerns about new viral variants to promote universal face masking and social distancing; Rhode
Islanders should be encouraged in all current restrictions (e.g., encouraged to shop locally) and should have a process to report non-compliance
of local businesses.
• Enhanced surveillance (quantitative wastewater, routine testing of at-risk individuals, and genomic surveillance) will provide early warning of
local increases in transmission and emergence/spread of viral variants. This will permit targeting of resources and efforts to identify areas that
are likely to require expansion of clinical services. Continue to stay ahead of staffing needs (medical or otherwise); the sooner these requests are
identified, the sooner interventions can be developed.
• Continue leveraging partnerships with community-based organizations to provide additional support focusing on outreach to refugees and New
Americans.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

RHODE ISLAND
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 9,665 85,599 1,744,828


+64%
(RATE PER 100,000) (912) (577) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
8.1% +0.5%* 8.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 77,425** 640,515** 9,104,878**


+7%**
(TESTS PER 100,000) (7,309**) (4,315**) (2,774**)

COVID-19 DEATHS 139 1,211 21,090


+90%
(RATE PER 100,000) (13.1) (8.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
38% N/A*† 27% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
59% N/A*† 49% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
15% N/A*† 15% 16%

TOTAL NEW COVID-19 HOSPITAL 217 +3% 5,332 165,234


ADMISSIONS (RATE PER 100 BEDS) (9) (+3%) (16) (23)

NUMBER OF HOSPITALS WITH 6 +0% 48 1,086


SUPPLY SHORTAGES (PERCENT) (50%) (+0%*) (26%) (21%)

NUMBER OF HOSPITALS WITH 5 -1% 30 1,177


STAFF SHORTAGES (PERCENT) (42%) (-17%*) (16%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
72,175 6,813 30,264 3.5%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 93% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

RHODE ISLAND
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

RHODE ISLAND
STATE REPORT | 01.10.2021

12 hospitals are expected to report in Rhode Island


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

RHODE ISLAND
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES

LOCALITIES
IN RED
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)

LOCALITIES
IN ORANGE
ZONE
1 Providence-Warwick 3 Providence
Kent
Bristol
■ (+0) ▲ (+1)

LOCALITIES
IN YELLOW
ZONE
0 N/A 1 Newport

■ (+0) ▼ (-1)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

RHODE ISLAND
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

RHODE ISLAND
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
SOUTH CAROLINA Issue 30
SUMMARY
• South Carolina is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 12th highest rate in the
country. South Carolina is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 9th highest rate in the country.
• South Carolina has seen an increase in new cases and test positivity, as well as rapidly rising hospitalizations, which is consistent with full
pandemic resurgence.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Greenville County, 2. Spartanburg County,
and 3. Horry County. These counties represent 29.2% of new cases in South Carolina.
• 100% of all counties in South Carolina have moderate or high levels of community transmission (yellow, orange, or red zones), with 96%
having high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 31% of nursing homes had at least one new resident COVID-19 case, 68% had at least one new staff
COVID-19 case, and 12% had at least one new resident COVID-19 death.
• South Carolina had 582 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 11 to support operations activities from
USCG.
• Between Jan 2 - Jan 8, on average, 291 patients with confirmed COVID-19 and 146 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in South Carolina. This is an increase of 14% in total new COVID-19 hospital admissions.
• As of Jan 8, 256,550 vaccine doses have been distributed to South Carolina. 64,729 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-
Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating
of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• South Carolina is in full pandemic resurgence and must significantly increase public mitigation and increase communication around the
importance of personal mitigation with masking, physical distancing, avoiding family gatherings.
• Ensure all hospitals and all communities have active monoclonal antibody infusion clinics for those with COVID-19 and at risk for
significant disease.
• Ensure aggressive, proactive testing as many more individuals may be asymptomatic and actively spreading virus in the community.
• All K-12 teachers and older students, community colleges, and universities should require weekly testing, as it dramatically decreases
COVID-19 viral spread by identifying and isolating the asymptomatic individuals, as well as symptomatic individuals, and allows for
contact tracing.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

SOUTH CAROLINA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 29,963 401,743 1,744,828


+16%
(RATE PER 100,000) (582) (600) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
20.1% +0.4%* 16.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 98,188** 1,521,048** 9,104,878**


+14%**
(TESTS PER 100,000) (1,907**) (2,273**) (2,774**)

COVID-19 DEATHS 201 3,680 21,090


-31%
(RATE PER 100,000) (3.9) (5.5) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
31% N/A*† 35% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
68% N/A*† 59% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
12% N/A*† 16% 16%

TOTAL NEW COVID-19 HOSPITAL 3,059 +14% 38,210 165,234


ADMISSIONS (RATE PER 100 BEDS) (31) (+13%) (25) (23)

NUMBER OF HOSPITALS WITH 21 +0% 160 1,086


SUPPLY SHORTAGES (PERCENT) (31%) (+0%*) (17%) (21%)

NUMBER OF HOSPITALS WITH 22 +2% 201 1,177


STAFF SHORTAGES (PERCENT) (33%) (+10%*) (22%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
256,550 4,982 64,729 1.6%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 91% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

SOUTH CAROLINA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

SOUTH CAROLINA
STATE REPORT | 01.10.2021

67 hospitals are expected to report in South Carolina


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

SOUTH CAROLINA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Greenville-Anderson Greenville
Columbia Spartanburg
Charleston-North Charleston Horry
LOCALITIES
17 44
Charlotte-Concord-Gastonia Richland
Spartanburg Lexington
IN RED Myrtle Beach-Conway-North Myrtle Beach York
Florence
ZONE Hilton Head Island-Bluffton
Charleston
Florence
■ (+0) Augusta-Richmond County ▲ (+3) Anderson
Sumter Pickens
Seneca Beaufort
Orangeburg Dorchester

LOCALITIES
IN ORANGE
ZONE
0 N/A 1 McCormick

■ (+0) ▼ (-1)

LOCALITIES
IN YELLOW
ZONE
1 Newberry 1 Newberry

■ (+0) ▼ (-2)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Greenville-Anderson, Columbia, Charleston-North Charleston, Charlotte-Concord-Gastonia, Spartanburg, Myrtle Beach-
Conway-North Myrtle Beach, Florence, Hilton Head Island-Bluffton, Augusta-Richmond County, Sumter, Seneca, Orangeburg,
Greenwood, Georgetown, Gaffney, Bennettsville, Union
All Red Counties: Greenville, Spartanburg, Horry, Richland, Lexington, York, Charleston, Florence, Anderson, Pickens, Beaufort,
Dorchester, Aiken, Berkeley, Lancaster, Oconee, Darlington, Sumter, Orangeburg, Laurens, Greenwood, Georgetown, Kershaw, Dillon,
Cherokee, Marion, Williamsburg, Chester, Chesterfield, Barnwell, Colleton, Marlboro, Clarendon, Jasper, Union, Edgefield, Fairfield, Lee,
Hampton, Calhoun, Abbeville, Saluda, Bamberg, Allendale

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

SOUTH CAROLINA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

SOUTH CAROLINA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
SOUTH DAKOTA Issue 30
SUMMARY
• South Dakota is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 34th highest rate in the country.
South Dakota is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 32nd highest rate in the country.
• South Dakota has seen an increase in new cases and a decrease in test positivity; 45 counties reported an increase in cases, and 37 reported an
increase in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Minnehaha County, 2. Pennington County, and 3.
Lincoln County. These counties represent 46.0% of new cases in South Dakota.
• 61% of all counties in South Dakota have moderate or high levels of community transmission (yellow, orange, or red zones), with 39% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 21% of nursing homes had at least one new resident COVID-19 case, 37% had at least one new staff COVID-
19 case, and 11% had at least one new resident COVID-19 death.
• South Dakota had 386 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 2 to support operations activities from FEMA.
• Between Jan 2 - Jan 8, on average, 21 patients with confirmed COVID-19 and 15 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in South Dakota. This is a decrease of 10% in total new COVID-19 hospital admissions.
• As of Jan 8, 67,925 vaccine doses have been distributed to South Dakota. 36,890 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the
Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our
large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000
total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and
Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of
monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given
that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we
must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help
identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on
a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should
have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination
sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should
instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the
number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent
vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Increase in reported cases may reflect catch-up reporting, but overall decreased testing since November raises concerns about data and
suggests need for enhanced surveillance, intensified public health messaging, and contact tracing capacity.
• Public health messaging should incorporate concerns about emergence of viral variants and the heightened need for universal face masking
and social distancing outside of the home.
• Surveillance should include quantitative wastewater testing, weekly testing of at-risk individuals regardless of symptoms, and expanded
genomic surveillance. Early identification of increased transmission or emergence of viral variants would help target resources, interventions,
and planning.
• Ensure equitable distribution plans for therapeutics and vaccines, and that all hospitals have up-to-date treatment protocols that include
recent recommendations for appropriate use of convalescent plasma and immune-modulating agents.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

SOUTH DAKOTA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 3,416 53,886 1,744,828


+30%
(RATE PER 100,000) (386) (440) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
10.9% -1.1%* 12.5% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 8,936** 417,166** 9,104,878**


+17%**
(TESTS PER 100,000) (1,010**) (3,403**) (2,774**)

COVID-19 DEATHS 68 629 21,090


+15%
(RATE PER 100,000) (7.7) (5.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
21% N/A*† 22% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
37% N/A*† 40% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
11% N/A*† 13% 16%

TOTAL NEW COVID-19 HOSPITAL 254 -10% 3,364 165,234


ADMISSIONS (RATE PER 100 BEDS) (10) (-10%) (14) (23)

NUMBER OF HOSPITALS WITH 6 +0% 70 1,086


SUPPLY SHORTAGES (PERCENT) (11%) (+0%*) (21%) (21%)

NUMBER OF HOSPITALS WITH 2 +1% 41 1,177


STAFF SHORTAGES (PERCENT) (4%) (+100%*) (12%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
67,925 7,678 36,890 5.5%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 88% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

SOUTH DAKOTA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

SOUTH DAKOTA
STATE REPORT | 01.10.2021

55 hospitals are expected to report in South Dakota


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

SOUTH DAKOTA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Minnehaha
Pennington
Sioux Falls Lincoln
LOCALITIES
8 26
Rapid City Yankton
Yankton Lawrence
IN RED Spearfish Meade
ZONE Sioux City
Mitchell
Union
Davison
▼ (-1) Vermillion ▼ (-1) Roberts
Huron Clay
Charles Mix
Butte
Brown
Brookings
LOCALITIES
3 10
Hughes
Oglala Lakota
IN ORANGE Aberdeen
Brookings
Beadle
ZONE Pierre
Edmunds
Todd
▲ (+3) ▲ (+8) Kingsbury
Spink
McPherson

LOCALITIES
IN YELLOW
ZONE
0 N/A 4 Lake
Lyman
Brule
Stanley
▼ (-1) ▼ (-2)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red Counties: Minnehaha, Pennington, Lincoln, Yankton, Lawrence, Meade, Union, Roberts, Davison, Clay,
Charles Mix, Butte, Turner, Walworth, Day, Hamlin, McCook, Custer, Bon Homme, Fall River, Grant, Moody,
Deuel, Hutchinson, Potter, Sully

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

SOUTH DAKOTA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

SOUTH DAKOTA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
TENNESSEE Issue 30
SUMMARY
• Tennessee is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 3rd highest rate in the country.
Tennessee is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 7th highest rate in the country.
• Tennessee has seen an increase in new cases and stability in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Davidson County, 2. Shelby County, and 3. Knox
County. These counties represent 24.2% of new cases in Tennessee.
• 100% of all counties in Tennessee have moderate or high levels of community transmission (yellow, orange, or red zones), with 99% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 45% of nursing homes had at least one new resident COVID-19 case, 66% had at least one new staff COVID-19
case, and 24% had at least one new resident COVID-19 death.
• Tennessee had 788 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 2 to support operations activities from FEMA;
12 to support medical activities from ASPR; and 7 to support operations activities from ASPR.
• Between Jan 2 - Jan 8, on average, 367 patients with confirmed COVID-19 and 123 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Tennessee. This is an increase of 5% in total new COVID-19 hospital admissions.
• As of Jan 8, 458,100 vaccine doses have been distributed to Tennessee. 196,642 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the
Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our
large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000
total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and
Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of
monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given
that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must
be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation;
without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could
quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and
where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on
a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should
have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination
sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead
be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the
number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent
vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• The COVID-19 pandemic spread is unyielding in Tennessee, impacting hospitals and staff. Effective mitigation is needed statewide.
Tennesseans must know that even though vaccines are coming, they will not immediately stop this current wave, which started weeks ago and
continues to surge. Have community leaders talk to their peers about vigilance and vaccination. Effective mitigation efforts include statewide
mask requirements, limited indoor dining, and bar closures.
• Early and limited data from returning university students and staff indicate COVID presence at universities; mandatory, weekly testing will
identify asymptomatic cases and can prevent transmission into the community.
• In K-12 schools, establish public health protocols to conduct active testing for teachers and students in districts with high positivity and cases.
In accordance with CDC guidelines, masks should be worn by students and teachers.
• Nearly 70% of LTCF sites have COVID-positive staff and nearly 50% have COVID-positive residents, indicating the depth of viral spread across
Tennessee. Continue weekly testing of all staff until residents and staff are fully vaccinated.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

TENNESSEE
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 53,804 401,743 1,744,828


+33%
(RATE PER 100,000) (788) (600) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
21.0% +0.2%* 16.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 111,440** 1,521,048** 9,104,878**


-28%**
(TESTS PER 100,000) (1,632**) (2,273**) (2,774**)

COVID-19 DEATHS 711 3,680 21,090


+49%
(RATE PER 100,000) (10.4) (5.5) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
45% N/A*† 35% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
66% N/A*† 59% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
24% N/A*† 16% 16%

TOTAL NEW COVID-19 HOSPITAL 3,431 +5% 38,210 165,234


ADMISSIONS (RATE PER 100 BEDS) (21) (+5%) (25) (23)

NUMBER OF HOSPITALS WITH 29 -2% 160 1,086


SUPPLY SHORTAGES (PERCENT) (28%) (-6%*) (17%) (21%)

NUMBER OF HOSPITALS WITH 48 +1% 201 1,177


STAFF SHORTAGES (PERCENT) (47%) (+2%*) (22%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
458,100 6,707 196,642 3.7%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 90% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

TENNESSEE
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

TENNESSEE
STATE REPORT | 01.10.2021

103 hospitals are expected to report in Tennessee


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

TENNESSEE
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Nashville-Davidson--Murfreesboro--Franklin Davidson
Knoxville Shelby
Memphis Knox
LOCALITIES
27 94
Chattanooga Hamilton
Johnson City Rutherford
IN RED Kingsport-Bristol Williamson
Clarksville
ZONE Jackson
Sumner
Montgomery
■ (+0) Morristown ■ (+0) Wilson
Cleveland Blount
Cookeville Sullivan
Sevierville Washington

LOCALITIES
IN ORANGE
ZONE
0 N/A 1 Houston

■ (+0) ▲ (+1)

LOCALITIES
IN YELLOW
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Nashville-Davidson--Murfreesboro--Franklin, Knoxville, Memphis, Chattanooga, Johnson City, Kingsport-Bristol, Clarksville, Jackson, Morristown,
Cleveland, Cookeville, Sevierville, Tullahoma-Manchester, Greeneville, Crossville, McMinnville, Athens, Lawrenceburg, Shelbyville, Dayton, Newport, Lewisburg,
Dyersburg, Martin, Union City, Paris, Brownsville
All Red Counties: Davidson, Shelby, Knox, Hamilton, Rutherford, Williamson, Sumner, Montgomery, Wilson, Blount, Sullivan, Washington, Sevier, Bradley, Maury,
Putnam, Robertson, Madison, Anderson, Greene, Hamblen, Cumberland, Roane, Loudon, Tipton, Jefferson, Coffee, Hawkins, Carter, Dickson, Monroe, Warren,
Gibson, Lawrence, McMinn, Bedford, Rhea, Giles, Cocke, Franklin, Lincoln, Campbell, Fayette, Cheatham, Marshall, Henderson, Dyer, Weakley, Obion, Carroll, Hardin,
White, Claiborne, Overton, DeKalb, McNairy, Morgan, Scott, Hickman, Marion, Grainger, Macon, Fentress, Henry, Chester, Smith, Hardeman, Lauderdale, Unicoi,
Sequatchie, Polk, Wayne, Crockett, Haywood, Grundy, Cannon, Union, Decatur, Meigs, Bledsoe, Humphreys, Johnson, Stewart, Benton, Trousdale, Moore, Lewis,
Perry, Lake, Pickett, Jackson, Clay, Van Buren, Hancock

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

TENNESSEE
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

TENNESSEE
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
TEXAS Issue 30
SUMMARY
• Texas is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 18th highest rate in the country. Texas is in
the red zone for test positivity, indicating a rate at or above 10.1%, with the 11th highest rate in the country.
• Texas has seen an increase in new cases and an increase in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Tarrant County, 2. Dallas County, and 3. Harris
County. These counties represent 33.7% of new cases in Texas.
• 83% of all counties in Texas have moderate or high levels of community transmission (yellow, orange, or red zones), with 78% having high
levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 32% of nursing homes had at least one new resident COVID-19 case, 52% had at least one new staff COVID-19
case, and 15% had at least one new resident COVID-19 death.
• Texas had 550 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 48 to support operations activities from FEMA;
10 to support operations activities from ASPR; and 17 to support operations activities from USCG.
• The federal government has supported surge testing in Harris County.
• Between Jan 2 - Jan 8, on average, 1,658 patients with confirmed COVID-19 and 658 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Texas. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 1,833,350 vaccine doses have been distributed to Texas. 618,298 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the
Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our
large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000
total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and
Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of
monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given
that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must
be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation;
without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could
quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and
where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on
a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should
have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination
sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead
be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the
number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent
vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Cases increased despite decreased testing. Rising test positivity, numbers of LTCF with positive residents, and hospitalizations suggest
significant, ongoing community spread.
• Significantly increase public mitigation and increase communication around the importance of personal mitigation with masking, physical
distancing, and avoiding family gatherings.
• Ensure aggressive, proactive testing as many more individuals may be asymptomatic and actively spreading virus in the community.
• All K-12 teachers and older students, community colleges, and universities should require weekly testing, as it dramatically decreases COVID-
19 viral spread by identifying and isolating the asymptomatic individuals, as well as symptomatic individuals, and allows for contact tracing.
• Ensure access to testing, monoclonal antibody infusions, and vaccination for all Tribal Nations.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

TEXAS
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 159,406 243,956 1,744,828


+36%
(RATE PER 100,000) (550) (571) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
20.1% +0.7%* 18.4% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 553,317** 853,979** 9,104,878**


-10%**
(TESTS PER 100,000) (1,908**) (1,999**) (2,774**)

COVID-19 DEATHS 1,615 2,639 21,090


+19%
(RATE PER 100,000) (5.6) (6.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
32% N/A*† 31% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
52% N/A*† 52% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
15% N/A*† 15% 16%

TOTAL NEW COVID-19 HOSPITAL 16,213 +0% 25,494 165,234


ADMISSIONS (RATE PER 100 BEDS) (26) (+0%) (27) (23)

NUMBER OF HOSPITALS WITH 77 -2% 211 1,086


SUPPLY SHORTAGES (PERCENT) (17%) (-3%*) (24%) (21%)

NUMBER OF HOSPITALS WITH 162 +2% 283 1,177


STAFF SHORTAGES (PERCENT) (35%) (+1%*) (32%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
1,833,350 6,322 618,298 2.9%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 80% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

TEXAS
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

TEXAS
STATE REPORT | 01.10.2021

458 hospitals are expected to report in Texas


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure. Anomalous confirmed admissions for the 18-19 year-old age group in TX on 8/15 have been corrected.
We look forward to working to improve data quality.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

TEXAS
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Dallas-Fort Worth-Arlington Tarrant
Houston-The Woodlands-Sugar Land Dallas
San Antonio-New Braunfels Harris
LOCALITIES
67 199
Austin-Round Rock-Georgetown Bexar
El Paso Collin
IN RED McAllen-Edinburg-Mission Travis
ZONE Lubbock
Killeen-Temple
Denton
El Paso
▲ (+1) Corpus Christi ▲ (+5) Fort Bend
Beaumont-Port Arthur Williamson
Laredo Montgomery
Wichita Falls Hidalgo

Taylor
Potter
LOCALITIES
2 9
Howard
IN ORANGE Big Spring
Terry
Gaines
ZONE Dumas
Moore
▲ (+2) ■ (+0) Freestone
Trinity
Swisher

LOCALITIES
IN YELLOW
ZONE
0 N/A 2 Pecos
Brooks

▼ (-4) ▼ (-4)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Dallas-Fort Worth-Arlington, Houston-The Woodlands-Sugar Land, San Antonio-New Braunfels, Austin-Round Rock-Georgetown, El Paso, McAllen-Edinburg-Mission, Lubbock, Killeen-
Temple, Corpus Christi, Beaumont-Port Arthur, Laredo, Wichita Falls, Waco, Longview, Brownsville-Harlingen, College Station-Bryan, San Angelo, Amarillo, Midland, Abilene, Sherman-Denison, Tyler, Lufkin,
Eagle Pass, Del Rio, Rio Grande City-Roma, Granbury, Palestine, Corsicana, Huntsville, Alice, Victoria, Paris, Brownwood, Gainesville, Uvalde, Kerrville, Mount Pleasant, Athens, Texarkana, Bonham,
Stephenville, Plainview, Mineral Wells, El Campo, Nacogdoches, Jacksonville, Fredericksburg, Beeville, Bay City, Snyder, Pearsall, Zapata, Vernon, Sulphur Springs, Brenham, Sweetwater, Kingsville,
Levelland, Raymondville, Andrews, Lamesa, Hereford, Rockport, Port Lavaca, Borger, Pampa
All Red Counties: Tarrant, Dallas, Harris, Bexar, Collin, Travis, Denton, El Paso, Fort Bend, Williamson, Montgomery, Hidalgo, Lubbock, Galveston, Brazoria, Bell, Ellis, Webb, Johnson, Nueces, McLennan,
Parker, Hays, Wichita, Cameron, Tom Green, Jefferson, Kaufman, Brazos, Midland, Grayson, Rockwall, Smith, Guadalupe, Randall, Angelina, Maverick, Val Verde, Wise, Starr, Hood, Anderson, Comal, Gregg,
Jasper, Navarro, Walker, Orange, Coryell, Hardin, Victoria, Lamar, Atascosa, Brown, Cooke, Uvalde, Kerr, Liberty, Wilson, Bastrop, Henderson, Tyler, Jim Wells, Bowie, Upshur, Harrison, Fannin, Chambers,
Erath, Hale, Waller, Hunt, Palo Pinto, Wharton, Nacogdoches, Medina, Titus, Cherokee, Rusk, Gillespie, Bee, Van Zandt, Wood, Montague, Kendall, Matagorda, Polk, Caldwell, Milam, Scurry, Frio, Zapata,
Wilbarger, Hill, Hopkins, Austin, Washington, Newton, Nolan, Jones, Runnels, Kleberg, Gonzales, Bandera, Zavala, Lee, Sabine, Clay, Burnet, Falls, Hockley, Young, Callahan, Dimmit, Panola, Willacy,
Houston, Coleman, Robertson, Comanche, Andrews, Jackson, Live Oak, Llano, Somervell, Colorado, Duval, Archer, Camp, Lampasas, Limestone, Dawson, Fayette, Eastland, Lamb, Grimes, Bosque, Deaf
Smith, Aransas, Karnes, Cass, DeWitt, Lavaca, Leon, Shelby, Hansford, Morris, Calhoun, Jack, Rains, Ward, Hutchinson, Childress, Burleson, Jim Hogg, Hemphill, Floyd, Martin, San Jacinto, Franklin, Gray,
Red River, Madison, Yoakum, Lynn, Refugio, Mitchell, San Saba, Hudspeth, Winkler, Mills, Mason, Wheeler, Kinney, Brewster, Castro, Crosby, Presidio, Real, Hall, Marion, Carson, Coke, Stephens, Oldham,
Haskell, Stonewall, Hardeman, Delta, Cottle, Upton, Fisher, Collingsworth, Bailey, Shackelford, Edwards, Reagan, Terrell, Knox

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

TEXAS
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

TEXAS
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions. Anomalous confirmed admissions
for the 18-19 year-old age group in TX on 8/15 have been corrected. We look forward to working to improve data quality.
STATE REPORT
01.10.2021
UTAH Issue 30
SUMMARY
• Utah is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 5th highest rate in the country. Utah is in the
red zone for test positivity, indicating a rate at or above 10.1%, with the 2nd highest rate in the country.
• Utah has seen an increase in new cases and an increase in test positivity; 22 counties reported an increase in cases, and 22 counties reported an
increase in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Salt Lake County, 2. Utah County, and 3. Davis County.
These counties represent 67.0% of new cases in Utah.
• 83% of all counties in Utah have moderate or high levels of community transmission (yellow, orange, or red zones), with 79% having high levels of
community transmission (red zone).
• During the week of Dec 28 - Jan 3, 21% of nursing homes had at least one new resident COVID-19 case, 44% had at least one new staff COVID-19
case, and 6% had at least one new resident COVID-19 death.
• Utah had 736 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 1 to support operations activities from FEMA and 1
to support epidemiology activities from CDC.
• The federal government has supported surge testing in Grantsville, UT and Tooele, UT.
• Between Jan 2 - Jan 8, on average, 90 patients with confirmed COVID-19 and 27 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Utah. This is an increase of 19% in total new COVID-19 hospital admissions.
• As of Jan 8, 207,500 vaccine doses have been distributed to Utah. 71,669 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased
cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains
slope in the fall and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral
spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large
metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total
COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast
suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies,
and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic
data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility,
and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and
mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation;
without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly
worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more
transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a
call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have
outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate
isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites
with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put
in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of
individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy,
continued active encouragement by the Governor, health officials, and community influencers are needed.
• The increasing transmission and possibility of circulating viral variants is highly concerning and will require intensified public health messaging,
enhanced surveillance, and expansion of timely contact tracing.
• Messaging should incorporate concerns about a more transmissible virus and the need for universal face-masking and social distancing outside of
the home, with procedures to report businesses that violate local ordinances and protocols to enforce.
• Enhancements in wastewater surveillance, weekly testing of at-risk individuals (regardless of symptoms) and genomic surveillance will help
identify areas to target resources, mitigation efforts, and mid-range planning (e.g., hospital expansion plans).
• Ensure equitable distribution of vaccine and therapeutics, accounting for communities with increased numbers of persons at risk for severe
disease. Ensure all treatment facilities have updated protocols, which include appropriate use of convalescent plasma and immune-modulating
agents. In areas where hospitals are stretched (or forecasted to be stretched in the near future) ensure nearby LTCFs are sufficiently capacitated to
help off-load chronic patients, with resources to upgrade to skilled nursing as needed.
• Ensure dedicated efforts to track outbreaks and interventions at LTCFs, with clear repercussions for non-compliance to CMS guidance.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

UTAH
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 23,600 53,886 1,744,828


+40%
(RATE PER 100,000) (736) (440) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
25.0% +3.6%* 12.5% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 115,486** 417,166** 9,104,878**


+31%**
(TESTS PER 100,000) (3,602**) (3,403**) (2,774**)

COVID-19 DEATHS 112 629 21,090


+70%
(RATE PER 100,000) (3.5) (5.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
21% N/A*† 22% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
44% N/A*† 40% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
6% N/A*† 13% 16%

TOTAL NEW COVID-19 HOSPITAL 820 +19% 3,364 165,234


ADMISSIONS (RATE PER 100 BEDS) (15) (+19%) (14) (23)

NUMBER OF HOSPITALS WITH 16 +0% 70 1,086


SUPPLY SHORTAGES (PERCENT) (33%) (+0%*) (21%) (21%)

NUMBER OF HOSPITALS WITH 3 +1% 41 1,177


STAFF SHORTAGES (PERCENT) (6%) (+50%*) (12%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
207,500 6,472 71,669 3.2%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 81% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

UTAH
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

UTAH
STATE REPORT | 01.10.2021

49 hospitals are expected to report in Utah


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

UTAH
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Salt Lake
Utah
Salt Lake City Davis
LOCALITIES
8 23
Provo-Orem Weber
Ogden-Clearfield Washington
IN RED St. George Cache
ZONE Logan
Heber
Tooele
Box Elder
■ (+0) Cedar City ▼ (-1) Summit
Vernal Iron
Sanpete
Wasatch

LOCALITIES
IN ORANGE
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)

LOCALITIES
IN YELLOW
ZONE
0 N/A 1 Emery

▼ (-1) ■ (+0)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red Counties: Salt Lake, Utah, Davis, Weber, Washington, Cache, Tooele, Box Elder, Summit, Iron, Sanpete,
Wasatch, Millard, Sevier, Uintah, Duchesne, Juab, Morgan, San Juan, Beaver, Garfield, Kane, Rich

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

UTAH
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

UTAH
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
VERMONT Issue 30
SUMMARY
• Vermont reported sharply increased cases, hospitalizations, and deaths last week for a second week. Vermont is in the red zone for cases, indicating 101 or
more new cases per 100,000 population, with the 49th highest rate in the country. Vermont is in the green zone for test positivity, indicating a rate at or below
4.9%, with the 49th highest rate in the country.
• Vermont has seen an increase in new cases and stability in test positivity. The following three counties had the highest number of new cases over the last 3
weeks: 1. Chittenden County, 2. Bennington County, and 3. Windham County. These counties represent 53.5% of new cases in Vermont.
• 29% of all counties in Vermont have moderate or high levels of community transmission (yellow, orange, or red zones), with none having high levels of
community transmission (red zone).
• Surveillance: an outbreak with 80 cases was linked to Christmas services at a church. The sharp increase in cases statewide was attributed to a record number
of holiday visitors. Although no cases of the B.1.1.7 variant have been detected to date, health leaders believe it is likely already circulating.
• Mitigation: On Nov 14, intensified mitigation measures went into effect; the state is maintaining these currently.
• During the week of Dec 28 - Jan 3, no nursing homes had at least one new resident COVID-19 case, 16% had at least one new staff COVID-19 case, and 3% had
at least one new resident COVID-19 death.
• Vermont had 193 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 2 to support operations activities from FEMA and 1 to support
operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 8 patients with confirmed COVID-19 and 8 patients with suspected COVID-19 were reported as newly admitted each day to
hospitals in Vermont. This is an increase of 14% in total new COVID-19 hospital admissions.
• As of Jan 8, 48,550 vaccine doses have been distributed to Vermont. 22,331 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased cases,
increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains slope in the fall
and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread, increasing
hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large metros.
Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-19
inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests increasing
and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data suggest
the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the presence of the UK
variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as more
transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible viruses
emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to action
for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient infusion sites
immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate isolation
and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with use of
EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms now; active and
aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public confidence and
maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of individuals vaccinated to
date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy, continued active encouragement by
the Governor, health officials, and community influencers are needed.
• We share the strong caution of Vermont’s leaders regarding recent increases in reported cases, as well as their continuing concern that the near-term forecast
for cases and deaths is dependent on the collective effort of Vermonters to follow the guidelines. The large number of holiday visitors and the multiple
outbreaks introduced will create large challenge, especially if a more transmissible variant has been introduced, with the church outbreak very concerning in
this regard. Continued messaging for residents to maintain their changes in personal behavior is key to limiting disease and death until the pandemic ends
with immunization. The Governor’s continued personal communication on these measures remains critical.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that could
limit morbidity and hospitalizations. The recent report confirming the benefit of convalescent plasma when administered early strengthens the case for
expanded utilization of plasma and monoclonal antibodies.
• Continue to prioritize efforts toward marginalized communities that are disproportionately being impacted by COVID-19, including a strategy that prioritizes
allocation of monoclonal antibody preparations to outpatient centers that serve more marginalized populations with higher levels of COVID-19 risk factors.
• Mitigation measures in public spaces remain critical and need careful balancing of risk and economic/social benefit. Proactive testing must be part of the
mitigation efforts inclusive of universal masking, physical distancing, hand hygiene, and the active promotion of activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in LTCFs as
vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Ensure all K-12 schools are following CDC guidelines, including wearing masks and routinely utilizing the BinaxNOW tests. Ensure all universities returning
after winter break implement mandatory weekly testing of all on and off campus students.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

VERMONT
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 1,207 85,599 1,744,828


+91%
(RATE PER 100,000) (193) (577) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
4.4% +0.4%* 8.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 30,860** 640,515** 9,104,878**


+8%**
(TESTS PER 100,000) (4,946**) (4,315**) (2,774**)

COVID-19 DEATHS 20 1,211 21,090


+25%
(RATE PER 100,000) (3.2) (8.2) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
0% N/A*† 27% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
16% N/A*† 49% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
3% N/A*† 15% 16%

TOTAL NEW COVID-19 HOSPITAL 115 +14% 5,332 165,234


ADMISSIONS (RATE PER 100 BEDS) (9) (+14%) (16) (23)

NUMBER OF HOSPITALS WITH 13 +0% 48 1,086


SUPPLY SHORTAGES (PERCENT) (87%) (+0%*) (26%) (21%)

NUMBER OF HOSPITALS WITH 1 +0% 30 1,177


STAFF SHORTAGES (PERCENT) (7%) (+0%*) (16%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
48,550 7,780 22,331 4.4%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 89% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

VERMONT
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

VERMONT
STATE REPORT | 01.10.2021

15 hospitals are expected to report in Vermont


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

VERMONT
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES

LOCALITIES
IN RED
ZONE
0 N/A 0 N/A

■ (+0) ■ (+0)

LOCALITIES
IN ORANGE
ZONE
0 N/A 3 Franklin
Addison
Essex
■ (+0) ▲ (+2)

LOCALITIES
IN YELLOW
ZONE
1 Lebanon 1 Windsor

▼ (-2) ▼ (-2)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

VERMONT
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

VERMONT
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
VIRGINIA Issue 30
SUMMARY
• Virginia is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 32nd highest rate in the country.
Virginia is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 4th highest rate in the country.
• Virginia has seen an increase in new cases and a decrease in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Fairfax County, 2. Prince William County, and
3. Virginia Beach City. These counties represent 23.1% of new cases in Virginia.
• 98% of all counties in Virginia have moderate or high levels of community transmission (yellow, orange, or red zones), with 94% having
high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 38% of nursing homes had at least one new resident COVID-19 case, 61% had at least one new staff
COVID-19 case, and 18% had at least one new resident COVID-19 death.
• Virginia had 388 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 30 to support operations activities from
FEMA and 107 to support operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 293 patients with confirmed COVID-19 and 284 patients with suspected COVID-19 were reported as
newly admitted each day to hospitals in Virginia. This is a minimal change in total new COVID-19 hospital admissions.
• As of Jan 8, 556,625 vaccine doses have been distributed to Virginia. 150,104 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over
130,000 total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-
Atlantic, and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation,
testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more
transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members
and on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every
hospital should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating
of the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• The increase in cases, high test positivity, percent of LTCF with positive residents, and rising hospitalizations suggest significant ongoing
community spread.
• Significantly increase public mitigation and increase communication around the importance of personal mitigation with masking,
physical distancing, and avoiding family gatherings.
• Ensure aggressive, proactive testing as many more individuals may be asymptomatic and actively spreading virus in the community.
• All K-12 teachers and older students, community colleges, and universities should require weekly testing, as it dramatically decreases
COVID-19 viral spread by identifying and isolating the asymptomatic individuals, as well as symptomatic individuals, and allows for
contact tracing.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

VIRGINIA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 33,154 126,056 1,744,828


+24%
(RATE PER 100,000) (388) (409) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
22.4% -1.0%* 14.2% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 212,125** 1,010,441** 9,104,878**


+10%**
(TESTS PER 100,000) (2,485**) (3,275**) (2,774**)

COVID-19 DEATHS 233 1,971 21,090


-11%
(RATE PER 100,000) (2.7) (6.4) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
38% N/A*† 37% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
61% N/A*† 62% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
18% N/A*† 21% 16%

TOTAL NEW COVID-19 HOSPITAL 4,040 +3% 18,632 165,234


ADMISSIONS (RATE PER 100 BEDS) (24) (+3%) (27) (23)

NUMBER OF HOSPITALS WITH 5 +1% 77 1,086


SUPPLY SHORTAGES (PERCENT) (6%) (+25%*) (20%) (21%)

NUMBER OF HOSPITALS WITH 32 +0% 92 1,177


STAFF SHORTAGES (PERCENT) (37%) (+0%*) (24%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
556,625 6,521 150,104 2.2%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 92% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

VIRGINIA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

VIRGINIA
STATE REPORT | 01.10.2021

86 hospitals are expected to report in Virginia


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

VIRGINIA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Washington-Arlington-Alexandria Fairfax
Virginia Beach-Norfolk-Newport News Prince William
Richmond Virginia Beach City
LOCALITIES
15 125
Lynchburg Henrico
Roanoke Chesterfield
IN RED Staunton Loudoun
ZONE Blacksburg-Christiansburg
Harrisonburg
Richmond City
Norfolk City
■ (+0) Charlottesville ■ (+0) Arlington
Winchester Chesapeake City
Kingsport-Bristol Newport News City
Danville Stafford

LOCALITIES
IN ORANGE
ZONE
0 N/A 4 Charlottesville City
Franklin City
Sussex
Falls Church City
■ (+0) ▲ (+1)

LOCALITIES
IN YELLOW
ZONE
0 N/A 1 Greensville

■ (+0) ▼ (-1)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Washington-Arlington-Alexandria, Virginia Beach-Norfolk-Newport News, Richmond, Lynchburg, Roanoke, Staunton, Blacksburg-Christiansburg, Harrisonburg, Charlottesville,
Winchester, Kingsport-Bristol, Danville, Bluefield, Martinsville, Big Stone Gap
All Red Counties: Fairfax, Prince William, Virginia Beach City, Henrico, Chesterfield, Loudoun, Richmond City, Norfolk City, Arlington, Chesapeake City, Newport News City, Stafford,
Alexandria City, Augusta, Spotsylvania, Portsmouth City, Hanover, Hampton City, Rockingham, Lynchburg City, Frederick, Roanoke, Suffolk City, Bedford, Tazewell, Montgomery, Washington,
Roanoke City, Albemarle, Campbell, Fauquier, James City, Henry, Pittsylvania, Shenandoah, Wise, Danville City, Harrisonburg City, Pulaski, Culpeper, Franklin, Smyth, Staunton City, York,
Amherst, Lee, Nottoway, Russell, Manassas City, Waynesboro City, Botetourt, Southampton, Wythe, Warren, Carroll, Isle of Wight, Petersburg City, Halifax, Richmond, Page, Winchester City,
Orange, Louisa, Accomack, Rockbridge, Buchanan, Alleghany, Bristol City, Gloucester, Powhatan, Buckingham, Hopewell City, Appomattox, Caroline, Mecklenburg, Prince George, Giles, New
Kent, King George, Prince Edward, Fredericksburg City, Scott, Salem City, Dinwiddie, Radford City, Martinsville City, Patrick, Fluvanna, Lexington City, Dickenson, Lunenburg, Brunswick,
Greene, Colonial Heights City, Grayson, Westmoreland, Goochland, Galax City, Buena Vista City, Nelson, Covington City, Manassas Park City, Amelia, Poquoson City, Clarke, King William,
Bland, Northumberland, Lancaster, Floyd, Essex, Northampton, Charlotte, Bath, Madison, Mathews, Norton City, Middlesex, Emporia City, Charles City, Rappahannock, King and Queen,
Williamsburg City, Cumberland, Surry

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

VIRGINIA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

VIRGINIA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
WASHINGTON Issue 30
SUMMARY
• Washington’s viral surge appeared to resume last week with a sharp increase in reported cases but a plateauing in hospitalizations. Washington is in the red
zone for cases, indicating 101 or more new cases per 100,000 population, with the 45th highest rate in the country. Washington is in the orange zone for test
positivity, indicating a rate between 8.0% and 10.0%, with the 38th highest rate in the country.
• Washington has seen a sharp increase in new cases and stability in test positivity. Positivity generally remained lower in Western Washington. Deaths
decreased.
• Viral transmission remains high in a majority of counties throughout the state. The following three counties had the highest number of new cases over the last
3 weeks: 1. King County, 2. Pierce County, and 3. Spokane County. These counties represent 45.2% of new cases in Washington.
• 87% of all counties in Washington have moderate or high levels of community transmission (yellow, orange, or red zones), with 41% having high levels of
community transmission (red zone).
• Mitigation: Emergency measures that prohibit indoor dining and limit other activities were extended until Jan 11 and can be progressively lifted based on
disease activity criteria under the “Healthy Washington” plan introduced by the Governor last week.
• During the week of Dec 28 - Jan 3, 16% of nursing homes had at least one new resident COVID-19 case, 28% had at least one new staff COVID-19 case, and 11%
had at least one new resident COVID-19 death.
• Washington had 287 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 48 to support operations activities from FEMA; 3 to support
operations activities from ASPR; and 21 to support operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 103 patients with confirmed COVID-19 and 110 patients with suspected COVID-19 were reported as newly admitted each
day to hospitals in Washington. This is an increase of 6% in total new COVID-19 hospital admissions.
• As of Jan 8, 518,550 vaccine doses have been distributed to Washington. 135,097 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased cases,
increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains slope in the fall
and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread, increasing
hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large metros.
Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-19
inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests increasing
and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data suggest
the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the presence of the UK
variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as more
transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible viruses
emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to action
for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient infusion sites
immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate isolation
and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with use of
EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms now; active and
aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public confidence and
maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of individuals vaccinated to
date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy, continued active encouragement by
the Governor, health officials, and community influencers are needed.
• We share the caution of Washington’s leaders that the instability in testing and reporting during the holidays makes it difficult to clearly identify trends,
although the increase in cases is worrisome. The near-term forecast for cases and deaths remains dependent on the collective effort of Washingtonians to
follow the guidelines. Continued messaging for residents to maintain their changes in personal behavior is key to limiting disease and death until the
pandemic ends with immunization. The Governor’s continued personal communication on these measures remains critical.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that could
limit morbidity and hospitalizations. The recent report confirming the benefit of convalescent plasma when administered early strengthens the case for
expanded utilization of plasma and monoclonal antibodies.
• Continue to prioritize efforts toward marginalized communities that are disproportionately being impacted by COVID-19, including a strategy that prioritizes
allocation of monoclonal antibody preparations to outpatient centers that serve more marginalized populations with higher levels of COVID-19 risk factors.
• Proactive testing must be part of the mitigation efforts inclusive of universal masking, physical distancing, hand hygiene, and the active promotion of
activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in LTCFs as
vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Ensure all K-12 schools are following CDC guidelines, including wearing masks and routinely utilizing the BinaxNOW tests. Ensure all universities returning
after winter break implement mandatory weekly testing of all on and off campus students.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

WASHINGTON
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 21,855 39,189 1,744,828


+60%
(RATE PER 100,000) (287) (273) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
9.8% +0.5%* 10.0% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 103,282** 288,163** 9,104,878**


+8%**
(TESTS PER 100,000) (1,356**) (2,008**) (2,774**)

COVID-19 DEATHS 242 431 21,090


-11%
(RATE PER 100,000) (3.2) (3.0) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
16% N/A*† 18% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
28% N/A*† 33% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
11% N/A*† 10% 16%

TOTAL NEW COVID-19 HOSPITAL 1,495 +6% 3,059 165,234


ADMISSIONS (RATE PER 100 BEDS) (12) (+5%) (13) (23)

NUMBER OF HOSPITALS WITH 16 -1% 39 1,086


SUPPLY SHORTAGES (PERCENT) (17%) (-6%*) (18%) (21%)

NUMBER OF HOSPITALS WITH 10 -3% 18 1,177


STAFF SHORTAGES (PERCENT) (11%) (-23%*) (8%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
518,550 6,809 135,097 2.3%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 87% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

WASHINGTON
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs)
through 1/6/2021.
COVID-19 Issue 30

WASHINGTON
STATE REPORT | 01.10.2021

92 hospitals are expected to report in Washington


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

WASHINGTON
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Spokane
Yakima
Spokane-Spokane Valley
Clark
Yakima
LOCALITIES
9 16
Franklin
Wenatchee
Grant
IN RED Moses Lake
Longview
Chelan
ZONE Centralia
Cowlitz
Lewis
▼ (-1) Shelton
Ellensburg
▼ (-1) Mason
Douglas
Lewiston
Kittitas
Okanogan
King
Pierce
Seattle-Tacoma-Bellevue
LOCALITIES
7 10
Snohomish
Portland-Vancouver-Hillsboro
Whatcom
IN ORANGE Bellingham
Aberdeen
Grays Harbor
ZONE Mount Vernon-Anacortes
Skagit
Clallam
▲ (+4) Port Angeles
Othello
▲ (+7) Adams
Pend Oreille
Jefferson
Benton
LOCALITIES
6 8
Kennewick-Richland Thurston
Olympia-Lacey-Tumwater Kitsap
IN YELLOW Bremerton-Silverdale-Port Orchard Walla Walla
ZONE Walla Walla
Pullman
Whitman
Island
■ (+0) Oak Harbor ▲ (+1) Pacific
Skamania

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red Counties: Spokane, Yakima, Clark, Franklin, Grant, Chelan, Cowlitz, Lewis, Mason, Douglas, Kittitas,
Okanogan, Stevens, Asotin, Klickitat, Ferry

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs) through
1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

WASHINGTON
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs) through
1/6/2021; week one month before is 12/3 - 12/9.
COVID-19 Issue 30

WASHINGTON
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
WEST VIRGINIA Issue 30
SUMMARY
• West Virginia is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 15th highest rate in the country.
West Virginia is in the red zone for test positivity, indicating a rate at or above 10.1%, with the 24th highest rate in the country.
• West Virginia has seen an increase in new cases and an increase in test positivity.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Berkeley County, 2. Kanawha County, and 3.
Wood County. These counties represent 20.3% of new cases in West Virginia.
• 100% of all counties in West Virginia have moderate or high levels of community transmission (yellow, orange, or red zones), with 80%
having high levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 32% of nursing homes had at least one new resident COVID-19 case, 54% had at least one new staff
COVID-19 case, and 17% had at least one new resident COVID-19 death.
• West Virginia had 562 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 7 to support operations activities from
FEMA; 6 to support epidemiology activities from CDC; and 29 to support operations activities from USCG.
• Between Jan 2 - Jan 8, on average, 90 patients with confirmed COVID-19 and 56 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in West Virginia. This is an increase of 7% in total new COVID-19 hospital admissions.
• As of Jan 8, 126,275 vaccine doses have been distributed to West Virginia. 87,215 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as
the Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in
our large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000
total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic,
and Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of
monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus.
Given that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible,
we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered
mitigation; without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing,
epidemics could quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will
help identify when and where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and
on a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital
should have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput
vaccination sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers
but should instead be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining
public confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of
the number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given
persistent vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• With the continued uptick in cases and positivity, aggressive targeted testing in counties with the highest increases is critical now to
prevent continuing surges.
• Early and limited data from returning university students and staff indicate COVID presence at universities; mandatory, weekly testing will
identify asymptomatic cases and can prevent transmission into the community.
• In K-12 schools, establish public health protocols to conduct active testing for teachers and students in districts with high positivity and
cases. In accordance with CDC guidelines, masks should be worn by students and teachers.
• With over 50% of LTCF sites having COVID-positive staff, continue weekly testing of all staff until residents and staff are fully vaccinated.
Similarly, conduct weekly testing of all correctional staff to identify asymptomatic cases and prevent spread within the correctional facility
and into the community.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

WEST VIRGINIA
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 10,078 126,056 1,744,828


+12%
(RATE PER 100,000) (562) (409) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
14.1% +1.0%* 14.2% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 92,552** 1,010,441** 9,104,878**


+12%**
(TESTS PER 100,000) (5,164**) (3,275**) (2,774**)

COVID-19 DEATHS 193 1,971 21,090


+68%
(RATE PER 100,000) (10.8) (6.4) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
32% N/A*† 37% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
54% N/A*† 62% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
17% N/A*† 21% 16%

TOTAL NEW COVID-19 HOSPITAL 1,026 +7% 18,632 165,234


ADMISSIONS (RATE PER 100 BEDS) (20) (+8%) (27) (23)

NUMBER OF HOSPITALS WITH 33 +0% 77 1,086


SUPPLY SHORTAGES (PERCENT) (62%) (+0%*) (20%) (21%)

NUMBER OF HOSPITALS WITH 23 -1% 92 1,177


STAFF SHORTAGES (PERCENT) (43%) (-4%*) (24%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
126,275 7,046 87,215 6.1%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 97% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

WEST VIRGINIA
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

WEST VIRGINIA
STATE REPORT | 01.10.2021

53 hospitals are expected to report in West Virginia


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

WEST VIRGINIA
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Charleston Berkeley
Huntington-Ashland Kanawha
Hagerstown-Martinsburg Wood
LOCALITIES
16 44
Morgantown Cabell
Parkersburg-Vienna Monongalia
IN RED Clarksburg Mercer
ZONE Beckley
Bluefield
Harrison
Marion
■ (+0) Wheeling ▼ (-1) Raleigh
Weirton-Steubenville Jefferson
Fairmont Greenbrier
Washington-Arlington-Alexandria Preston

Putnam
LOCALITIES
0 8
McDowell
Nicholas
IN ORANGE N/A
Summers
ZONE Tucker
Roane
▼ (-1) ▲ (+1) Webster
Clay

LOCALITIES
IN YELLOW
ZONE
1 Elkins 3 Randolph
Mason
Pocahontas
▲ (+1) ▲ (+1)
Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Charleston, Huntington-Ashland, Hagerstown-Martinsburg, Morgantown, Parkersburg-Vienna, Clarksburg,


Beckley, Bluefield, Wheeling, Weirton-Steubenville, Fairmont, Washington-Arlington-Alexandria, Mount Gay-Shamrock,
Winchester, Point Pleasant, Cumberland
All Red Counties: Berkeley, Kanawha, Wood, Cabell, Monongalia, Mercer, Harrison, Marion, Raleigh, Jefferson, Preston,
Greenbrier, Hancock, Ohio, Marshall, Logan, Fayette, Brooke, Upshur, Wayne, Pleasants, Mingo, Braxton, Hampshire,
Barbour, Jackson, Hardy, Boone, Wyoming, Lincoln, Taylor, Mineral, Lewis, Wetzel, Grant, Morgan, Monroe, Gilmer,
Pendleton, Tyler, Ritchie, Doddridge, Wirt, Calhoun

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

WEST VIRGINIA
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

WEST VIRGINIA
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
WISCONSIN Issue 30
SUMMARY
• After declining for several weeks, last week’s data show a trend of increasing disease activity with increased cases, test positivity, and deaths. Wisconsin is in
the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 35th highest rate in the country. Wisconsin is in the red zone for test
positivity, indicating a rate at or above 10.1%, with the 33rd highest rate in the country.
• Wisconsin has seen an increase in new cases and an increase in test positivity. New hospitalizations edged up (+8%) while current hospitalizations fluctuated
considerably ending up the week with little change. Deaths increased.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Milwaukee County, 2. Waukesha County, and 3. Dane County.
These counties represent 31.4% of new cases in Wisconsin.
• 99% of all counties in Wisconsin have moderate or high levels of community transmission (yellow, orange, or red zones), with 54% having high levels of
community transmission (red zone).
• Very high-level community virus transmission continues throughout the state with all of 72 counties still reporting >100 cases per 100,000 population.
• During the week of Dec 28 - Jan 3, 18% of nursing homes had at least one new resident COVID-19 case, 34% had at least one new staff COVID-19 case, and 12%
had at least one new resident COVID-19 death.
• Wisconsin had 379 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 45 to support medical activities from DoD; 7 to support
operations activities from FEMA; 1 to support operations activities from ASPR; 1 to support epidemiology activities from CDC; and 1 to support operations
activities from USCG.
• The federal government has supported surge testing at the University of Wisconsin System, in Neenah, and in surrounding towns.
• Between Jan 2 - Jan 8, on average, 238 patients with confirmed COVID-19 and 92 patients with suspected COVID-19 were reported as newly admitted each day
to hospitals in Wisconsin. This is an increase of 8% in total new COVID-19 hospital admissions.
• As of Jan 8, 323,075 vaccine doses have been distributed to Wisconsin. 98,373 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity, increased cases,
increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the Northern Plains slope in the fall
and has continued into November, December, and now January with more states entering the rapid acceleration phase of viral spread, increasing
hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our large metros.
Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000 total COVID-19
inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and Northeast suggests increasing
and aggressive community spread, which requires aggressive and increased mitigation, testing, use of monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the epidemiologic data suggest
the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given that possibility, and the presence of the UK
variant that is already spreading in our communities and may be 50% more transmissible, we must be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation; without
uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could quickly worsen as more
transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and where more transmissible viruses
emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on a call to action
for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should have outpatient infusion sites
immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive, immediate isolation
and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination sites with use of
EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead be put in arms now; active and
aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public confidence and
maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the number of individuals vaccinated to
date, as well as vaccine-related information and messaging; these are a best practice. Given persistent vaccine hesitancy, continued active encouragement by
the Governor, health officials, and community influencers are needed.
• We share the caution of Wisconsin’s leaders that the recent data may indicate a resurgence of viral transmission. Continued messaging for residents to
maintain their changes in personal behavior is key to limiting disease and death until the pandemic ends with immunization. The Governor’s continued
personal communication on these measures remains critical.
• Work with healthcare institutions to ensure capacity for outpatient infusion is accessible to COVID-19 patients who may benefit from IV therapies that could
limit morbidity and hospitalizations. The recent report confirming the benefit of convalescent plasma when administered early strengthens the case for
expanded utilization of plasma and monoclonal antibodies.
• Continue to prioritize efforts toward marginalized communities that are disproportionately being impacted by COVID-19, including a strategy that prioritizes
allocation of monoclonal antibody preparations to outpatient centers that serve more marginalized populations with higher levels of COVID-19 risk factors.
• Mitigation measures in public spaces remain critical and need careful balancing of risk and economic/social benefit. Proactive testing must be part of the
mitigation efforts inclusive of universal masking, physical distancing, hand hygiene, and the active promotion of activities in outdoor settings.
• Given continuing outbreaks and deaths in nursing homes, ensure increased frequency of LTCF testing and rapid implementation of vaccination in LTCFs as
vaccine becomes available. Continue weekly testing of staff until all residents and staff are fully vaccinated.
• Ensure all K-12 schools are following CDC guidelines, including wearing masks and routinely utilizing the BinaxNOW tests. Ensure all universities returning
after winter break implement mandatory weekly testing of all on and off campus students.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

WISCONSIN
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 22,095 220,780 1,744,828


+29%
(RATE PER 100,000) (379) (420) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
10.9% +1.8%* 11.3% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 178,600** 1,504,419** 9,104,878**


+2%**
(TESTS PER 100,000) (3,067**) (2,863**) (2,774**)

COVID-19 DEATHS 277 3,714 21,090


+22%
(RATE PER 100,000) (4.8) (7.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
18% N/A*† 27% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
34% N/A*† 45% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
12% N/A*† 19% 16%

TOTAL NEW COVID-19 HOSPITAL 2,308 +8% 22,662 165,234


ADMISSIONS (RATE PER 100 BEDS) (18) (+8%) (19) (23)

NUMBER OF HOSPITALS WITH 38 +1% 192 1,086


SUPPLY SHORTAGES (PERCENT) (29%) (+3%*) (22%) (21%)

NUMBER OF HOSPITALS WITH 42 +2% 185 1,177


STAFF SHORTAGES (PERCENT) (32%) (+5%*) (21%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
323,075 5,548 98,373 2.2%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 88% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

WISCONSIN
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

WISCONSIN
STATE REPORT | 01.10.2021

130 hospitals are expected to report in Wisconsin


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

WISCONSIN
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Milwaukee-Waukesha Milwaukee
Green Bay Waukesha
Racine Brown
LOCALITIES
16 39
Appleton Racine
Janesville-Beloit Outagamie
IN RED Chicago-Naperville-Elgin Rock
ZONE Wausau-Weston
Eau Claire
Kenosha
Washington
▲ (+5) Sheboygan ▲ (+14) Marathon
Whitewater Sheboygan
Watertown-Fort Atkinson Walworth
Manitowoc Eau Claire
Fond du Lac
St. Croix
Dodge
LOCALITIES
4 14
Sauk
Fond du Lac Columbia
IN ORANGE Beaver Dam Waupaca
ZONE Baraboo
Marinette
Oconto
Washburn
▼ (-2) ▼ (-4) Ashland
Taylor
Lafayette
Rusk
Dane
Winnebago
La Crosse
Madison
LOCALITIES
7 18
Grant
Oshkosh-Neenah
Clark
IN YELLOW Minneapolis-St. Paul-Bloomington
La Crosse-Onalaska
Green
ZONE Duluth
Jackson
Trempealeau
▼ (-2) Platteville
Iron Mountain
▼ (-4) Marinette
Vernon
Iowa
Green Lake

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red CBSAs: Milwaukee-Waukesha, Green Bay, Racine, Appleton, Janesville-Beloit, Chicago-Naperville-Elgin, Wausau-Weston, Eau Claire, Sheboygan,
Whitewater, Watertown-Fort Atkinson, Manitowoc, Wisconsin Rapids-Marshfield, Stevens Point, Shawano, Menomonie
All Red Counties: Milwaukee, Waukesha, Brown, Racine, Outagamie, Rock, Kenosha, Washington, Marathon, Sheboygan, Walworth, Eau Claire, Ozaukee,
Jefferson, Manitowoc, Wood, Chippewa, Portage, Douglas, Barron, Monroe, Dunn, Polk, Calumet, Pierce, Shawano, Juneau, Lincoln, Door, Oneida,
Kewaunee, Vilas, Sawyer, Adams, Langlade, Buffalo, Pepin, Forest, Menominee
All Orange Counties: Fond du Lac, St. Croix, Dodge, Sauk, Columbia, Waupaca, Oconto, Washburn, Ashland, Taylor, Lafayette, Rusk, Burnett, Price
All Yellow Counties: Dane, Winnebago, La Crosse, Grant, Clark, Green, Jackson, Trempealeau, Marinette, Vernon, Iowa, Green Lake, Richland, Waushara,
Bayfield, Crawford, Marquette, Iron

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

WISCONSIN
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. The week one month before is 12/3 - 12/9.
COVID-19 Issue 30

WISCONSIN
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
STATE REPORT
01.10.2021
WYOMING Issue 30
SUMMARY
• Wyoming is in the red zone for cases, indicating 101 or more new cases per 100,000 population, with the 33rd highest rate in the country.
Wyoming is in the yellow zone for test positivity, indicating a rate between 5.0% and 7.9%, with the 46th highest rate in the country.
• Wyoming has seen an increase in new cases and stability in test positivit. Reported cases increased in 17 counties; test positivity increased in
10.
• The following three counties had the highest number of new cases over the last 3 weeks: 1. Laramie County, 2. Natrona County, and 3.
Sweetwater County. These counties represent 35.1% of new cases in Wyoming.
• 87% of all counties in Wyoming have moderate or high levels of community transmission (yellow, orange, or red zones), with 57% having high
levels of community transmission (red zone).
• During the week of Dec 28 - Jan 3, 23% of nursing homes had at least one new resident COVID-19 case, 45% had at least one new staff COVID-19
case, and 19% had at least one new resident COVID-19 death.
• Wyoming had 387 new cases per 100,000 population, compared to a national average of 532 per 100,000.
• Current staff deployed from the federal government as assets to support the state response are: 3 to support operations activities from FEMA
and 3 to support testing activities from CDC.
• Between Jan 2 - Jan 8, on average, 18 patients with confirmed COVID-19 and 15 patients with suspected COVID-19 were reported as newly
admitted each day to hospitals in Wyoming. This is a decrease of 10% in total new COVID-19 hospital admissions.
• As of Jan 8, 41,375 vaccine doses have been distributed to Wyoming. 10,791 individuals have received the first dose.

RECOMMENDATIONS
• Data reporting has stabilized and reveals a clear continuation of the pre-holiday high rate of spread as measured by rising test positivity,
increased cases, increased hospitalization rates, and rising fatalities. The slope of the rate of rise across the country remains the same as the
Northern Plains slope in the fall and has continued into November, December, and now January with more states entering the rapid
acceleration phase of viral spread, increasing hospitalizations and deaths.
• Nearly all metro areas over 500,000 persons are in full resurgence, and aggressive action must meet this increasing community spread in our
large metros. Metros that continued to improve post-Thanksgiving are now destabilizing.
• The United States remains at a high plateau of 150-160,000 confirmed and suspected new COVID-19 admissions per week and over 130,000
total COVID-19 inpatients. Significant, continued deterioration from California across the Sunbelt and up into the Southeast, Mid-Atlantic, and
Northeast suggests increasing and aggressive community spread, which requires aggressive and increased mitigation, testing, use of
monoclonal antibodies, and vaccination.
• This fall/winter surge has been at nearly twice the rate of rise of cases as the spring and summer surges. This acceleration and the
epidemiologic data suggest the possibility that some strains of the US COVID-19 virus may have evolved into a more transmissible virus. Given
that possibility, and the presence of the UK variant that is already spreading in our communities and may be 50% more transmissible, we must
be ready for and mitigate a much more rapid transmission.
• Aggressive mitigation must be used to match a more aggressive virus, moving beyond what worked in the summer to more layered mitigation;
without uniform implementation of effective face masking (two or three ply and well-fitting) and strict physical distancing, epidemics could
quickly worsen as more transmissible variants spread and become predominant. Enhanced genotypic surveillance will help identify when and
where more transmissible viruses emerge, which could help galvanize communities to action.
• Messaging must be focused on proactive testing of those under 40 to prevent asymptomatic silent spread to their household members and on
a call to action for immediate testing and rapid infusion of monoclonal antibodies for those at risk for severe disease. Every hospital should
have outpatient infusion sites immediately available to save lives.
• Strongly recommend the creation of young adult testing sites with BinaxNOW to encourage rapid testing and, for those testing positive,
immediate isolation and aggressive protection of vulnerable household members.
• Do not delay the rapid immunization of those over 65 and vulnerable to severe disease; recommend creation of high throughput vaccination
sites with use of EMT personnel and nursing students to monitor for potential anaphylaxis. No vaccines should be in freezers but should instead
be put in arms now; active and aggressive immunization in the face of this surge would save lives.
• Careful planning, efficient implementation, and transparent messaging on the state's vaccination campaign are critical to maintaining public
confidence and maximizing vaccine acceptance. Multiple states have launched vaccine-specific dashboards with regular updating of the
number of individuals vaccinated to date, as well as vaccine-related information and messaging; these are a best practice. Given persistent
vaccine hesitancy, continued active encouragement by the Governor, health officials, and community influencers are needed.
• Given concerns about limited testing and a potential for a rebound in transmission, an expanded public health messaging campaign and
expanded surveillance are warranted.
• Public health messages should communicate concern about the possibility of a more transmissible virus and emphasize the need for universal
face-masking and social distancing as a way to reduce mortality among Wyomingites.
• Expansion of wastewater surveillance, weekly testing of at-risk individuals (regardless of symptoms) and genomic surveillance will help identify
areas to target resources, mitigation efforts and mid-range planning (e.g., hospital expansion plans); where the emergence of viral variants are
detected, mitigation should be more intense.
• Ensure that all hospitals have up-to-date treatment protocols that include appropriate use of convalescent plasma and immune-modulating
agents and that hospitals in areas that are projected to have an increase in cases have expansion plans and that nearby LTCFs in corresponding
service areas can be enhanced to serve as skilled nursing facilities to off-load chronic patients.
• Specific, detailed guidance on community mitigation measures can be found on the CDC website.

The purpose of this report is to develop a shared understanding of the current status of the pandemic at the national, regional, state and
local levels. We recognize that data at the state level may differ from that available at the federal level. Our objective is to use consistent
data sources and methods that allow for comparisons to be made across localities. We appreciate your continued support in identifying data COVID-19
discrepancies and improving data completeness and sharing across systems. We look forward to your feedback.
COVID-19 Issue 30

WYOMING
STATE REPORT | 01.10.2021

STATE, % CHANGE
STATE FROM PREVIOUS WEEK FEMA/HHS REGION UNITED STATES

NEW COVID-19 CASES 2,238 53,886 1,744,828


+28%
(RATE PER 100,000) (387) (440) (532)

VIRAL (RT-PCR) LAB


TEST POSITIVITY RATE
6.1% +0.2%* 12.5% 14.3%

TOTAL VIRAL (RT-PCR) LAB TESTS 19,785** 417,166** 9,104,878**


+0%**
(TESTS PER 100,000) (3,419**) (3,403**) (2,774**)

COVID-19 DEATHS 51 629 21,090


-22%
(RATE PER 100,000) (8.8) (5.1) (6.4)

SNFs WITH ≥1 NEW RESIDENT


COVID-19 CASE
23% N/A*† 22% 29%

SNFs WITH ≥1 NEW STAFF


COVID-19 CASE
45% N/A*† 40% 49%

SNFs WITH ≥1 NEW RESIDENT


COVID-19 DEATH
19% N/A*† 13% 16%

TOTAL NEW COVID-19 HOSPITAL 233 -10% 3,364 165,234


ADMISSIONS (RATE PER 100 BEDS) (16) (-11%) (14) (23)

NUMBER OF HOSPITALS WITH 10 +0% 70 1,086


SUPPLY SHORTAGES (PERCENT) (36%) (+0%*) (21%) (21%)

NUMBER OF HOSPITALS WITH 4 -1% 41 1,177


STAFF SHORTAGES (PERCENT) (14%) (-20%*) (12%) (23%)

DOSES DISTRIBUTED 1ST DOSES ADMINISTERED


TOTAL RATE PER 100,000 TOTAL PERCENT OF ADULTS
COVID-19 VACCINE SUMMARY
41,375 7,148 10,791 2.4%

* Indicates absolute change in percentage points.


** Due to delayed reporting, this figure may underestimate total diagnostic tests and week-on-week changes in diagnostic tests.
† Skilled nursing facility data entry is experiencing a data submission lag. Therefore, the most current week's data should not be compared to previous
data. 84% of facilities reported during the most current week.
DATA SOURCES – Additional data details available under METHODS
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021; previous week is 12/26 - 1/1.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021. Previous week is 12/24 - 12/30.
SNFs: Skilled nursing facilities. National Healthcare Safety Network. Data is through 1/3/2020, previous week is 12/21-12/27.
Admissions: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
Shortages: Unified hospital dataset in HHS Protect. Values presented show the latest reports from hospitals in the week ending 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.
COVID-19 Issue 30

WYOMING
STATE REPORT | 01.10.2021
NEW CASES
TESTING
TOP COUNTIES

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: CELR (COVID-19 Electronic Lab Reporting) state health department-reported data through 1/6/2021.
COVID-19 Issue 30

WYOMING
STATE REPORT | 01.10.2021

28 hospitals are expected to report in Wyoming


HOSPITAL ADMISSIONS
HOSPITAL PPE SUPPLIES

DATA SOURCES – Additional data details available under METHODS


Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-
medical hospitals. Hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded
from the percent reporting figure.
PPE: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals.
Values presented show the latest reports from hospitals in the week ending 1/6/2021.
COVID-19 Issue 30

WYOMING
STATE REPORT | 01.10.2021
COVID-19 COUNTY AND METRO ALERTS*
Top 12 shown in table (full lists below)

METRO AREA (CBSA) COUNTIES


Sweetwater
Teton
Uinta
LOCALITIES
4 13
Sheridan
Rock Springs Albany
IN RED Evanston Big Horn
ZONE Sheridan
Laramie
Lincoln
Johnson
▼ (-1) ▲ (+1) Goshen
Converse
Platte
Hot Springs

LOCALITIES
IN ORANGE
ZONE
1 Jackson 1 Washakie

▼ (-1) ▼ (-3)

LOCALITIES
4 6
Laramie
Cheyenne Natrona
IN YELLOW Casper Park
ZONE Gillette
Riverton
Campbell
Fremont
▲ (+3) ▲ (+4) Carbon

Change from previous week’s alerts: ▲ Increase ■ Stable ▼ Decrease

All Red Counties: Sweetwater, Teton, Uinta, Sheridan, Albany, Big Horn, Lincoln, Johnson, Goshen, Converse,
Platte, Hot Springs, Sublette

* Localities with fewer than 10 cases last week have been excluded from these alerts.
Note: Lists of red, orange, and yellow localities are sorted by the number of new cases in the last 3 weeks, from highest to lowest. Some dates may have
incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
DATA SOURCES – Additional data details available under METHODS
Cases and Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs) through
1/6/2021.
COVID-19 Issue 30

Top 12 counties based on number of new cases in the


last 3 weeks
TOTAL DAILY CASES

DATA SOURCES – Additional data details available under METHODS


Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. Last 3 weeks is 12/19 - 1/8.
COVID-19 Issue 30

WYOMING
STATE REPORT | 01.10.2021

CASE RATES AND VIRAL LAB TEST POSITIVITY

NEW CASES PER 100,000 VIRAL (RT-PCR) LABORATORY TEST


POSITIVITY

NEW CASES PER 100,000 ONE VIRAL (RT-PCR) LABORATORY TEST


MONTH BEFORE POSITIVITY ONE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Testing: HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs) through
1/6/2021; week one month before is 12/3 - 12/9.
COVID-19 Issue 30

WYOMING
STATE REPORT | 01.10.2021

HOSPITAL ADMISSIONS AND DEATH RATES

TOTAL NEW COVID-19 ADMISSIONS NEW DEATHS PER 100,000


PER 100 INPATIENT BEDS

TOTAL NEW COVID-19 ADMISSIONS PER 100 NEW DEATHS PER 100,000 ONE
INPATIENT BEDS ONE MONTH BEFORE MONTH BEFORE

DATA SOURCES – Additional data details available under METHODS


Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments; therefore,
the values may not match those reported directly by the state. Data is through 1/8/2021. The week one month before is 12/5 - 12/11.
Hospitalizations: Unified hospitalization dataset in HHS Protect. Totals include confirmed and suspected COVID-19 admissions.
COVID-19 Issue 30

National Picture
NATIONAL
RANKING OF
NEW CASES
PER 100,000
NEW CASES PER 100,000
National
Rank State
1 RI
2 AZ
3 TN
4 OK
5 UT
6 CA
7 KY
8 MA
9 AR
10 NC
11 FL
12 SC
13 CT
14 LA
15 WV
16 GA
17 DE
18 TX
19 NY
20 NV
21 OH
22 IN
23 MS
24 KS
25 NJ
26 AL
27 NH
28 NM
29 PA
30 IL
31 ID
32 VA
33 WY
34 SD
35 WI
36 MT
37 IA
38 MO
COVID-19 VACCINE SUMMARY 39 AK
40 NE
TOTAL DOSES DISTRIBUTED TOTAL 1ST DOSES ADMINISTERED 41 CO
42 MD
(RATE PER 100,000) (PERCENT OF ADULTS) 43 MI
44 MN
22,137,350 6,688,231 45 WA
46 ME
(6,667) (2.5%*) 47 DC
48 ND
49 VT
50 OR
51 HI

DATA SOURCES
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health departments;
therefore, the values may not match those reported directly by the state. Data is through 1/8/2021.
Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of
16:56 EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older. * Excludes territories
and federal entities since adult population is not available for these.
COVID-19

National Picture
NEW CASES PER 100,000 IN THE WEEK:

ONE MONTH BEFORE TWO MONTHS BEFORE

THREE MONTHS BEFORE FOUR MONTHS BEFORE

FIVE MONTHS BEFORE SIX MONTHS BEFORE

DATA SOURCES
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week
changes.
Cases: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. The week one month before is 12/5 - 12/11; the
week two months before is 11/7 - 11/13; the week three months before is 10/10 - 10/16; the week four months before is 9/12 - 9/18; the
week five months before is 8/15 - 8/21; the week six months before is 7/18 - 7/24.
COVID-19 Issue 30

National Picture
VIRAL (RT-PCR) LAB TEST POSITIVITY NATIONAL RANKING OF TEST
POSITIVITY
National National
Rank State Rank State
1 OK 27 LA
2 UT 28 MT
3 NV 29 CT
4 VA 30 NJ
5 AZ 31 NM
6 ID 32 SD
7 TN 33 WI
8 GA 34 IL
9 SC 35 NY
10 AL 36 DE
11 TX 37 MD
12 NE 38 WA
13 MO 39 MI
14 CA 40 OR
15 IN 41 MA
16 MS 42 RI
17 KY 43 CO
18 KS 44 MN
19 NC 45 ME
20 NH 46 WY
21 OH 47 DC
22 AR 48 AK
23 IA 49 VT
24 WV 50 ND
25 PA 51 HI
26 FL

VIRAL (RT-PCR) LAB TEST POSITIVITY IN THE WEEK:

ONE MONTH BEFORE TWO MONTHS BEFORE THREE MONTHS BEFORE

DATA SOURCES
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week
changes.
Testing: Combination of CELR (COVID-19 Electronic Lab Reporting) state health department-reported data and HHS Protect laboratory
data (provided directly to Federal Government from public health labs, hospital labs, and commercial labs) through 1/6/2021. The week
one month before is 12/3 - 12/9; the week two months before is 11/5 - 11/11; the week three months before is 10/8 - 10/14.
COVID-19 Issue No.

National Picture
TOTAL NEW COVID-19 ADMISSIONS PER 100 INPATIENT BEDS NATIONAL RANKING OF
ADMISSIONS PER 100 BEDS
National National
Rank State Rank State
1 AZ 27 WI
2 AR 28 MA
3 MD 29 MS
4 GA 30 KS
5 OK 31 NV
6 CA 32 OR
7 SC 33 MT
8 KY 34 NH
9 DC 35 WY
10 AL 36 UT
11 TX 37 LA
12 PA 38 MI
13 VA 39 CO
14 NM 40 NE
15 OH 41 ID
16 NC 42 WA
17 IN 43 MN
18 MO 44 ME
19 DE 45 SD
20 NJ 46 ND
21 TN 47 VT
22 FL 48 RI
23 WV 49 IA
24 IL 50 HI
25 CT 51 AK
26 NY

TOTAL NEW COVID-19 ADMISSIONS PER 100 INPATIENT BEDS IN THE WEEK:

ONE MONTH BEFORE TWO MONTHS BEFORE THREE MONTHS BEFORE

DATA SOURCES
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week
changes.
Admissions: Unified hospitalization dataset in HHS Protect through 1/8/2021. Totals include confirmed and suspected COVID-19
admissions. The week one month before is 12/5 - 12/11; the week two months before is 11/7 - 11/13; the week three months before is
10/10 - 10/16.
COVID-19 Issue 30

National Picture
NEW DEATHS PER 100,000 NATIONAL RANKING OF NEW
DEATHS PER 100,000
National National
Rank State Rank State
1 RI 27 ND
2 AZ 28 TX
3 WV 29 NC
4 TN 30 ME
5 NM 31 MN
6 PA 32 OK
7 MS 33 NE
8 KS 34 KY
9 CT 35 OH
10 MI 36 ID
11 IL 37 WI
12 WY 38 FL
13 AR 39 CO
14 MT 40 MD
15 MA 41 SC
16 NV 42 UT
17 IN 43 GA
18 SD 44 VT
19 LA 45 WA
20 CA 46 DC
21 IA 47 DE
22 MO 48 VA
23 NJ 49 AK
24 AL 50 OR
25 NH 51 HI
26 NY

NEW DEATHS PER 100,000 IN THE WEEK:

ONE MONTH BEFORE TWO MONTHS BEFORE THREE MONTHS BEFORE

DATA SOURCES
Note: Some dates may have incomplete data due to delays in reporting. Data may be backfilled over time, resulting in week-to-week
changes.
Deaths: State values are calculated by aggregating county-level data from a CDC-managed dataset compiled from state and local health
departments; therefore, the values may not match those reported directly by the state. The week one month before is 12/5 - 12/11; the
week two months before is 11/7 - 11/13; the week three months before is 10/10 - 10/16.
COVID-19 Issue 30

METHODS
STATE REPORT | 01.10.2021
Dark Light Light Darkest
Metric Yellow Orange Red Dark Red
Green Green Red Red
New cases per 100,000 population
≤4 5–9 10 – 50 51 – 100 101 – 199 200 – 499 500 – 749 ≥750
per week
Percent change in new cases per
≤-26% -25% – -11% -10% – 0% 1% – 10% 11% – 99% 100% – 999% ≥1000%
100,000 population
Diagnostic test result positivity rate 10.1% – 15.1% – 20.1% –
≤2.9% 3.0% – 4.9% 5.0% – 7.9% 8.0% – 10.0% ≥25.1%
15.0% 20.0% 25.0%
Change in test positivity ≤-2.1% -2.0% – -0.6% -0.5% – 0.0% 0.1% – 0.5% 0.6% – 2.0% ≥2.1%
Total diagnostic tests resulted per
≥5000 3001 – 4999 2000 – 2999 1000 – 1999 500 – 999 ≤499
100,000 population per week
Percent change in tests per 100,000
≥26% 11% – 25% 1% – 10% -10% – 0% -25% – -11% ≤-26%
population
COVID-19 deaths per 100,000
0.0 0.1 – 1.0 1.1 – 2.0 2.1 – 5.0 5.1 – 10.0 10.1 – 15.0 ≥15.1
population per week
Percent change in deaths per
≤-26% -25% – -11% -10% – 0% 1% – 10% 11% – 25% ≥26%
100,000 population
Skilled Nursing Facilities with at least
0% 1% – 5% ≥6%
one resident COVID-19 case, death
Change in SNFs with at least one
≤-2% -1% – 1% ≥2%
resident COVID-19 case, death
Total new COVID-19 hospital
≤2 3–5 6 – 10 11 – 15 16 – 20 21 – 25 ≥26
admissions per 100 beds
Change in total new COVID-19
≤-26% -25% – -11% -10% – 0% 1% – 10% 11% – 25% ≥26%
hospital admissions per 100 beds
Percent of hospitals with supply/staff
≤0% 1% – 9% 10% – 19% 20% – 24% 25% – 29% ≥30%
shortages
Change in percent of hospitals with
≤-10% -9% – -5% -4% – 0% 1% – 4% 5% – 9% ≥10%
supply/staff shortages
• Some dates may have incomplete data due to delays and/or differences in state reporting. Data may be backfilled over time, resulting in week-to-week changes.
It is critical that states provide as up-to-date data as possible. Figures and values may also differ from state reports due to differing methodologies.
• Color threshold values are rounded before color classification.
• Cases and Deaths: County-level data from CDC managed aggregate county dataset as of 17:26 EST on 01/10/2021. State values are calculated by aggregating
county-level data. Data are reviewed on a daily basis against internal and verified external sources and, if needed, adjusted.
• Testing: The data presented represent viral COVID-19 laboratory diagnostic and screening test (reverse transcription polymerase chain reaction, RT-PCR)
results—not individual people—and exclude antibody and antigen tests, unless stated otherwise. CELR (COVID-19 Electronic Lab Reporting) state health
department-reported data are used to describe county-level viral COVID-19 RT-PCR result totals when information is available on patients’ county of residence or
healthcare providers’ practice location. HHS Protect laboratory data (provided directly to Federal Government from public health labs, hospital labs, and
commercial labs) are used otherwise. Because the data are deidentified, total RT-PCR tests are the number of tests performed, not the number of individuals
tested. RT-PCR test positivity rate is the number of positive tests divided by the number of tests performed and resulted. Last week data are from 12/31 to 1/6;
previous week data are from 12/24 to 12/30; the week one month before data are from 12/3 to 12/9. HHS Protect data is recent as of 16:57 EST on 01/10/2021.
Testing data are inclusive of everything received and processed by the CELR system as of 19:00 EST on 01/09/2021.
• Hospitalizations: Unified hospitalization dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals. In addition,
hospitals explicitly identified by states/regions as those from which we should not expect reports were excluded from the percent reporting figure. The data
presented represents raw data provided; we are working diligently with state liaisons to improve reporting consistency. Data is recent as of 17:02 EST on
01/10/2021.
• Hospital PPE: Unified hospitalization dataset in HHS Protect. This figure may differ from state data due to differences in hospital lists and reporting between
federal and state systems. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals. Hospitals explicitly identified by states/regions as
those from which we should not expect reports were excluded from the percent reporting figure. Data is recent as of 18:25 EST on 01/10/2021.
• Skilled Nursing Facilities: National Healthcare Safety Network (NHSN). Data report resident and staff cases independently. Quality checks are performed on
data submitted to the NHSN. Data that fail these quality checks or appear inconsistent with surveillance protocols may be excluded from analyses. Data
presented in this report are more recent than data publicly posted by CMS. Last week is 12/28-1/3, previous week is 12/21-12/27.
• County and Metro Area Color Categorizations
• Red Zone: Those core-based statistical areas (CBSAs) and counties that during the last week reported both new cases at or above 101 per 100,000
population, and a lab test positivity result at or above 10.1%.
• Orange Zone: Those CBSAs and counties that during the last week reported both new cases between 51–100 per 100,000 population, and a lab test
positivity result between 8.0–10.0%, or one of those two conditions and one condition qualifying as being in the “Red Zone.”
• Yellow Zone: Those CBSAs and counties that during the last week reported both new cases between 10–50 per 100,000 population, and a lab test
positivity result between 5.0–7.9%, or one of those two conditions and one condition qualifying as being in the “Orange Zone” or “Red Zone.”
• Shortages: Unified hospital dataset in HHS Protect. These data exclude psychiatric, rehabilitation, and religious non-medical hospitals. Includes hospitals
reporting a staffing shortage currently or projected within one week. Low supply is defined as a hospital reporting 0 or 1-3 days’ supply, not able to obtain, or not
able to maintain a 3-day supply of N95s, face masks, gloves, gowns, or eye protection. Data is recent as of 18:25 EST on 01/10/2021.
• Vaccinations: CDC COVID Data Tracker. Data includes both the Moderna and Pfizer BioNTech COVID-19 vaccines and reflects current data available as of 16:56
EST on 01/10/2021. Data last updated 09:00 EST on 01/08/2021. Adults is defined as the population 18 years old and older.

Вам также может понравиться